Study;Theme
COVID-19 outbreak at a large homeless shelter in Boston: Implications for universal testing;Management of patients who are underhoused or otherwise lower social economic status.
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science;Management of patients who are underhoused or otherwise lower social economic status.
U.S. county-level characteristics to inform equitable COVID-19 response;Management of patients who are underhoused or otherwise lower social economic status.
Epidemiology of COVID-19 among people experiencing homelessness: Early evidence from Boston;Management of patients who are underhoused or otherwise lower social economic status.
The Challenge of Preventing COVID-19 Spread in Correctional Facilities;Management of patients who are underhoused or otherwise lower social economic status.
Mitigating and learning from the impact of COVID-19 infection on addictive disorders;Management of patients who are underhoused or otherwise lower social economic status.
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness;Management of patients who are underhoused or otherwise lower social economic status.
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons;Management of patients who are underhoused or otherwise lower social economic status.
Fighting covid-19 outbreaks in prisons;Management of patients who are underhoused or otherwise lower social economic status.
Addressing the Threat of COVID-19-Related Housing Instability and Displacement in Delaware;Management of patients who are underhoused or otherwise lower social economic status.
"Estimated Emergency and Observational/ Quarantine Capacity Need for the US Homeless Population Related to COVID-19 Exposure by County; Projected Hospitalizations, Intensive Care Units and Mortality";Management of patients who are underhoused or otherwise lower social economic status.
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically;Management of patients who are underhoused or otherwise lower social economic status.
Efforts escalate to protect homeless people from COVID-19 in UK;Management of patients who are underhoused or otherwise lower social economic status.
Covid-19: control measures must be equitable and inclusive;Management of patients who are underhoused or otherwise lower social economic status.
Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid’s Response to COVID-19;Management of patients who are underhoused or otherwise lower social economic status.
Prisons and custodial settings are part of a comprehensive response to COVID-19;Management of patients who are underhoused or otherwise lower social economic status.
The Coronavirus Could Hit People Experiencing Homelessness Hard;Management of patients who are underhoused or otherwise lower social economic status.
COVID-19: a potential public health problem for homeless populations;Management of patients who are underhoused or otherwise lower social economic status.
Flattening the Curve by Getting Ahead of It: How the VA Healthcare System Is Leveraging Telehealth to Provide Continued Access to Care for Rural Veterans.;Measures to reach marginalized and disadvantaged populations.
Compounding Health Risks and Increased Vulnerability to SARS-CoV-2 for Racial and Ethnic Minorities and Low Socioeconomic Status Individuals in the United States;Measures to reach marginalized and disadvantaged populations.
Mental Health Services in Lombardy during COVID-19 outbreak.;Measures to reach marginalized and disadvantaged populations.
Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery.;Measures to reach marginalized and disadvantaged populations.
Telemedicine in the Time of Coronavirus;Measures to reach marginalized and disadvantaged populations.
Feeding Low-Income Children during the Covid-19 Pandemic;Measures to reach marginalized and disadvantaged populations.
Use of a Real-Time Locating System for Contact Tracing of Health Care Workers During the COVID-19 Pandemic at an Infectious Disease Center in Singapore: Validation Study;Methods to control the spread in communities.
Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate;Methods to control the spread in communities.
Early Transmission Dynamics of COVID-19 in a Southern Hemisphere Setting: Lima-Peru: February 29th-March 30th, 2020;Methods to control the spread in communities.
Coping With Diabetes During the COVID - 19 Lockdown in India: Results of an Online Pilot Survey;Methods to control the spread in communities.
To Mask or Not to Mask Children to Overcome COVID-19;Methods to control the spread in communities.
Criminal Justice-Involved Women Navigate COVID-19: Notes From the Field.;Methods to control the spread in communities.
COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020.;Methods to control the spread in communities.
Quantifying the Impact of Physical Distance Measures on the Transmission of COVID-19 in the UK;Methods to control the spread in communities.
Modeling Behavioral Change and COVID-19 Containment in Mexico: A Trade-Off Between Lockdown and Compliance;Methods to control the spread in communities.
Mathematical Assessment of the Impact of Non-Pharmaceutical Interventions on Curtailing the 2019 Novel Coronavirus;Methods to control the spread in communities.
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak;Methods to control the spread in communities.
Disability, Urban Health Equity, and the Coronavirus Pandemic: Promoting Cities for All.;Methods to control the spread in communities.
The Role of Community-Wide Wearing of Face Mask for Control of Coronavirus Disease 2019 (COVID-19) Epidemic Due to SARS-CoV-2;Methods to control the spread in communities.
Inter Nation Social Lockdown Versus Medical Care Against COVID-19, a Mild Environmental Insight With Special Reference to India;Methods to control the spread in communities.
To Mask or Not to Mask: Modeling the Potential for Face Mask Use by the General Public to Curtail the COVID-19 Pandemic;Methods to control the spread in communities.
Preparedness, prevention and control of coronavirus disease (COVID-19) for refugees and migrants in non-camp settings;Methods to control the spread in communities.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Methods to control the spread in communities.
COVID-19 Preparedness in Michigan Nursing Homes.;Methods to control the spread in communities.
Special Article: Risk Communication During COVID-19;Methods to control the spread in communities.
Public perceptions and experiences of social distancing and social isolation during the COVID-19 pandemic: A UK-based focus group study;Methods to control the spread in communities.
Self-reported compliance and attitudes about social distancing during the COVID-19 outbreak;Methods to control the spread in communities.
Self-Isolation Compliance in the COVID-19 Era Influenced by Compensation: Findings From a Recent Survey In Israel;Methods to control the spread in communities.
Quarantine Alone or in Combination With Other Public Health Measures to Control COVID-19: A Rapid Review;Methods to control the spread in communities.
Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review;Methods to control the spread in communities.
Political Beliefs affect Compliance with COVID-19 Social Distancing Orders;Methods to control the spread in communities.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Methods to control the spread in communities.
Functional Fear Predicts PublicHelath Compliance in the COVID-19 Pandemic;Methods to control the spread in communities.
The effectiveness of moral messages on public health behavioral intentions during the COVID-19 pandemic;Methods to control the spread in communities.
Age-structured impact of social distancing on the COVID-19 epidemic in India;Methods to control the spread in communities.
Community pharmacists and communication in the time of COVID-19: Applying the health belief model;Methods to control the spread in communities.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study;Methods to control the spread in communities.
Getting your workplace ready for COVID-19;Methods to control the spread in communities.
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;Methods to control the spread in communities.
Emojis in public health and how they might be used for hand hygiene and infection prevention and control;Methods to control the spread in communities.
Assessment of COVID-19 Knowledge Among University Students: Implications for Future Risk Communication Strategies;Modes of communicating with target high-risk populations.
Knowledge, Perceptions and Preventive Practices Towards COVID-19 Early in the Outbreak Among Jimma University Medical Center Visitors, Southwest Ethiopia;Modes of communicating with target high-risk populations.
Public Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Study in Malaysia;Modes of communicating with target high-risk populations.
The Value of Remote Monitoring for the COVID-19 Pandemic;Modes of communicating with target high-risk populations.
Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.;Modes of communicating with target high-risk populations.
Going viral: how to boost the spread of coronavirus science on social media;Modes of communicating with target high-risk populations.
Access to Telemedicine-Are We Doing All That We Can during the COVID-19 Pandemic?;Modes of communicating with target high-risk populations.
Creation of Educational Videos for Patients Undergoing Nonelective Surgery: Tools for the COVID-19 Era.;Modes of communicating with target high-risk populations.
Bereavement support on the frontline of COVID-19: Recommendations for hospital clinicians.;Modes of communicating with target high-risk populations.
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic.;Modes of communicating with target high-risk populations.
Healthy communication in the promotion of healthy aging during COVID-19 pandemic;Modes of communicating with target high-risk populations.
Interdisciplinary Perspectives on Health Literacy Research Around the World: More Important Than Ever in a Time of COVID-19.;Modes of communicating with target high-risk populations.
Humanism in the Age of COVID-19: Renewing Focus on Communication and Compassion;Modes of communicating with target high-risk populations.
Information Overload: A Method to Share Updates among Frontline Staff during the COVID-19 Pandemic;Modes of communicating with target high-risk populations.
Secure Communication Conduits During COVID19 Lockdown;Modes of communicating with target high-risk populations.
Preparedness, prevention and control of coronavirus disease (COVID-19) for refugees and migrants in non-camp settings;Modes of communicating with target high-risk populations.
More effective strategies are required to strengthen public awareness of COVID-19: Evidence from Google Trends.;Modes of communicating with target high-risk populations.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Modes of communicating with target high-risk populations.
A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study;Modes of communicating with target high-risk populations.
Use of Handheld Transceiver for Hospital Healthcare Workers-Caregiver Communication During the Coronavirus disease 2019 (COVID-19) Outbreak in Pediatric Emergency Department;Modes of communicating with target high-risk populations.
The effective use of telemedicine to save lives and maintain structure in a healthcare system: Current response to COVID-19;Modes of communicating with target high-risk populations.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures;Modes of communicating with target high-risk populations.
Communication Skills in the Age of COVID-19;Modes of communicating with target high-risk populations.
"COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception";Modes of communicating with target high-risk populations.
Applying Palliative Care Principles to Communicate with Children about COVID-19;Modes of communicating with target high-risk populations.
Protecting the psychological health of children through effective communication about COVID-19;Modes of communicating with target high-risk populations.
COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes;Modes of communicating with target high-risk populations.
Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19);Modes of communicating with target high-risk populations.
Bearing the brunt of covid-19: older people in low and middle income countries;Modes of communicating with target high-risk populations.
WeChat, a Chinese social media, may early detect the SARS-CoV-2 outbreak in 2019;Modes of communicating with target high-risk populations.
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know;Modes of communicating with target high-risk populations.
Communication, transparency key as Canada faces new coronavirus threat;Modes of communicating with target high-risk populations.
Communication, collaboration and cooperation can stop the 2019 coronavirus;Modes of communicating with target high-risk populations.
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Application An expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians;What are recommendations for combating_overcoming resource failures_.
Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-10 Outbreak in Daegu, Korea;What are recommendations for combating_overcoming resource failures_.
N95 Mask Decontamination using Standard Hospital Sterilization Technologies;What are recommendations for combating_overcoming resource failures_.
Can N95 respirators be reused after disinfection? And for how many times?;What are recommendations for combating_overcoming resource failures_.
Where to buy face masks? Survey of applications using Taiwan's open data in the time of COVID-19;What are recommendations for combating_overcoming resource failures_.
Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.;What are recommendations for combating_overcoming resource failures_.
When Resources Are Scarce - Feasibility of Emergency Ventilation of Two Patients With One Ventilator;What are recommendations for combating_overcoming resource failures_.
FFP-2 respirator masks in times of crisis;What are recommendations for combating_overcoming resource failures_.
Modifying reusable elastomeric respirators to utilise breathing system filters with 3D printed adapters, a safe alternative to N95 during COVID-19;What are recommendations for combating_overcoming resource failures_.
Separate Fever Clinics Prevent the Spread of COVID-19 and Offload Emergency Resources: Analysis from a large tertiary hospital in China;What are recommendations for combating_overcoming resource failures_.
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the Covid-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
The Importance of Minimum Dosage Necessary for UVC Decontamination of N95 Respirators during the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States;What are recommendations for combating_overcoming resource failures_.
Concise Communication: COVID-19 and the N95 Respirator Shortage: Closing the Gap;What are recommendations for combating_overcoming resource failures_.
Hospital Emergency Management Plan During the COVID‐19 Epidemic;What are recommendations for combating_overcoming resource failures_.
Use of a Single Ventilator to Support Multiple Patients: Modeling Tidal Volume Response to Heterogeneous Lung Mechanics;What are recommendations for combating_overcoming resource failures_.
Alternative Qualitative  Fit Testing Method for N95 Equivalent Respirators in the Setting of Resource Scarcity at the George Washington University;What are recommendations for combating_overcoming resource failures_.
Management of Ovarian cancer during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Nonmedical Masks in Public for Respiratory Pandemics: Droplet Retention by Two-Layer Textile Barrier Fully Protects Germ-free Mice from Bacteria in Droplets;What are recommendations for combating_overcoming resource failures_.
Coping with COID-19: ventilator splitting with differential driving pressures using standard hospital equipment;What are recommendations for combating_overcoming resource failures_.
Possible consequences of a shortage of hydroxychloroquine for Lupus patients amid the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
A Simulated Single Ventilator / Dual Patient Ventilation Strategy for Acute Respiratory Distress Syndrome During the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.;What are recommendations for combating_overcoming resource failures_.
Calculated decisions: COVID-19 calculators during extreme resource-limited situations.;What are recommendations for combating_overcoming resource failures_.
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multi level risks;What are recommendations for combating_overcoming resource failures_.
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations;What are recommendations for combating_overcoming resource failures_.
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process;What are recommendations for combating_overcoming resource failures_.
Opinion to address a potential personal protective equipment shortage in the global community during the COVID-19 outbreak;What are recommendations for combating_overcoming resource failures_.
Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy;What are recommendations for combating_overcoming resource failures_.
Echo in Pandemic: Front Line Perspective, Expanding Role of Ultrasound and Ethics of Resource Allocation;What are recommendations for combating_overcoming resource failures_.
Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures;What are recommendations for combating_overcoming resource failures_.
Medication Shortages During the COVID-19 Crisis: What We Must Do;What are recommendations for combating_overcoming resource failures_.
Rural Healthcare Center Preparation and Readiness Response to Threat of COVID-19;What are recommendations for combating_overcoming resource failures_.
Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review;What are recommendations for combating_overcoming resource failures_.
Care of Patients with Liver disease during the COVID-19 pandemic: EASL-ESCMID position paper;What are recommendations for combating_overcoming resource failures_.
Fangcang shelter hospitals: a novel concept for responding to public health emergencies;What are recommendations for combating_overcoming resource failures_.
Emerging infectious diseases and outbreaks: implications for women’s reproductive health and rights in resource-poor settings;What are recommendations for combating_overcoming resource failures_.
Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Demand for hospitalization services for COVID-19 patients in Brazil;What are recommendations for combating_overcoming resource failures_.
The Essential Role of Patient Blood Management in a Pandemic: A Call for Action;What are recommendations for combating_overcoming resource failures_.
Creating a Palliative Care Inpatient Response Plan for COVID19- The UW Medicine Experience;What are recommendations for combating_overcoming resource failures_.
Caring for children and adolescents with eating disorders in the current COVID-19 Pandemic: A Singapore perspective;What are recommendations for combating_overcoming resource failures_.
Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.;What are recommendations for combating_overcoming resource failures_.
Individualized System for Augmenting Ventilator Efficacy (iSAVE): A Rapidly deployable system to expand ventilator capacity;What are recommendations for combating_overcoming resource failures_.
Response and Operating Room Preparation for the COVID-19 Outbreak: A Perspective From the National Heart Centre in Singapore;What are recommendations for combating_overcoming resource failures_.
What Should Palliative Care’s Response Be to the COVID-19 Pandemic?;What are recommendations for combating_overcoming resource failures_.
Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse;What are recommendations for combating_overcoming resource failures_.
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment from a Comprehensive Cancer Center in the United States;What are recommendations for combating_overcoming resource failures_.
Challenges for NHS hospitals during covid-19 epidemic;What are recommendations for combating_overcoming resource failures_.
Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19);What are recommendations for combating_overcoming resource failures_.
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China;What are recommendations for combating_overcoming resource failures_.
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform;What are recommendations for combating_overcoming resource failures_.
Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta‐analysis;What are recommendations for combating_overcoming resource failures_.
Adoption of COVID-19 triage strategies for low-income settings;What are recommendations for combating_overcoming resource failures_.
The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities;What are recommendations for combating_overcoming resource failures_.
Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2;What are recommendations for combating_overcoming resource failures_.
Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19);What are recommendations for combating_overcoming resource failures_.
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China;What are recommendations for combating_overcoming resource failures_.
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation;What are recommendations for combating_overcoming resource failures_.
Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China;What are recommendations for combating_overcoming resource failures_.
Infection Prevention and Control Compliance in Tanzanian Outpatient Facilities: A Cross-Sectional Study With Implications for the Control of COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Absence of Nosocomial Transmission of Coronavirus Disease 2019 (COVID-19) Due to SARS-CoV-2 in the Pre-Pandemic Phase in Hong Kong;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Safe and Effective Management of Tracheostomy in COVID-19 Patients;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Personal Protective Equipment for Preventing Highly Infectious Diseases Due to Exposure to Contaminated Body Fluids in Healthcare Staff;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Precautions and Recommendations for Orthodontic Settings During the COVID-19 Outbreak: A Review;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Elective Tracheostomy During Mechanical Ventilation in Patients Affected by COVID-19: Preliminary Case Series From Lombardy, Italy;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Cancer Treatment During the Coronavirus Disease 2019 Pandemic: Do Not Postpone, Do It!;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Quantifying the Improvement in Confirmation Efficiency of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During the Early Phase of the Outbreak in Hong Kong in 2020;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: the experience of a tertiary hospital in Singapore.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Repurposing and reshaping of hospitals during the COVID-19 outbreak in South Korea.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19, superinfections and antimicrobial development: What can we expect?;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Environmental Contamination of SARS-CoV-2 in Healthcare Premises.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Rapid Implementation of an Adult COVID-19 Unit in a Children's Hospital.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Limiting the Risks for Eye Care Professionals.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2);What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The prevention and management of the coronavirus disease 2019 (COVID-19) outbreak in radiology departments in epidemic areas.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Can N95 respirators be reused after disinfection? And for how many times?;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Nosocomial infections in psychiatric hospitals during the new coronavirus pneumonia (NCP) outbreak.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
How to avoid nosocomial spread during Tracheostomy for Covid-19 patients.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
How to transform a general hospital into an “infectious disease hospital” during the epidemic of COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Nosocomial infection among patients with coronavirus disease-2019: a retrospective data analysis of 918 cases from a single center in Wuhan city, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Assessment of preparedness against emerging infectious disease among private hospitals in a district of South India;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Application of refined management in prevention and control of the coronavirus disease 2019 epidemic in non-isolated areas of a general hospital;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Guidelines for dental care provision during the COVID-19 pandemic;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A model to forecast regional demand for COVID-19 related hospital beds;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Separate Fever Clinics Prevent the Spread of COVID-19 and Offload Emergency Resources: Analysis from a large tertiary hospital in China;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Fangcang shelter hospitals: a novel concept for responding to public health emergencies;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Practitioners specialized in oral health and coronavirus disease 2019: Professional guidelines from the French society of stomatology, maxillofacial surgery and oral surgery, to form a common front against the infectious risk.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Radiotherapy Workflow and Protection Procedures During the Coronavirus Disease 2019 (COVID-19) Outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19);What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
RESOURCES FOR SMOKE & GAS EVACUATION DURING OPEN, LAPAROSCOPIC, AND ENDOSCOPIC PROCEDURES;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Screening and managing of suspected or confirmed novel coronavirus (COVID-19) patients: experiences from a tertiary hospital outside Hubei province;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Forecasting short term hospital needs in France;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19 outbreak: less stethoscope, more ultrasound;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The prevention of nosocomial SARS-CoV2 transmission in endoscopy: a systematic review of recommendations within gastroenterology to identify best practice.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A high efficient hospital emergency responsive mode is the key of successful treatment of 100 COVID-19 patients in Zhuhai;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Recommendations for Management of Elective Surgical Procedures;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Guidance for health system contingency planning during widespread transmission of SARS-CoV-2 with high impact on healthcare services;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Hospital biopreparedness in the Looming Presence of SARS‐CoV‐2/COVID‐19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Practical experiences and suggestions for the ‘eagle-eyed observer’: a novel promising role for controlling nosocomial infection in the COVID-19 outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staff Protection during the Coronavirus Disease 2019 Outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Healthcare Facilities: Preparing for Community Transmission / Interim Guidance for Healthcare Facilities: Preparing for Community Transmission of COVID-19 in the United States;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Staff safety during emergency airway management for COVID-19 in Hong Kong;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Reply to “Coronavirus 2019-nCoV: A brief perspective from the front line”: Nosocomial SARS-CoV-2 infection among nurses in Wuhan from a single center;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Protecting health-care workers from subclinical coronavirus infection;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Optimal policies for control of the novel coronavirus (COVID-19);Effectiveness of a multifactorial strategy to prevent secondary transmission.
A model for COVID-19 with isolation, quarantine and testing as control measures;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling and forecasting of the COVID-19 pandemic in India;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Now casting and Forecasting of COVID-19 outbreak in the National Capital Region of Delhi;Effectiveness of a multifactorial strategy to prevent secondary transmission.
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling serological testing to inform relaxation of social distancing for COVID-19 control;Effectiveness of a multifactorial strategy to prevent secondary transmission.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of Social Distancing Measures on COVID-19 Healthcare Demand in Central Texas;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Social interventions can lower COVID-19 deaths in middle-income countries;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Data Driven Modeling of Projected Mitigation and Suppressing Strategy Interventions for SARS-COV 2 in Ghana;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Estimating cost-benefit of quarantine length for COVID-19 mitigation;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Evidence Based Management Guideline for the COVID-19 Pandemic - Review article;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Sustainable social distancing through facemask use and testing during the Covid-19 pandemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
New measures for COVID-19 response: a lesson from the Wenzhou experience;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of a multifactorial strategy to prevent secondary transmission.
General Model for COVID-19 Spreading with Consideration of Intercity Migration, Insufficient Testing and Active Intervention: Application to Study of Pandemic Progression in Japan and USA;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study The Lancet Public Health;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A COVID-19 Epidemiological Model for Community and Policy Maker Use;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the epidemic dynamics and control of COVID-19 outbreak in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The impact of social distancing and epicenter lockdown on the COVID-19 epidemic in mainland China: A data-driven SEIQR model study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A simple model to assess Wuhan lock-down effect and region efforts during COVID-19 epidemic in China Mainland;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model medrxiv;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Spatially Explicit Modeling of 2019-nCoV Epidemic Trend based on Mobile Phone Data in Mainland China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Using epidemic simulators for monitoring an ongoing epidemic;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Contact tracing strategies for COVID-19 containment with attenuated physical distancing;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Now casting and Forecasting of COVID-19 outbreak in the National Capital Region of Delhi;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A stochastic epidemic model of COVID-19 disease;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Impact of virus testing on COVID-19 case fatality rate: estimate using a fixed-effects model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Institutional, not home-based, isolation could contain the COVID-19 outbreak;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management medrxiv;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A simulation of a COVID-19 epidemic based on a deterministic SEIR model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
How Reliable are Test Numbers for Revealing the COVID-19 Ground Truth and Applying Interventions?;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Data Driven Modeling of Projected Mitigation and Suppressing Strategy Interventions for SARS-COV 2 in Ghana;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Analysis of the COVID-19 epidemic in french overseas department Mayotte based on a modified deterministic and stochastic SEIR model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the transmission of new coronavirus in Sao Paulo State, Brazil -- Assessing epidemiological impacts of isolating young and elder persons;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Household Secondary Attack Rate of COVID-19 and Associated Determinants;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A hybrid multi-scale model of COVID-19 transmission dynamics to assess the potential of non-pharmaceutical interventions;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The Effectiveness of Targeted Quarantine for Minimising Impact of COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Different scenarios in the Dynamics of SARS-Cov-2 Infection: an adapted ODE model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 infection and recovery in various countries: Modeling the dynamics and evaluating the non-pharmaceutical mitigation scenarios;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A single holiday was the turning point of the COVID-19 policy of Israel;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Symptom-Based Isolation Policies: Evidence from a Mathematical Model of Outbreaks of Influenze and COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Scientific and ethical basis for social-distancing interventions against COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis medrxiv;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Short-term predictions and prevention strategies for COVID-2019: A model based study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Calibrated Intervention and Containment of the COVID-19 Pandemic;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the epidemic dynamics and control of COVID-19 outbreak in China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A Time Delay Dynamical Model for Outbreak of 2019-nCoV and the Parameter Identification;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability;Effectiveness of community contact reduction.
A model for COVID-19 with isolation, quarantine and testing as control measures;Effectiveness of community contact reduction.
Social Distancing is Effective at Mitigating COVID-19 Transmission in the United States;Effectiveness of community contact reduction.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of community contact reduction.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of community contact reduction.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of community contact reduction.
A stochastic epidemic model of COVID-19 disease;Effectiveness of community contact reduction.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of community contact reduction.
Investigating duration and intensity of Covid-19 social-distancing strategies;Effectiveness of community contact reduction.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of community contact reduction.
Modelling the potential impact of social distancing on the COVID-19 epidemic in South Africa;Effectiveness of community contact reduction.
Mathematical modeling of COVID-19 containment strategies with considerations for limited medical resources;Effectiveness of community contact reduction.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of community contact reduction.
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus;Effectiveness of community contact reduction.
The December 2019 New Corona Virus (SARS-CoV-2) Outbreak: A Behavioral Infectious Disease Policy Model;Effectiveness of community contact reduction.
Optimal Control applied to a SEIR model of 2019-nCoV with social distancing;Effectiveness of community contact reduction.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of community contact reduction.
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness;Effectiveness of community contact reduction.
Flattening the curve before it flattens us: hospital critical care capacity limits and mortality from novel coronavirus (SARS-CoV2) cases in US counties;Effectiveness of community contact reduction.
COVID-19 infection and recovery in various countries: Modeling the dynamics and evaluating the non-pharmaceutical mitigation scenarios;Effectiveness of community contact reduction.
The SARS-CoV-2 epidemic outbreak: a review of plausible scenarios of containment and mitigation for Mexico;Effectiveness of community contact reduction.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China;Effectiveness of community contact reduction.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of community contact reduction.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of community contact reduction.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan, China through status dynamic modeling;Effectiveness of community contact reduction.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of community contact reduction.
Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess;Effectiveness of community contact reduction.
Modeling and forecasting of the COVID-19 pandemic in India;Effectiveness of inter_inner travel restriction.
COVID-19 pandemic control: balancing detection policy and lockdown intervention under ICU sustainability;Effectiveness of inter_inner travel restriction.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of inter_inner travel restriction.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of inter_inner travel restriction.
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States;Effectiveness of inter_inner travel restriction.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of inter_inner travel restriction.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of inter_inner travel restriction.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management;Effectiveness of inter_inner travel restriction.
COVID-19 pandemic scenario in India compared to China and rest of the world: a data driven and model analysis medrxiv;Effectiveness of inter_inner travel restriction.
Lockdown, one, two, none, or smart. Modeling containing covid-19 infection. A conceptual model;Effectiveness of inter_inner travel restriction.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of inter_inner travel restriction.
The effect of inter-city travel restrictions on geographical spread of COVID-19: Evidence from Wuhan, China;Effectiveness of inter_inner travel restriction.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of inter_inner travel restriction.
Derivation of the effective reproduction number R for COVID-19 in relation to mobility restrictions and confinement;Effectiveness of inter_inner travel restriction.
Assessment of 21 Days Lockdown Effect in Some States and Overall India: A Predictive Mathematical Study on COVID-19 Outbreak;Effectiveness of inter_inner travel restriction.
Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US;Effectiveness of inter_inner travel restriction.
Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China;Effectiveness of inter_inner travel restriction.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan, China through status dynamic modeling;Effectiveness of inter_inner travel restriction.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of inter_inner travel restriction.
Lessons learnt from 288 COVID-19 international cases: importations over time, effect of interventions, underdetection of imported cases;Effectiveness of inter_inner travel restriction.
Estimation of the epidemic properties of the 2019 novel coronavirus: A mathematical modeling study;Effectiveness of inter_inner travel restriction.
Estimating the Efficacy of Traffic Blockage and Quarantine for the Epidemic Caused by 2019-nCoV (COVID-19);Effectiveness of inter_inner travel restriction.
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19);Effectiveness of inter_inner travel restriction.
The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated;Effectiveness of inter_inner travel restriction.
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of school distancing.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of school distancing.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis medrxiv;Effectiveness of school distancing.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of school distancing.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of school distancing.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of school distancing.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of school distancing.
Can the COVID-19 epidemic be controlled on the basis of daily test reports?;Effectiveness of school distancing.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of workplace distancing to prevent secondary transmission.
Estimating cost-benefit of quarantine length for COVID-19 mitigation;Effectiveness of workplace distancing to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of workplace distancing to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of workplace distancing to prevent secondary transmission.
SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19;Effectiveness of workplace distancing to prevent secondary transmission.
Spatially Explicit Modeling of 2019-nCoV Epidemic Trend based on Mobile Phone Data in Mainland China;Effectiveness of workplace distancing to prevent secondary transmission.
Is COVID-19 the first pandemic that evolves into a panzootic?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
A rapid review of evidence of infection of pets and livestock with human-associated coronavirus diseases, SARS, MERS, and COVID-19, and evidence of the fomite potential of pets and livestock;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Serological survey of SARS‐CoV‐2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
An Overview of SARS‐CoV‐2 and Animal Infection;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
COVID-19 and pets: When pandemic meets panic;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Can companion animals become infected with Covid-19?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-3;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-4;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-5;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-6;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-7;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Coronavirus Disease 2019 (COVID-19) Outbreak: Could Pigs Be Vectors for Human Infections?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Containing the Spread of Coronavirus Disease 2019 (COVID-19): Meteorological Factors and Control Strategies;How does temperature and humidity affect the transmission of 2019-nCoV_.
COVID-19: Effects of weather conditions on the propagation of respiratory droplets;How does temperature and humidity affect the transmission of 2019-nCoV_.
The Modest Impact of Weather and Air Pollution on COVID-19 Transmission;How does temperature and humidity affect the transmission of 2019-nCoV_.
Higher Temperature, Pressure, and Ultraviolet Are Associated with Less COVID-19 Prevalence: Meta-Regression of Japanese Prefectural Data;How does temperature and humidity affect the transmission of 2019-nCoV_.
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2;How does temperature and humidity affect the transmission of 2019-nCoV_.
The effect of ambient temperature on worldwide COVID-19 cases and deaths - an epidemiological study;How does temperature and humidity affect the transmission of 2019-nCoV_.
Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature and relative humidity are not major contributing factor on the occurrence 2 of COVID-19 pandemic: An observational study in 57 countries (2020-05-08);How does temperature and humidity affect the transmission of 2019-nCoV_.
Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-;How does temperature and humidity affect the transmission of 2019-nCoV_.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effect of Temperature on the Transmission of COVID-19: A Machine Learning Case Study in Spain;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil;How does temperature and humidity affect the transmission of 2019-nCoV_.
The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature and humidity on the spread of COVID-19: A systematic review;How does temperature and humidity affect the transmission of 2019-nCoV_.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;How does temperature and humidity affect the transmission of 2019-nCoV_.
Evidence that higher temperatures are associated with lower incidence of COVID-19 in pandemic state, cumulative cases reported up to March 27, 2020;How does temperature and humidity affect the transmission of 2019-nCoV_.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;How does temperature and humidity affect the transmission of 2019-nCoV_.
Meteorological factors correlate with transmission of 2019-nCoV: Proof of incidence of novel coronavirus pneumonia in Hubei Province, China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature, humidity, and wind speed are associated with lower Covid-19 incidence;How does temperature and humidity affect the transmission of 2019-nCoV_.
No Evidence for Temperature-Dependence of the COVID-19 Epidemic;How does temperature and humidity affect the transmission of 2019-nCoV_.
COVID-19 transmission in Mainland China is associated with temperature and humidity: a time-series analysis;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature on COVID-19 transmission;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;How does temperature and humidity affect the transmission of 2019-nCoV_.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Association between ambient temperature and COVID-19 infection in 122 cities from China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Roles of meteorological conditions in COVID-19 transmission on a worldwide scale;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature variation and humidity on the mortality of COVID-19 in Wuhan;How does temperature and humidity affect the transmission of 2019-nCoV_.
High Temperature and High Humidity Reduce the Transmission of COVID-19;How does temperature and humidity affect the transmission of 2019-nCoV_.
Role of temperature and humidity in the modulation of the doubling time of COVID-19 cases;How does temperature and humidity affect the transmission of 2019-nCoV_.
Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period;How does temperature and humidity affect the transmission of 2019-nCoV_.
Potential Factors Influencing Repeated SARS Outbreaks in China.;How does temperature and humidity affect the transmission of 2019-nCoV_.
"The Effects of ""Fangcang Huoshenshan and Leishenshan"" Makeshift Hospitals and Temperature on the Mortality of COVID-19";How does temperature and humidity affect the transmission of 2019-nCoV_.
Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV);How does temperature and humidity affect the transmission of 2019-nCoV_.
Analysis of meteorological conditions and prediction of epidemic trend of 2019-nCoV infection in 2020;How does temperature and humidity affect the transmission of 2019-nCoV_.
The role of absolute humidity on transmission rates of the COVID-19 outbreak;How does temperature and humidity affect the transmission of 2019-nCoV_.
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo;Methods to understand and regulate the spread in communities.
Quantifying human mobility behavior changes in response to non-pharmaceutical interventions during the COVID-19 outbreak in the United States.;Methods to understand and regulate the spread in communities.
A reality check on the use of face masks during the COVID-19 outbreak in Hong Kong;Methods to understand and regulate the spread in communities.
Non-compliance with COVID-19-related public health measures among young adults: Insights from a longitudinal cohort study;Methods to understand and regulate the spread in communities.
Mapping the intercounty transmission risk of COVID-19 in New York State;Methods to understand and regulate the spread in communities.
Modelling the role of media induced fear conditioning in mitigating post-lockdown COVID-19 pandemic: perspectives on India;Methods to understand and regulate the spread in communities.
Agent-Level Pandemic Simulation (ALPS) for Analyzing Effects of Lockdown Measures;Methods to understand and regulate the spread in communities.
What are the Underlying Transmission Patterns of COVID-19 Outbreak? - An Age-specific Social Contact Characterization;Methods to understand and regulate the spread in communities.
Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.;Methods to understand and regulate the spread in communities.
Voluntary and Mandatory Social Distancing: Evidence on COVID-19 Exposure Rates from Chinese Provinces and Selected Countries;Methods to understand and regulate the spread in communities.
Association of County-Level Socioeconomic and Political Characteristics with Engagement in Social Distancing for COVID-19;Methods to understand and regulate the spread in communities.
Adoption of Personal Protective Measures by Ordinary Citizens during the COVID-19 Outbreak in Japan;Methods to understand and regulate the spread in communities.
Little Risk of the COVID-19 Resurgence on Students in China (outside Hubei) Caused by School Reopening;Methods to understand and regulate the spread in communities.
Exponential Phase of COVID19 Expansion is not Driven by Climate at Global Scale;Methods to understand and regulate the spread in communities.
Impact of School Closures for COVID-19 on the US Health-Care Workforce and Net Mortality: a Modelling Study.;Methods to understand and regulate the spread in communities.
Eliminating COVID-19: A Community-based Analysis;Methods to understand and regulate the spread in communities.
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.;Methods to understand and regulate the spread in communities.
Compliance with COVID-19 Social-Distancing Measures in Italy: The Role of Expectations and Duration;Methods to understand and regulate the spread in communities.
Containing the Spread of Coronavirus Disease 2019 (COVID-19): Meteorological Factors and Control Strategies;Seasonality of transmission.
COVID-19: Effects of weather conditions on the propagation of respiratory droplets;Seasonality of transmission.
The Modest Impact of Weather and Air Pollution on COVID-19 Transmission;Seasonality of transmission.
Higher Temperature, Pressure, and Ultraviolet Are Associated with Less COVID-19 Prevalence: Meta-Regression of Japanese Prefectural Data;Seasonality of transmission.
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2;Seasonality of transmission.
Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study;Seasonality of transmission.
The effect of ambient temperature on worldwide COVID-19 cases and deaths - an epidemiological study;Seasonality of transmission.
Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-;Seasonality of transmission.
Temperature and relative humidity are not major contributing factor on the occurrence 2 of COVID-19 pandemic: An observational study in 57 countries (2020-05-08);Seasonality of transmission.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;Seasonality of transmission.
Effect of Temperature on the Transmission of COVID-19: A Machine Learning Case Study in Spain;Seasonality of transmission.
Warmer weather and global trends in the coronavirus COVID-19;Seasonality of transmission.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;Seasonality of transmission.
Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries;Seasonality of transmission.
Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil;Seasonality of transmission.
Trends of SARS-Cov-2 infection in 67 countries: Role of climate zone, temperature, humidity and curve behavior of cumulative frequency on duplication time;Seasonality of transmission.
Climatic factors influence COVID-19 outbreak as revealed by worldwide mortality;Seasonality of transmission.
Seasonality and uncertainty in COVID-19 growth rates;Seasonality of transmission.
The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change;Seasonality of transmission.
Meteorological factors and domestic new cases of coronavirus disease (COVID-19) in nine Asian cities: A time-series analysis;Seasonality of transmission.
Effects of temperature and humidity on the spread of COVID-19: A systematic review;Seasonality of transmission.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;Seasonality of transmission.
Evidence that higher temperatures are associated with lower incidence of COVID-19 in pandemic state, cumulative cases reported up to March 27, 2020;Seasonality of transmission.
Climatic influences on the worldwide spread of SARS-CoV-2;Seasonality of transmission.
Susceptible supply limits the role of climate in the COVID-19 pandemic;Seasonality of transmission.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;Seasonality of transmission.
Meteorological factors correlate with transmission of 2019-nCoV: Proof of incidence of novel coronavirus pneumonia in Hubei Province, China;Seasonality of transmission.
Eco-epidemiological assessment of the COVID-19 epidemic in China, January-February 2020;Seasonality of transmission.
Temperature, humidity, and wind speed are associated with lower Covid-19 incidence;Seasonality of transmission.
No Evidence for Temperature-Dependence of the COVID-19 Epidemic;Seasonality of transmission.
Climate effect on COVID-19 spread rate: an online surveillance tool;Seasonality of transmission.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;Seasonality of transmission.
Temperature dependence of COVID-19 transmission;Seasonality of transmission.
COVID-19 transmission in Mainland China is associated with temperature and humidity: a time-series analysis;Seasonality of transmission.
Effects of temperature on COVID-19 transmission;Seasonality of transmission.
Climate affects global patterns of COVID-19 early outbreak dynamics;Seasonality of transmission.
Modeling the Corona Virus Outbreak in IRAN;Seasonality of transmission.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;Seasonality of transmission.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;Seasonality of transmission.
Social distancing strategies for curbing the COVID-19 epidemic;Seasonality of transmission.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;Seasonality of transmission.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;What is the likelihood of significant changes in transmissibility in changing seasons_.
Association between climate variables and global transmission oF SARS-CoV-2;What is the likelihood of significant changes in transmissibility in changing seasons_.
The correlation between the spread of COVID-19 infections and weather variables in 30 Chinese provinces and the impact of Chinese government mitigation plans;What is the likelihood of significant changes in transmissibility in changing seasons_.
Seasonality and uncertainty in COVID-19 growth rates;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020;What is the likelihood of significant changes in transmissibility in changing seasons_.
Investigation of effective climatology parameters on COVID-19 outbreak in Iran;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climate variability and seasonal weather related to COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Global COVID-19 transmission rate is influenced by precipitation seasonality and the speed of climate temperature warming;What is the likelihood of significant changes in transmissibility in changing seasons_.
Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climatic influences on the worldwide spread of SARS-CoV-2;What is the likelihood of significant changes in transmissibility in changing seasons_.
No Association of COVID-19 transmission with temperature or UV radiation in Chinese cities;What is the likelihood of significant changes in transmissibility in changing seasons_.
Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;What is the likelihood of significant changes in transmissibility in changing seasons_.
The Effect of Temperature Upon Transmission of COVID-19: Australia And Egypt Case Study.;What is the likelihood of significant changes in transmissibility in changing seasons_.
Eco-epidemiological assessment of the COVID-19 epidemic in China, January-February 2020;What is the likelihood of significant changes in transmissibility in changing seasons_.
Association between ambient temperature and COVID-19 infection in 122 cities from China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature dependence of COVID-19 transmission;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climate affects global patterns of COVID-19 early outbreak dynamics;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;What is the likelihood of significant changes in transmissibility in changing seasons_.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Transmissibility of COVID-19 and its association with temperature and humidity;What is the likelihood of significant changes in transmissibility in changing seasons_.
The Role of Environmental Factors on Transmission Rates of the COVID-19 Outbreak: An Initial Assessment in Two Spatial Scales.;What is the likelihood of significant changes in transmissibility in changing seasons_.
High Temperature and High Humidity Reduce the Transmission of COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
"The Effects of ""Fangcang, Huoshenshan, and Leishenshan"" Makeshift Hospitals and Temperature on the Mortality of COVID-19";What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature significant change COVID-19 Transmission in 429 cities;What is the likelihood of significant changes in transmissibility in changing seasons_.
The role of absolute humidity on transmission rates of the COVID-19 outbreak;What is the likelihood of significant changes in transmissibility in changing seasons_.
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020;Can the virus be transmitted asymptomatically or during the incubation period_.
Modes of contact and risk of transmission in COVID-19 among close contacts;Can the virus be transmitted asymptomatically or during the incubation period_.
Temporal dynamics in viral shedding and transmissibility of COVID-19;Can the virus be transmitted asymptomatically or during the incubation period_.
Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province;Can the virus be transmitted asymptomatically or during the incubation period_.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Can the virus be transmitted asymptomatically or during the incubation period_.
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;Can the virus be transmitted asymptomatically or during the incubation period_.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical and virological data of the first cases of COVID-19 in Europe;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
A Well Infant With Coronavirus Disease 2019 With High Viral Load;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Understanding COVID-19: what does viral RNA load really mean?;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Temporal dynamics in viral shedding and transmissibility of COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Duration of viral detection in throat and rectum of a patient with COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Virological assessment of hospitalized cases of coronavirus disease 2019;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Significantly longer Covid-19 incubation times for the elderly, from a case study of 136 patients throughout China;Incubation period across different age groups.
Journal of Infection;Incubation period across different age groups.
Children are unlikely to have been the primary source of household SARS-CoV-2 infections;Incubation period across different age groups.
Viral Kinetics and Antibody responses in Patients with COVID-19;Incubation period across different age groups.
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?;Incubation period across different age groups.
Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series;Incubation period across different age groups.
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Incubation period across different age groups.
Estimate the incubation period of coronavirus 2019 (COVID-19);Incubation period across different age groups.
Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study;Length of viral shedding after illness onset.
Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan;Length of viral shedding after illness onset.
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review;Length of viral shedding after illness onset.
The duration of viral shedding of discharged patients with severe COVID-19;Length of viral shedding after illness onset.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study;Length of viral shedding after illness onset.
Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19);Length of viral shedding after illness onset.
Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China;Length of viral shedding after illness onset.
Viral Kinetics and Antibody Responses in Patients with COVID-19;Length of viral shedding after illness onset.
Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients;Length of viral shedding after illness onset.
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples;Length of viral shedding after illness onset.
Patients with respiratory symptoms are at greater risk of COVID-19 transmission;Length of viral shedding after illness onset.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Length of viral shedding after illness onset.
COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province China;Length of viral shedding after illness onset.
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gender-Based Disparities in COVID-19 Patient Outcomes: A Propensity-matched Analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID19 Infection;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gastrointestinal symptoms as Covid-19 onset in hospitalized Italian patients;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Cardiac and arrhythmic complications in patients with COVID-19.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Features of COVID-19-Related Liver Damage;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19);Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Predicting COVID-19 malignant progression with AI techniques;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
COVID-19 Myocarditis and Severity Factors： An Adult Cohort Study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19);Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: A cross-sectional study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Acute Myocardial Injury of Patients with Coronavirus Disease 2019;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China;Proportion of all positive COVID19 patients who were asymptomatic.
The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington;Proportion of all positive COVID19 patients who were asymptomatic.
The first 100 days of SARS-CoV-2 control in Vietnam;Proportion of all positive COVID19 patients who were asymptomatic.
CT imaging features of 34 patients infected with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Identifying baseline clinical features of people with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis;Proportion of all positive COVID19 patients who were asymptomatic.
A systematic review of asymptomatic infections with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Study on Transmission Dynamic of 15 Clusters of Coronavirus Disease 2019 Cases in Ningbo;Proportion of all positive COVID19 patients who were asymptomatic.
Viral dynamics in asymptomatic patients with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Contagiousness and Secondary Attack Rate of 2019 Novel Coronavirus Based on Cluster Epidemics of COVID-19 in Guangzhou;Proportion of all positive COVID19 patients who were asymptomatic.
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China;Proportion of all positive COVID19 patients who were asymptomatic.
High proportion of asymptomatic and presymptomatic COVID-19 infections in travelers and returning residents to Brunei;Proportion of all positive COVID19 patients who were asymptomatic.
Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological and clinical features of asymptomatic patients with SARS‐CoV‐2 infection;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;Proportion of all positive COVID19 patients who were asymptomatic.
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility;Proportion of all positive COVID19 patients who were asymptomatic.
Early epidemiological and clinical manifestations of COVID-19 in Ja;Proportion of all positive COVID19 patients who were asymptomatic.
Cluster of COVID-19 in northern France: A retrospective closed cohort study;Proportion of all positive COVID19 patients who were asymptomatic.
Suppression of COVID-19 outbreak in the municipality of Vo, Italy;Proportion of all positive COVID19 patients who were asymptomatic.
COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020;Proportion of all positive COVID19 patients who were asymptomatic.
A considerable proportion of individuals with asymptomatic SARS-CoV-2 infection in Tibetan population;Proportion of all positive COVID19 patients who were asymptomatic.
Modes of contact and risk of transmission in COVID-19 among close contacts;Proportion of all positive COVID19 patients who were asymptomatic.
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China;Proportion of all positive COVID19 patients who were asymptomatic.
High transmissibility of COVID-19 near symptom onset;Proportion of all positive COVID19 patients who were asymptomatic.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Proportion of all positive COVID19 patients who were asymptomatic.
Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Proportion of all positive COVID19 patients who were asymptomatic.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China;Proportion of all positive COVID19 patients who were asymptomatic.
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020;Proportion of all positive COVID19 patients who were asymptomatic.
Characteristics of COVID-19 infection in Beijing;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea;Proportion of all positive COVID19 patients who were asymptomatic.
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19);Proportion of all positive COVID19 patients who were asymptomatic.
Clinical and Transmission Dynamics Characteristics of 406 Children with Coronavirus Disease 2019 in China: A Review;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical features of pediatric patients with coronavirus disease (COVID-19);Proportion of pediatric COVID19 patients who were asymptomatic.
A follow-up study of children infected with SARS-CoV-2 from Western China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis;Proportion of pediatric COVID19 patients who were asymptomatic.
Epidemiological and Clinical Characteristics of Children with Coronavirus Disease 2019;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study;Proportion of pediatric COVID19 patients who were asymptomatic.
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China;Proportion of pediatric COVID19 patients who were asymptomatic.
SARS-CoV-2 Infection in Children;Proportion of pediatric COVID19 patients who were asymptomatic.
Epidemiology of COVID-19 Among Children in China;Proportion of pediatric COVID19 patients who were asymptomatic.
The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan, China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China;Proportion of pediatric COVID19 patients who were asymptomatic.
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data;Proportion of pediatric COVID19 patients who were asymptomatic.
Estimation of the incubation period of SARS-CoV-2 in Vietnam;What is the incubation period of the virus_.
The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research;What is the incubation period of the virus_.
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;What is the incubation period of the virus_.
Statistical and network analysis of 1212 COVID-19 patients in Henan, China;What is the incubation period of the virus_.
Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories;What is the incubation period of the virus_.
Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19;What is the incubation period of the virus_.
Epidemiological Characteristics of COVID-19: A Systemic Review and Meta-Analysis;What is the incubation period of the virus_.
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study;What is the incubation period of the virus_.
Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis;What is the incubation period of the virus_.
Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study;What is the incubation period of the virus_.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia;What is the incubation period of the virus_.
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study;What is the incubation period of the virus_.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;What is the incubation period of the virus_.
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms;What is the incubation period of the virus_.
A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet;What is the incubation period of the virus_.
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: The need of a longer quarantine period;What is the incubation period of the virus_.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures;What is the incubation period of the virus_.
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study;What is the incubation period of the virus_.
Epidemiologic Characteristics of COVID-19 in Guizhou, China;What is the incubation period of the virus_.
Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population;What is the incubation period of the virus_.
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application;What is the incubation period of the virus_.
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;What is the incubation period of the virus_.
The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease;What is the incubation period of the virus_.
Transmission interval estimates suggest pre-symptomatic spread of COVID-19;What is the incubation period of the virus_.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China;What is the incubation period of the virus_.
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing China;What is the incubation period of the virus_.
Transmission characteristics of the COVID-19 outbreak in China: a study driven by data;What is the incubation period of the virus_.
Estimate the incubation period of coronavirus 2019 (COVID-19);What is the incubation period of the virus_.
Clinical Characteristics of Coronavirus Disease 2019 in China;What is the incubation period of the virus_.
Characteristics of COVID-19 infection;What is the incubation period of the virus_.
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series;What is the incubation period of the virus_.
The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province;What is the incubation period of the virus_.
A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention;What is the incubation period of the virus_.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;What is the incubation period of the virus_.
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data;What is the incubation period of the virus_.
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea;What is the incubation period of the virus_.
The incubation period of 2019-nCoV infections among travellers from Wuhan, China;What is the incubation period of the virus_.
The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application;What is the incubation period of the virus_.
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection.;Are there studies about phenotypic change_.
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells;Are there studies about phenotypic change_.
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series;Are there studies about phenotypic change_.
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells;Are there studies about phenotypic change_.
The phenotypic changes of γδ T cells in COVID-19 patients;Are there studies about phenotypic change_.
Zoonotic origins of human coronaviruses;Are there studies about phenotypic change_.
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019;Are there studies about phenotypic change_.
Assessment of COVID-19 Knowledge Among University Students: Implications for Future Risk Communication Strategies;Efforts to develop qualitative assessment frameworks.
Knowledge, Perceptions and Preventive Practices Towards COVID-19 Early in the Outbreak Among Jimma University Medical Center Visitors, Southwest Ethiopia;Efforts to develop qualitative assessment frameworks.
Public Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Study in Malaysia;Efforts to develop qualitative assessment frameworks.
Analysis of Public Perception of the Israeli Government's Early Emergency Instructions Regarding COVID-19: Online Survey Study;Efforts to develop qualitative assessment frameworks.
Knowledge and Behaviors Toward COVID-19 Among US Residents During the Early Days of the Pandemic: Cross-Sectional Online Questionnaire;Efforts to develop qualitative assessment frameworks.
No Place Like Home: A Cross-National Assessment of the Efficacy of Social Distancing During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
The urgent need for integrated science to fight COVID-19 pandemic and beyond;Efforts to develop qualitative assessment frameworks.
Implications of the Lack of a Unified Research Project Framework: An Investigation Into the Registration of Clinical Trials of COVID-19;Efforts to develop qualitative assessment frameworks.
Dynamic Interventions to Control COVID-19 Pandemic: A Multivariate Prediction Modelling Study Comparing 16 Worldwide Countries;Efforts to develop qualitative assessment frameworks.
Mobile Health Clinic Model in the COVID-19 Pandemic: Lessons Learned and Opportunities for Policy Changes and Innovation;Efforts to develop qualitative assessment frameworks.
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps and Opportunities;Efforts to develop qualitative assessment frameworks.
Modeling COVID-19 Latent Prevalence to Assess a Public Health Intervention at a State and Regional Scale;Efforts to develop qualitative assessment frameworks.
Predictions of Covid-19 Related Unemployment On Suicide and Excess Mortality in the United States;Efforts to develop qualitative assessment frameworks.
Digital Health and the COVID-19 Epidemic: An Assessment Framework for Apps From an Epidemiological and Legal Perspective;Efforts to develop qualitative assessment frameworks.
What Is Inconvenient for You Is Life-saving for Me': How Health Inequities Are Playing Out During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
Royal Flying Doctor Service COVID-19 Activity and Surge Modelling in Australia;Efforts to develop qualitative assessment frameworks.
Forecasting COVID-19-Associated Hospitalizations Under Different Levels of Social Distancing in Lombardy and Emilia-Romagna, Northern Italy: Results From an Extended SEIR Compartmental Model;Efforts to develop qualitative assessment frameworks.
[Quarantine Alone or in Combination With Other Public Health Measures to Control COVID-19: A Rapid Review (Review)];Efforts to develop qualitative assessment frameworks.
Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level;Efforts to develop qualitative assessment frameworks.
A Simple Remote Nutritional Screening Tool and Practical Guidance for Nutritional Care in Primary Practice During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
Social Media as a Recruitment Platform for a Nationwide Online Survey of COVID-19 Knowledge, Beliefs, and Practices in the United States: Methodology and Feasibility Analysis;Efforts to develop qualitative assessment frameworks.
The Predictive Capacity of Air Travel Patterns During the Global Spread of the COVID-19 Pandemic: Risk, Uncertainty and Randomness;Efforts to develop qualitative assessment frameworks.
Assessing the Effects of Metropolitan-Wide Quarantine on the Spread of COVID-19 in Public Space and Households;Efforts to develop qualitative assessment frameworks.
Predictors of adherence to public health instructions during the COVID-19 pandemic;Efforts to develop qualitative assessment frameworks.
Coping with diabetes during the COVID – 19 lockdown in India: Results of an online pilot survey;Efforts to develop qualitative assessment frameworks.
Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: what are the mental health risks?;Efforts to develop qualitative assessment frameworks.
Data Mining and Content Analysis of the Chinese Social Media Platform Weibo During the Early COVID-19 Outbreak: Retrospective Observational Infoveillance Study;Efforts to develop qualitative assessment frameworks.
Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis;Efforts to develop qualitative assessment frameworks.
Modeling the COVID-19 outbreaks and the effectiveness of the containment measures adopted across countries;Efforts to develop qualitative assessment frameworks.
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study;Efforts to develop qualitative assessment frameworks.
Perceptions of the Adult US Population Regarding the Novel Coronavirus Outbreak;Efforts to develop qualitative assessment frameworks.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Efforts to develop qualitative assessment frameworks.
Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic;Efforts to develop qualitative assessment frameworks.
Data-Driven Study of the COVID-19 Pandemic via Age-Structured Modelling and Prediction of the Health System Failure in Brazil amid Diverse Intervention Strategies;Efforts to develop qualitative assessment frameworks.
Coronavirus Disease 2019 (COVID-19) and Mental Health for Children and Adolescents;Efforts to develop qualitative assessment frameworks.
KCDC Risk Assessments on the Initial Phase of the COVID-19 Outbreak in Korea;Efforts to develop qualitative assessment frameworks.
Data for Understanding the Risk Perception of COVID-19 From Vietnamese Sample;Efforts to develop qualitative assessment frameworks.
The missing pieces in the jigsaw and need for cohesive research amidst COVID 19 global response;Efforts to develop qualitative assessment frameworks.
Increased Detection coupled with Social Distancing and Health Capacity Planning Reduce the Burden of COVID-19 Cases and Fatalities: A Proof of Concept Study using a Stochastic Computational Simulation Model;Efforts to develop qualitative assessment frameworks.
Political Beliefs affect Compliance with COVID-19 Social Distancing Orders;Efforts to develop qualitative assessment frameworks.
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review.;Efforts to develop qualitative assessment frameworks.
Travel health risk perceptions of Chinese international students in Australia – Implications for COVID-19;Efforts to develop qualitative assessment frameworks.
School Opening Delay Effect on Transmission Dynamics of Coronavirus Disease 2019 in Korea: Based on Mathematical Modeling and Simulation Study.;Efforts to develop qualitative assessment frameworks.
Considering inequalities in the school closure response to COVID-19.;Efforts to develop qualitative assessment frameworks.
Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19;Efforts to develop qualitative assessment frameworks.
"COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception";Efforts to develop qualitative assessment frameworks.
Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19;Efforts to develop qualitative assessment frameworks.
Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020;Efforts to develop qualitative assessment frameworks.
Measuring Two Distinct Psychological Threats of COVID-19 and their Unique Impacts on Well-being and Adherence to Public Health Behaviors;Efforts to develop qualitative assessment frameworks.
COVID-19 pandemic and addiction: Current problems and future concerns;Efforts to develop qualitative assessment frameworks.
Data and Statistics on Children's Mental Health;Efforts to develop qualitative assessment frameworks.
Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries;Efforts to develop qualitative assessment frameworks.
COVID-19 Modelling: the Effects of Social Distancing;Efforts to develop qualitative assessment frameworks.
Age-structured impact of social distancing on the COVID-19 epidemic in India;Efforts to develop qualitative assessment frameworks.
Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management;Efforts to develop qualitative assessment frameworks.
Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people;Efforts to develop qualitative assessment frameworks.
Scientific and ethical basis for social-distancing interventions against COVID-19;Efforts to develop qualitative assessment frameworks.
Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19);Efforts to develop qualitative assessment frameworks.
Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries;Efforts to develop qualitative assessment frameworks.
Impact of city and residential unit lockdowns on prevention and control of COVID-19;Efforts to develop qualitative assessment frameworks.
Knowledge, Attitudes, and Practices Towards COVID-19 Among Chinese Residents During the Rapid Rise Period of the COVID-19 Outbreak: A Quick Online Cross-Sectional Survey;Efforts to develop qualitative assessment frameworks.
The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19;Efforts to develop qualitative assessment frameworks.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Efforts to develop qualitative assessment frameworks.
How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know;Efforts to develop qualitative assessment frameworks.
Research Frontiers of Health Emergency and Disaster Risk Management: What Do We Know So Far?;Efforts to develop qualitative assessment frameworks.
How will country-based mitigation measures influence the course of the COVID-19 epidemic?;Efforts to develop qualitative assessment frameworks.
Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are Under Quarantine;Efforts to develop qualitative assessment frameworks.
Psychological interventions for people affected by the COVID-19 epidemic;Efforts to develop qualitative assessment frameworks.
Clinical Laboratory Parameters Associated with Severe or Critical Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-analysis;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Case fatality rate in COVID-19: a systematic review and meta-analysis;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Current Trends in Diagnostics of Viral Infections of Unknown Etiology Viruses;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Clinical onset serial interval and diagnostic serial interval of SARS-CoV-2/COVID-19 in South Korea;Serial Interval (time between symptom onset in infector-infectee pair).
Estimation of the time-varying reproduction number of COVID-19 outbreakin China;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;Serial Interval (time between symptom onset in infector-infectee pair).
COVID-19 serial interval estimates based on confirmed cases in public reports from 86 Chinese cities;Serial Interval (time between symptom onset in infector-infectee pair).
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study;Serial Interval (time between symptom onset in infector-infectee pair).
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China;Serial Interval (time between symptom onset in infector-infectee pair).
Analysis on epidemiological characteristics of new-type coronavirus pneumonia family aggregation epidemic in Zhejiang Province;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Serial Interval (time between symptom onset in infector-infectee pair).
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;Serial Interval (time between symptom onset in infector-infectee pair).
Close contacts and household transmission of SARS-CoV-2 in China: a content analysis based on local Heath Commissions' public disclosures.;Serial Interval (time between symptom onset in infector-infectee pair).
Transmission interval estimates suggest pre-symptomatic spread of COVID-19;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiologic Characteristics of COVID-19 in Guizhou, China;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts;Serial Interval (time between symptom onset in infector-infectee pair).
The serial interval of COVID-19 from publicly reported confirmed cases;Serial Interval (time between symptom onset in infector-infectee pair).
Serial interval of novel coronavirus (2019-nCoV) infections;Serial Interval (time between symptom onset in infector-infectee pair).
Estimation of the Time-Varying Reproduction Number of COVID-19 Outbreak in China;Serial Interval (time between symptom onset in infector-infectee pair).
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters;Studies to monitor potential adaptations.
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology;Studies to monitor potential adaptations.
Coronavirus Infection and PARP Expression Dysregulate the NAD Metabolome: A Potentially Actionable Component of Innate Immunity;Studies to monitor potential adaptations.
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series;Studies to monitor potential adaptations.
Potential Factors for Prediction of Disease Severity of COVID-19 Patients;Studies to monitor potential adaptations.
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2;Studies to monitor potential adaptations.
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019;Studies to monitor potential adaptations.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;Studies to monitor potential adaptations.
Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions;Studies to monitor potential adaptations.
Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China;Studies to monitor potential adaptations.
Current Trends in Diagnostics of Viral Infections of Unknown Etiology Viruses;Studies to monitor potential adaptations.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;Studies to monitor potential adaptations.
The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against COVID-19 biorxiv;Studies to monitor potential adaptations.
2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus;Studies to monitor potential adaptations.
Transmission in Latent Period Causes A Large Number of Infected People in the United States;What do models for transmission predict_.
Tracking R of COVID-19: A New Real-Time Estimation Using the Kalman Filter;What do models for transmission predict_.
Inferring change points in the COVID-19 spreading reveals the effectiveness of interventions;What do models for transmission predict_.
Real-time time-series modelling for prediction of COVID-19 spread and intervention assessment;What do models for transmission predict_.
COVID-19 in Iran: A Deeper Look Into The Future;What do models for transmission predict_.
Estimating the impact of mobility patterns on COVID-19 infection rates in 11 European countries;What do models for transmission predict_.
Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis;What do models for transmission predict_.
The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States;What do models for transmission predict_.
COVID-19 Asymptomatic Infection Estimation;What do models for transmission predict_.
The Effect of Population Size for Pathogen Transmission on Prediction of COVID-19 Pandemic Spread;What do models for transmission predict_.
Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19;What do models for transmission predict_.
A Bayesian analysis of the total number of cases of the COVID 19 when only a few data is available. A case study in the state of Goias, Brazil;What do models for transmission predict_.
Modeling the COVID-19 epidemic in Okinawa;What do models for transmission predict_.
Sequential data assimilation of the stochastic SEIR epidemic model for regional COVID-19 dynamics;What do models for transmission predict_.
Epidemic Landscape and Forecasting of SARS-CoV-2 in India;What do models for transmission predict_.
A Bayesian Logistic Growth Model for the Spread of COVID-19 in New York;What do models for transmission predict_.
COVID-19 in India: Predictions, Reproduction Number and Public Health Preparedness;What do models for transmission predict_.
Long-term predictions for COVID-19 pandemic dynamics in Ukraine, Austria and Italy;What do models for transmission predict_.
Outbreak dynamics of COVID-19 in China and the United States;What do models for transmission predict_.
Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom;What do models for transmission predict_.
COVID-19 UK Lockdown Forecasts and R0;What do models for transmission predict_.
Monitoring Italian COVID-19 spread by an adaptive SEIRD model;What do models for transmission predict_.
Parametric analysis of early data on COVID-19 expansion in selected European countries;What do models for transmission predict_.
Forecasting COVID 19 growth in India using Susceptible-Infected-Recovered (S.I.R) model;What do models for transmission predict_.
Early behavior of Madrid Covid-19 disease outbreak: A mathematical model;What do models for transmission predict_.
Transmission Dynamics and Control Methodology of COVID-19: a Modeling Study;What do models for transmission predict_.
Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission;What do models for transmission predict_.
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing;What do models for transmission predict_.
COVID-19 outbreak in Algeria: A mathematical Model to predict cumulative cases;What do models for transmission predict_.
Estimating unobserved SARS-CoV-2 infections in the United States;What do models for transmission predict_.
Estimation of Basic Reproduction Number of the COVID-19 Epidemic in Denmark using a Two-Step Model;What do models for transmission predict_.
Strongly heterogeneous transmission of COVID-19 in mainland China: local and regional variation.;What do models for transmission predict_.
Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative;What do models for transmission predict_.
Inferring the number of COVID-19 cases from recently reported deaths;What do models for transmission predict_.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan China through status dynamic modeling;What do models for transmission predict_.
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province;What do models for transmission predict_.
Relations of parameters for describing the epidemic of COVID―19 by the Kermack―McKendrick model;What do models for transmission predict_.
Estimating the basic reproduction number of COVID-19 in Wuhan China;What do models for transmission predict_.
Infection Dynamics of Coronavirus Disease 2019 (Covid-19) Modeled with the Integration of the Eyring Rate Process Theory and Free Volume Concept;What do models for transmission predict_.
A mathematical model for simulating the phase-based transmissibility of a novel coronavirus;What do models for transmission predict_.
The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system;What do models for transmission predict_.
Estimation of the epidemic properties of the 2019 novel coronavirus: A mathematical modeling study;What do models for transmission predict_.
Early dynamics of transmission and control of COVID-19: a mathematical modelling study;What do models for transmission predict_.
Assessing the Tendency of 2019-nCoV (COVID-19) Outbreak in China;What do models for transmission predict_.
Reporting Epidemic Growth and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic;What do models for transmission predict_.
Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions;What do models for transmission predict_.
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology;What is known about adaptations (mutations) of the virus_.
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites;What is known about adaptations (mutations) of the virus_.
Translational adaptation of human viruses to the tissues they infect;What is known about adaptations (mutations) of the virus_.
Re-insights into origin and adaptation of SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage;What is known about adaptations (mutations) of the virus_.
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del) Clinical Microbiology and Infection;What is known about adaptations (mutations) of the virus_.
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies;What is known about adaptations (mutations) of the virus_.
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site;What is known about adaptations (mutations) of the virus_.
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability;What is known about adaptations (mutations) of the virus_.
Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis;What is known about adaptations (mutations) of the virus_.
Zoonotic origins of human coronaviruses;What is known about adaptations (mutations) of the virus_.
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV;What is known about adaptations (mutations) of the virus_.
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species;What is known about adaptations (mutations) of the virus_.
Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients;What is known about adaptations (mutations) of the virus_.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;What is known about adaptations (mutations) of the virus_.
Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions Healthcare;What is known about adaptations (mutations) of the virus_.
Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China;What is known about adaptations (mutations) of the virus_.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy;What regional genetic variations (mutations) exist.
Genomic characterization of a novel SARS-CoV-2;What regional genetic variations (mutations) exist.
A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses;What regional genetic variations (mutations) exist.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;What regional genetic variations (mutations) exist.
Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2);What regional genetic variations (mutations) exist.
Potential T-cell and B-cell Epitopes of 2019-nCoV;What regional genetic variations (mutations) exist.
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis;What regional genetic variations (mutations) exist.
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2;What regional genetic variations (mutations) exist.
Mutations, Recombination and Insertion in the Evolution of 2019-nCoV;What regional genetic variations (mutations) exist.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;What regional genetic variations (mutations) exist.
Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2;What regional genetic variations (mutations) exist.
Genetic diversity and evolution of SARS-CoV-2;What regional genetic variations (mutations) exist.
Review Article;Adhesion to hydrophilic_phobic surfaces.
Detection of Air and Surface Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients;Adhesion to hydrophilic_phobic surfaces.
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1;Adhesion to hydrophilic_phobic surfaces.
Can N95 respirators be reused after disinfection? And for how many times?;Coronavirus susceptibility to heat light and radiation.
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process;Coronavirus susceptibility to heat light and radiation.
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the COVID-19 Pandemic;Coronavirus susceptibility to heat light and radiation.
Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse;Coronavirus susceptibility to heat light and radiation.
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents;How long can other HCoV strains remain viable on common surfaces_.
Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials.;How long can other HCoV strains remain viable on common surfaces_.
Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections;How long can other HCoV strains remain viable on common surfaces_.
Stability and inactivation of SARS coronavirus;How long can other HCoV strains remain viable on common surfaces_.
Isothermal evaporation rate of deposited liquid aerosols and the SARS-CoV-2 coronavirus survival;Persistence of virus on surfaces of different materials.
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1;Persistence of virus on surfaces of different materials.
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency;Susceptibility to environmental cleaning agents.
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient (Journal of the American Medical Association);Susceptibility to environmental cleaning agents.
Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols (bioRxiv);Susceptibility to environmental cleaning agents.
Coronavirus disease 2019 (covid-19): a guide for UK GPs (BMJ (British Medical Journal));Susceptibility to environmental cleaning agents.
Water, sanitation, hygiene and waste management for the COVID-19 virus (WHO);Susceptibility to environmental cleaning agents.
The outbreak of COVID-19 An overview (Journal of the Chinese Medical Association);Susceptibility to environmental cleaning agents.
Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of COVID-19 in Non-Healthcare Premises;Susceptibility to environmental cleaning agents.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in blood_.
Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients;What do we know about viral shedding in blood_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in blood_.
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity;What do we know about viral shedding in blood_.
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes;What do we know about viral shedding in blood_.
The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients;What do we know about viral shedding in stool_.
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.;What do we know about viral shedding in stool_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in stool_.
Prolonged Viral Shedding in Feces of Pediatric Patients with Coronavirus Disease 2019;What do we know about viral shedding in stool_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in stool_.
Do children need a longer time to shed SARS-CoV-2 in stool than adults?;What do we know about viral shedding in stool_.
Prolonged Presence of SARS-CoV-2 Viral RNA in faecal samples;What do we know about viral shedding in stool_.
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau;What do we know about viral shedding in stool_.
Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster;What do we know about viral shedding in stool_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in stool_.
Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia;What do we know about viral shedding in stool_.
Evidence for gastrointestinal infection of SARS-CoV-2;What do we know about viral shedding in stool_.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;What do we know about viral shedding in the nasopharynx_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in the nasopharynx_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in the nasopharynx_.
Viral dynamics in mild and severe cases of COVID-19;What do we know about viral shedding in the nasopharynx_.
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau;What do we know about viral shedding in the nasopharynx_.
Patients with respiratory symptoms are at greater risk of COVID-19 transmission;What do we know about viral shedding in the nasopharynx_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in the nasopharynx_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in urine_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in urine_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in urine_.
COVID-19-associated nephritis: early warning for disease severity and complications?;What do we know about viral shedding in urine_.
Detection of SARS-CoV-2 in Different Types of Clinical Specimens;What do we know about viral shedding in urine_.
Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.;Development of a point-of-care test and rapid bed-side tests.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Development of a point-of-care test and rapid bed-side tests.
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING;Development of a point-of-care test and rapid bed-side tests.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Development of a point-of-care test and rapid bed-side tests.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Development of a point-of-care test and rapid bed-side tests.
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor;Development of a point-of-care test and rapid bed-side tests.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Development of a point-of-care test and rapid bed-side tests.
Point‐of‐care lung ultrasound in patients with COVID‐19 – a narrative review;Development of a point-of-care test and rapid bed-side tests.
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis;Development of a point-of-care test and rapid bed-side tests.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Development of a point-of-care test and rapid bed-side tests.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR;Development of a point-of-care test and rapid bed-side tests.
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department;Development of a point-of-care test and rapid bed-side tests.
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge;Development of a point-of-care test and rapid bed-side tests.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Development of a point-of-care test and rapid bed-side tests.
Coronavirus disease 2019, whart we know : Review;Development of a point-of-care test and rapid bed-side tests.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Development of a point-of-care test and rapid bed-side tests.
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing medrxiv;Development of a point-of-care test and rapid bed-side tests.
Molecular immune pathogenesis and diagnosis of COVID-19;Development of a point-of-care test and rapid bed-side tests.
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection medrxiv;Development of a point-of-care test and rapid bed-side tests.
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area;Development of a point-of-care test and rapid bed-side tests.
Recent advances and perspectives of nucleic acid detection for coronavirus;Development of a point-of-care test and rapid bed-side tests.
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv;Development of a point-of-care test and rapid bed-side tests.
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis;Development of a point-of-care test and rapid bed-side tests.
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Euro Surveill;Development of a point-of-care test and rapid bed-side tests.
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?;Development of a point-of-care test and rapid bed-side tests.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Development of a point-of-care test and rapid bed-side tests.
SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.;Development of a point-of-care test and rapid bed-side tests.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Development of a point-of-care test and rapid bed-side tests.
Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO;Development of a point-of-care test and rapid bed-side tests.
Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification;Development of a point-of-care test and rapid bed-side tests.
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19);Development of a point-of-care test and rapid bed-side tests.
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Development of a point-of-care test and rapid bed-side tests.
2020 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Development of a point-of-care test and rapid bed-side tests.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Development of a point-of-care test and rapid bed-side tests.
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan medrxiv;Development of a point-of-care test and rapid bed-side tests.
Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology;Development of a point-of-care test and rapid bed-side tests.
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia;Development of a point-of-care test and rapid bed-side tests.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR;Development of a point-of-care test and rapid bed-side tests.
Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity;Development of a point-of-care test and rapid bed-side tests.
Evaluation of nine commercial SARS-CoV-2 immunoassays;Diagnosing SARS-COV-2 with antibodies.
Diagnosing COVID-19: The Disease and Tools for Detection;Diagnosing SARS-COV-2 with antibodies.
Pixelated colorimetric nucleic acid assay;Diagnosing SARS-COV-2 with antibodies.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with antibodies.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Diagnosing SARS-COV-2 with antibodies.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Diagnosing SARS-COV-2 with antibodies.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Diagnosing SARS-COV-2 with antibodies.
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis;Diagnosing SARS-COV-2 with antibodies.
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection medrxiv;Diagnosing SARS-COV-2 with antibodies.
Molecular immune pathogenesis and diagnosis of COVID-19;Diagnosing SARS-COV-2 with antibodies.
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing medrxiv;Diagnosing SARS-COV-2 with antibodies.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with antibodies.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Diagnosing SARS-COV-2 with antibodies.
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department;Diagnosing SARS-COV-2 with antibodies.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Diagnosing SARS-COV-2 with antibodies.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Diagnosing SARS-COV-2 with antibodies.
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING;Diagnosing SARS-COV-2 with antibodies.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Diagnosing SARS-COV-2 with antibodies.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with antibodies.
Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnosing COVID-19: The Disease and Tools for Detection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Sensitive one-step isothermal detection of pathogen-derived RNAs medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design biorxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Pixelated colorimetric nucleic acid assay;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2 biorxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Development and Evaluation of A CRISPR-based Diagnostic 2 For 2019-novel Coronavirus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19);Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Euro Surveill;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Recent advances and perspectives of nucleic acid detection for coronavirus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Molecular immune pathogenesis and diagnosis of COVID-19;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Coronavirus disease 2019, whart we know : Review;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Acute limb ischemia in patients with COVID-19 pneumonia;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
COVID-19 Coagulopathy in Caucasian patients;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Heparin therapy improving hypoxia in COVID-19 patients - a case series;What is the best method to combat the hypercoagulable state seen in COVID-19_.
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Hospital-based use of thromboprophylaxis in patients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-1;What is the best method to combat the hypercoagulable state seen in COVID-19_.
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Incidence of thrombotic complications in critically ill ICU patients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series;What is the best method to combat the hypercoagulable state seen in COVID-19_.
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study;What is the efficacy of novel therapeutics being tested currently_.
Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome;What is the efficacy of novel therapeutics being tested currently_.
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study.;What is the efficacy of novel therapeutics being tested currently_.
An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI);What is the efficacy of novel therapeutics being tested currently_.
Why Tocilizumab could be an effective treatment for severe COVID-19;What is the efficacy of novel therapeutics being tested currently_.
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial;What is the efficacy of novel therapeutics being tested currently_.
Compassionate Use of Remdesivir for Patients with Severe Covid-19;What is the efficacy of novel therapeutics being tested currently_.
A Review of SARS-CoV-2 and the Ongoing Clinical Trials. [Review];What is the efficacy of novel therapeutics being tested currently_.
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.;What is the efficacy of novel therapeutics being tested currently_.
Current Drugs with Potential for Treatment of COVID-19: A Literature Review.;What is the efficacy of novel therapeutics being tested currently_.
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection;What is the efficacy of novel therapeutics being tested currently_.
Treatment of 5 critically ill patients with COVID-19 with Convalescent Plasma;What is the efficacy of novel therapeutics being tested currently_.
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants;What is the efficacy of novel therapeutics being tested currently_.
The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study;What is the efficacy of novel therapeutics being tested currently_.
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019;What is the efficacy of novel therapeutics being tested currently_.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;What is the efficacy of novel therapeutics being tested currently_.
Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19;What is the efficacy of novel therapeutics being tested currently_.
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study;What is the efficacy of novel therapeutics being tested currently_.
Medication Patterns and Disease Progression Among 165 Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective, Observational Study;What is the efficacy of novel therapeutics being tested currently_.
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies;What is the efficacy of novel therapeutics being tested currently_.
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China;What is the efficacy of novel therapeutics being tested currently_.
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study;What is the efficacy of novel therapeutics being tested currently_.
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19;What is the efficacy of novel therapeutics being tested currently_.
A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Traditional Chinese medicine for COVID-19 treatment;What is the efficacy of novel therapeutics being tested currently_.
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report.;What is the efficacy of novel therapeutics being tested currently_.
Therapeutic options for the 2019 novel coronavirus (2019-nCoV);What is the efficacy of novel therapeutics being tested currently_.
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.;What is the efficacy of novel therapeutics being tested currently_.
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines;What is the efficacy of novel therapeutics being tested currently_.
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease;What is the efficacy of novel therapeutics being tested currently_.
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;What is the efficacy of novel therapeutics being tested currently_.
Discovering drugs to treat coronavirus disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Age.
Obesity and COVID-19: an Italian snapshot;Age.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Age.
Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history;Age.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Age.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication;Age.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Age.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Age.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Age.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Age.
Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China;Age.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Age.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Age.
Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool;Age.
High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation;Age.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Age.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;Age.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up;Age.
A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China;Age.
Radiographic Findings and other Predictors in Adults with Covid-19;Age.
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China;Age.
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study;Age.
Prognostic value of C-reactive protein in patients with COVID-19;Age.
Clinical progression of patients with COVID-19 in Shanghai, China;Age.
Epidemiological characteristics of confirmed COVID-19 cases in Tianjin;Age.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Age.
Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19;Age.
Case fatality risk of novel coronavirus diseases 2019 in China;Age.
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China;Age.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Age.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Age.
Clinical Presentation of COVID19 in Dementia Patients;Age.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Asthma.
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.;Asthma.
Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience;Asthma.
Asthma prolongs intubation in COVID-19;Asthma.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Asthma.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Asthma.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Asthma.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Asthma.
Clinical Characteristics of Covid-19 in New York City;Asthma.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Autoimmune disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Autoimmune disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Autoimmune disorders.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Cancer.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Cancer.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Cancer.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Cancer.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Cancer.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Cancer.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Cancer.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Cancer.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Cancer.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Cancer.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Cancer.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Cancer.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Cancer.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Cancer.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Cancer.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Cancer.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Cancer.
Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis;Cancer.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Cancer.
Systematic investigations of COVID-19 in 283 cancer patients;Cancer.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Cancer.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Cancer.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Cancer.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Cancer.
Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City. Title: Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York;Cancer.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Cancer.
Outcomes of the 2019 Novel Coronavirus in patients with or without a history of cancer - a multi-centre North London experience;Cancer.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Cancer.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Cancer.
Factors associated with hospitalization and critical illness among 4,103 patients with;Cancer.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Cancer.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Cancer.
Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings;Cancer.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Cancer.
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis;Cancer.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Cancer.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Cardio- and cerebrovascular disease.
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors;Cardio- and cerebrovascular disease.
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study;Cardio- and cerebrovascular disease.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Cardio- and cerebrovascular disease.
Predicting COVID-19 malignant progression with AI techniques;Cardio- and cerebrovascular disease.
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China;Cardio- and cerebrovascular disease.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Cardio- and cerebrovascular disease.
Caution on Kidney Dysfunctions of COVID-19 Patients;Cardio- and cerebrovascular disease.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Cerebrovascular disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Cerebrovascular disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Cerebrovascular disease.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Cerebrovascular disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Cerebrovascular disease.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Cerebrovascular disease.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Cerebrovascular disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Cerebrovascular disease.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Cerebrovascular disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Cerebrovascular disease.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Cerebrovascular disease.
Systematic investigations of COVID-19 in 283 cancer patients;Cerebrovascular disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Cerebrovascular disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Cerebrovascular disease.
Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature;Cerebrovascular disease.
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28;Cerebrovascular disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Cerebrovascular disease.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Cerebrovascular disease.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up;Cerebrovascular disease.
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study;Cerebrovascular disease.
Prognostic value of C-reactive protein in patients with COVID-19;Cerebrovascular disease.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Cerebrovascular disease.
Epidemiological characteristics of confirmed COVID-19 cases in Tianjin;Cerebrovascular disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Cerebrovascular disease.
Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression;Cerebrovascular disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Cerebrovascular disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Cerebrovascular disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic digestive disorders.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic digestive disorders.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Chronic digestive disorders.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic digestive disorders.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Chronic digestive disorders.
Predicting COVID-19 malignant progression with AI techniques;Chronic digestive disorders.
Caution on Kidney Dysfunctions of COVID-19 Patients;Chronic digestive disorders.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Chronic kidney disease.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Chronic kidney disease.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Chronic kidney disease.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Chronic kidney disease.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Chronic kidney disease.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Chronic kidney disease.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19;Chronic kidney disease.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Chronic kidney disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic kidney disease.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Chronic kidney disease.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Chronic kidney disease.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Chronic kidney disease.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Chronic kidney disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic kidney disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Chronic kidney disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic kidney disease.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Chronic kidney disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic kidney disease.
When a nephrology ward becomes a COVID-19 ward: the Cremona experience;Chronic kidney disease.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Chronic kidney disease.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Chronic kidney disease.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Chronic kidney disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Chronic kidney disease.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Chronic kidney disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Chronic kidney disease.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Chronic kidney disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Chronic kidney disease.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Chronic kidney disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Chronic kidney disease.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Chronic kidney disease.
Systematic investigations of COVID-19 in 283 cancer patients;Chronic kidney disease.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Chronic kidney disease.
The Chronic Kidney Disease and Acute Kidney Injury Involvement in COVID-19 Pandemic: A Systematic Review and Meta-analysis;Chronic kidney disease.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Chronic kidney disease.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Chronic kidney disease.
ICU and ventilator mortality among critically ill adults with COVID-19;Chronic kidney disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Chronic kidney disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Chronic kidney disease.
Characterization and Clinical Course of 1000 Patients with COVID-19 in New York: retrospective case series;Chronic kidney disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic kidney disease.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Chronic kidney disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Chronic kidney disease.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;Chronic kidney disease.
Factors associated with hospitalization and critical illness among 4,103 patients with;Chronic kidney disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Chronic kidney disease.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic kidney disease.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Chronic kidney disease.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Chronic kidney disease.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Chronic kidney disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Chronic liver disease.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Chronic liver disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Chronic liver disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic liver disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic liver disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic liver disease.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Chronic liver disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Chronic liver disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic liver disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Chronic liver disease.
Systematic investigations of COVID-19 in 283 cancer patients;Chronic liver disease.
Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China;Chronic liver disease.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Chronic liver disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Chronic liver disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Chronic liver disease.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic liver disease.
Prognostic value of C-reactive protein in patients with COVID-19;Chronic liver disease.
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan China;Chronic liver disease.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Chronic respiratory diseases.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Chronic respiratory diseases.
Obesity and COVID-19: an Italian snapshot;Chronic respiratory diseases.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Chronic respiratory diseases.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-21;Chronic respiratory diseases.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic respiratory diseases.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Chronic respiratory diseases.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Chronic respiratory diseases.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Chronic respiratory diseases.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic respiratory diseases.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Chronic respiratory diseases.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic respiratory diseases.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic respiratory diseases.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Chronic respiratory diseases.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Chronic respiratory diseases.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic respiratory diseases.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Chronic respiratory diseases.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Chronic respiratory diseases.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Chronic respiratory diseases.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Chronic respiratory diseases.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Chronic respiratory diseases.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Chronic respiratory diseases.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Chronic respiratory diseases.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Chronic respiratory diseases.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Chronic respiratory diseases.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic respiratory diseases.
Early prediction of mortality risk among severe COVID-19 patients using machine learning;Chronic respiratory diseases.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia;Chronic respiratory diseases.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Chronic respiratory diseases.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic respiratory diseases.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Chronic respiratory diseases.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Chronic respiratory diseases.
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China;Chronic respiratory diseases.
Prognostic value of C-reactive protein in patients with COVID-19;Chronic respiratory diseases.
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study;Chronic respiratory diseases.
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study [medrxiv];Chronic respiratory diseases.
Caution on Kidney Dysfunctions of COVID-19 Patients;Chronic respiratory diseases.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;COPD.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;COPD.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;COPD.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;COPD.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;COPD.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;COPD.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;COPD.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;COPD.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;COPD.
The impact of COPD and smoking history on the severity of COVIDâ€19: A systemic review and metaâ€analysis;COPD.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;COPD.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;COPD.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;COPD.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;COPD.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;COPD.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;COPD.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;COPD.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;COPD.
Systematic investigations of COVID-19 in 283 cancer patients;COPD.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;COPD.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;COPD.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;COPD.
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol;COPD.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;COPD.
Clinical Characteristics of Covid-19 in New York City;COPD.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;COPD.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;COPD.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;COPD.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;COPD.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;COPD.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;COPD.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;COPD.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up [Journal of Infection];COPD.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;COPD.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;COPD.
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis [medrxiv];COPD.
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19);COPD.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;COPD.
Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection;COPD.
Prognostic value of NT-proBNP in patients with severe COVID-19;COPD.
Clinical Characteristics of Coronavirus Disease 2019 in China;COPD.
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis [medrxiv];COPD.
Clinical characteristics of 2019 novel coronavirus infection in China;COPD.
Obesity and COVID-19: an Italian snapshot;Dementia.
Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study;Dementia.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Dementia.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Dementia.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Dementia.
Clinical Presentation of COVID19 in Dementia Patients;Dementia.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Dementia.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Dementia.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Dementia.
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Diabetes.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Diabetes.
Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.;Diabetes.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Diabetes.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Diabetes.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Diabetes.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Diabetes.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Diabetes.
Obesity and COVID-19: an Italian snapshot;Diabetes.
Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients;Diabetes.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Diabetes.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Diabetes.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-23;Diabetes.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Diabetes.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Diabetes.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Diabetes.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Diabetes.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Diabetes.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Diabetes.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Diabetes.
Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study;Diabetes.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Diabetes.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Diabetes.
COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter;Diabetes.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Diabetes.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Diabetes.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Diabetes.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Diabetes.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Diabetes.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Diabetes.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Diabetes.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;Diabetes.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study;Diabetes.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Diabetes.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Diabetes.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Diabetes.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Diabetes.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Diabetes.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Diabetes.
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis Q1 patients with SARS-CoV-2 infection;Diabetes.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Diabetes.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Diabetes.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Diabetes.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Diabetes.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Diabetes.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Diabetes.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Diabetes.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Diabetes.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Diabetes.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Diabetes.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2024;Diabetes.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Diabetes.
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis;Diabetes.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Diabetes.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Diabetes.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Diabetes.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Diabetes.
Systematic investigations of COVID-19 in 283 cancer patients;Diabetes.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Diabetes.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Diabetes.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Diabetes.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Diabetes.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Diabetes.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Diabetes.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Diabetes.
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection;Diabetes.
Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China;Diabetes.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Diabetes.
Clinical determinants for fatality of 44,672 patients with COVID-19;Diabetes.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Diabetes.
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes;Diabetes.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Diabetes.
ICU and ventilator mortality among critically ill adults with COVID-19;Diabetes.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Diabetes.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Diabetes.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Diabetes.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Diabetes.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Diabetes.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Diabetes.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Diabetes.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Diabetes.
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis;Diabetes.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Drinking.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Drinking.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Drinking.
Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage;Drinking.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Endocrine diseases.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Endocrine diseases.
The clinical course and its correlated immune status in COVID-19 pneumonia;Endocrine diseases.
Caution on Kidney Dysfunctions of COVID-19 Patients;Endocrine diseases.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Ethnicity_ Hispanic vs. non-Hispanic.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Ethnicity_ Hispanic vs. non-Hispanic.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Ethnicity_ Hispanic vs. non-Hispanic.
Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history;Ethnicity_ Hispanic vs. non-Hispanic.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Ethnicity_ Hispanic vs. non-Hispanic.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Ethnicity_ Hispanic vs. non-Hispanic.
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans;Ethnicity_ Hispanic vs. non-Hispanic.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Ethnicity_ Hispanic vs. non-Hispanic.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Ethnicity_ Hispanic vs. non-Hispanic.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Ethnicity_ Hispanic vs. non-Hispanic.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Ethnicity_ Hispanic vs. non-Hispanic.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Ethnicity_ Hispanic vs. non-Hispanic.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Ethnicity_ Hispanic vs. non-Hispanic.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Ethnicity_ Hispanic vs. non-Hispanic.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Ethnicity_ Hispanic vs. non-Hispanic.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Ethnicity_ Hispanic vs. non-Hispanic.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;Ethnicity_ Hispanic vs. non-Hispanic.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Heart Disease.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Heart Disease.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Heart Disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Heart Disease.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Heart Disease.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Heart Disease.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Heart Disease.
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.;Heart Disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Heart Disease.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Heart Disease.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Heart Disease.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-20;Heart Disease.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Heart Disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Heart Disease.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Heart Disease.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Heart Disease.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Heart Disease.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Heart Disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Heart Disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Heart Disease.
COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter;Heart Disease.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Heart Disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Heart Disease.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Heart Disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Heart Disease.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Heart Disease.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Heart Disease.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Heart Disease.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Heart Disease.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Heart Disease.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Heart Disease.
Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression;Heart Disease.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Heart Disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Heart Disease.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Heart Disease.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Heart Disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Heart Disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Heart Disease.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Heart Disease.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Heart Disease.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Heart Disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Heart Disease.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Heart Disease.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Heart Disease.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Heart Disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Heart Disease.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Heart Disease.
Systematic investigations of COVID-19 in 283 cancer patients;Heart Disease.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Heart Disease.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019;Heart Disease.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Heart Disease.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Heart Disease.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Heart Disease.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Heart Disease.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Heart Disease.
Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis;Heart Disease.
Clinical determinants for fatality of 44,672 patients with COVID-19;Heart Disease.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Heart Disease.
ICU and ventilator mortality among critically ill adults with COVID-19;Heart Disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Heart Disease.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Heart Disease.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Heart Disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Heart Disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Heart Disease.
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis;Heart Disease.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Heart Disease.
Clinical Characteristics of Covid-19 in New York City;Heart Disease.
Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts;Heart Disease.
Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui;Heart Disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Disease.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv];Heart Disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Disease.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis;Heart Disease.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Heart Disease.
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28;Heart Disease.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Heart Disease.
Factors associated with hospitalization and critical illness among 4,103 patients with;Heart Disease.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Heart Disease.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Heart Disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Heart Disease.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Heart Disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Heart Failure.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Heart Failure.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Heart Failure.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Heart Failure.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Heart Failure.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Heart Failure.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Heart Failure.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Heart Failure.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Heart Failure.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Heart Failure.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Heart Failure.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Heart Failure.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Heart Failure.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Heart Failure.
ICU and ventilator mortality among critically ill adults with COVID-19;Heart Failure.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Heart Failure.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Failure.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis;Heart Failure.
Factors associated with hospitalization and critical illness among 4,103 patients with;Heart Failure.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Heart Failure.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Heart Failure.
Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV;Heart Failure.
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Hypertension.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Hypertension.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Hypertension.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Hypertension.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Hypertension.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Hypertension.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Hypertension.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Hypertension.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Hypertension.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Hypertension.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Hypertension.
Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis;Hypertension.
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.;Hypertension.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Hypertension.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Hypertension.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Hypertension.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Hypertension.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-22;Hypertension.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Hypertension.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Hypertension.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Hypertension.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Hypertension.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Hypertension.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Hypertension.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Hypertension.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Hypertension.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Hypertension.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Hypertension.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Hypertension.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Hypertension.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Hypertension.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;Hypertension.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Hypertension.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Hypertension.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Hypertension.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Hypertension.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Hypertension.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Hypertension.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Hypertension.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Hypertension.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Hypertension.
Clinical characteristics of patients diagnosed with COVID-19 in Beijing;Hypertension.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Hypertension.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Hypertension.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Hypertension.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Hypertension.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Hypertension.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Hypertension.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Hypertension.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Hypertension.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Hypertension.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2022;Hypertension.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Hypertension.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Hypertension.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Hypertension.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Hypertension.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Hypertension.
Systematic investigations of COVID-19 in 283 cancer patients;Hypertension.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Hypertension.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Hypertension.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Hypertension.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Hypertension.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Hypertension.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Hypertension.
Hypertension and Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19;Hypertension.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Hypertension.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Hypertension.
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection;Hypertension.
Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China;Hypertension.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Hypertension.
Clinical determinants for fatality of 44,672 patients with COVID-19;Hypertension.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Hypertension.
Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission;Hypertension.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Hypertension.
Characterization of clinical progression of COVID-19 patients in Shenzhen, China;Hypertension.
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes;Hypertension.
ICU and ventilator mortality among critically ill adults with COVID-19;Hypertension.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Hypertension.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Hypertension.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Hypertension.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Hypertension.
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients;Hypertension.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Hypertension.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Hypertension.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Immune system disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Immune system disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Immune system disorders.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Immune system disorders.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Immune system disorders.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Immune system disorders.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Male gender.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Male gender.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Male gender.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Male gender.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Male gender.
Anakinra for severe forms of COVID-19: a cohort study;Male gender.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Male gender.
Obesity and COVID-19: an Italian snapshot;Male gender.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Male gender.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Male gender.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Male gender.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-24;Male gender.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Male gender.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Male gender.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Male gender.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study;Male gender.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Male gender.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Male gender.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Male gender.
Clinical characteristics of patients diagnosed with COVID-19 in Beijing;Male gender.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Male gender.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Male gender.
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City;Male gender.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Male gender.
Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored;Male gender.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Male gender.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Male gender.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Male gender.
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.;Male gender.
Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center Report;Male gender.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Male gender.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2021;Male gender.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Male gender.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Male gender.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Male gender.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Male gender.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Male gender.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Male gender.
Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China;Male gender.
Incidence of venous thromboembolism in hospitalized patients with COVID-20;Male gender.
Cohort profile: Preliminary experience of 500 COVID-19 postive cases at a South West London District General Hospital.;Male gender.
Characteristics of COVID-19 infection in Beijing;Male gender.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Male gender.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Male gender.
Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals;Male gender.
Gender-Based Disparities in COVID-19: Clinical Characteristics and Propensity-matched Analysis of Outcomes;Male gender.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Male gender.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Male gender.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Male gender.
Clinical determinants for fatality of 44,672 patients with COVID-19;Male gender.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Male gender.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Male gender.
Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China;Male gender.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Male gender.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Male gender.
No Clear Benefit to the Use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study;Male gender.
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes.;Male gender.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Male gender.
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients;Male gender.
Impact of blood analysis and immune function on the prognosis of patients with COVID-19;Male gender.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Male gender.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Male gender.
Early prediction of mortality risk among severe COVID-19 patients using machine learning;Male gender.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Male gender.
Clinical Characteristics of Covid-19 in New York City;Male gender.
Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts;Male gender.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Male gender.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Male gender.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv];Male gender.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Male gender.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Male gender.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv];Male gender.
Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study;Male gender.
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors;Male gender.
The clinical course and its correlated immune status in COVID-19 pneumonia;Male gender.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Male gender.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Male gender.
Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China;Male gender.
Factors associated with hospitalization and critical illness among 4,103 patients with;Male gender.
Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool;Male gender.
Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression;Male gender.
Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China;Male gender.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Male gender.
Compassionate Use of Remdesivir for Patients with Severe Covid-19;Male gender.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Neurological disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Neurological disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Neurological disorders.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Neurological disorders.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Neurological disorders.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Neurological disorders.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Overweight or obese.
Obesity and COVID-19: an Italian snapshot;Overweight or obese.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Overweight or obese.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Overweight or obese.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Overweight or obese.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Overweight or obese.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Overweight or obese.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Overweight or obese.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Overweight or obese.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Overweight or obese.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Overweight or obese.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Overweight or obese.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Overweight or obese.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Overweight or obese.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Overweight or obese.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Overweight or obese.
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.;Overweight or obese.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Overweight or obese.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2026;Overweight or obese.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Overweight or obese.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Overweight or obese.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Overweight or obese.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Overweight or obese.
Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals;Overweight or obese.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Overweight or obese.
Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease;Overweight or obese.
Clinical Characteristics of Covid-19 in New York City;Overweight or obese.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Overweight or obese.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Overweight or obese.
Factors associated with hospitalization and critical illness among 4,103 patients with;Overweight or obese.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Overweight or obese.
Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission;Overweight or obese.
High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation;Overweight or obese.
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China;Overweight or obese.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Overweight or obese.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Overweight or obese.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Race_ Asian vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Asian vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Asian vs. White.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Race_ Asian vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Asian vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Asian vs. White.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Race_ Asian vs. White.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Race_ Asian vs. White.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Race_ Black vs. White.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Race_ Black vs. White.
Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people;Race_ Black vs. White.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Race_ Black vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Black vs. White.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Race_ Black vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Black vs. White.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Race_ Black vs. White.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Race_ Black vs. White.
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans;Race_ Black vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Black vs. White.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Race_ Black vs. White.
Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area;Race_ Black vs. White.
Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study;Race_ Black vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Black vs. White.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Race_ Black vs. White.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Race_ Black vs. White.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Race_ Black vs. White.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Race_ Black vs. White.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Race_ Black vs. White.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Race_ Black vs. White.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Race_ Black vs. White.
ICU and ventilator mortality among critically ill adults with COVID-19;Race_ Black vs. White.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Race_ Black vs. White.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Race_ Black vs. White.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Race_ Other vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Other vs. White.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Race_ Other vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Other vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Other vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Other vs. White.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Race_ Other vs. White.
ICU and ventilator mortality among critically ill adults with COVID-19;Race_ Other vs. White.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Respiratory system diseases.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Respiratory system diseases.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Respiratory system diseases.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Respiratory system diseases.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Respiratory system diseases.
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis;Respiratory system diseases.
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis;Respiratory system diseases.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Respiratory system diseases.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Smoking Status.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Smoking Status.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Smoking Status.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Smoking Status.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Smoking Status.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Smoking Status.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Smoking Status.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Smoking Status.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Smoking Status.
Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience;Smoking Status.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Smoking Status.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Smoking Status.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Smoking Status.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Smoking Status.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Smoking Status.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Smoking Status.
Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis;Smoking Status.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2025;Smoking Status.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Smoking Status.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Smoking Status.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Smoking Status.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Smoking Status.
Systematic investigations of COVID-19 in 283 cancer patients;Smoking Status.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Smoking Status.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Smoking Status.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Smoking Status.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Smoking Status.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Smoking Status.
Smoking is Associated with COVID-19 Progression: A Meta-Analysis;Smoking Status.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv];Smoking Status.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Smoking Status.
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score;Smoking Status.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Smoking Status.
The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis;Smoking Status.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Smoking Status.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;Smoking Status.
Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19;Smoking Status.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Smoking Status.
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis;Smoking Status.
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China;Smoking Status.
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China;Smoking Status.
Prognostic value of C-reactive protein in patients with COVID-19;Smoking Status.
Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence;Smoking Status.
Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship Â“Diamond PrincessÂ” in Japan;Smoking Status.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Smoking Status.
Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence;Smoking Status.
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan;Smoking Status.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Smoking Status.
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19);Smoking Status.
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study;Smoking Status.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Smoking Status.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Smoking Status.
Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China;Smoking Status.
Clinical Characteristics of Coronavirus Disease 2019 in China;Smoking Status.
Clinical characteristics of 2019 novel coronavirus infection in China;Smoking Status.
Review Article;Adhesion to hydrophilic_phobic surfaces.
Detection of Air and Surface Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients;Adhesion to hydrophilic_phobic surfaces.
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1;Adhesion to hydrophilic_phobic surfaces.
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection.;Are there studies about phenotypic change_.
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells;Are there studies about phenotypic change_.
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series;Are there studies about phenotypic change_.
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells;Are there studies about phenotypic change_.
The phenotypic changes of γδ T cells in COVID-19 patients;Are there studies about phenotypic change_.
Zoonotic origins of human coronaviruses;Are there studies about phenotypic change_.
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019;Are there studies about phenotypic change_.
Pre-symptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data;Can the virus be transmitted asymptomatically or during the incubation period_.
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020;Can the virus be transmitted asymptomatically or during the incubation period_.
Modes of contact and risk of transmission in COVID-19 among close contacts;Can the virus be transmitted asymptomatically or during the incubation period_.
Temporal dynamics in viral shedding and transmissibility of COVID-19;Can the virus be transmitted asymptomatically or during the incubation period_.
Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province;Can the virus be transmitted asymptomatically or during the incubation period_.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Can the virus be transmitted asymptomatically or during the incubation period_.
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;Can the virus be transmitted asymptomatically or during the incubation period_.
Can N95 respirators be reused after disinfection? And for how many times?;Coronavirus susceptibility to heat light and radiation.
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process;Coronavirus susceptibility to heat light and radiation.
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the COVID-19 Pandemic;Coronavirus susceptibility to heat light and radiation.
Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse;Coronavirus susceptibility to heat light and radiation.
Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.;Development of a point-of-care test and rapid bed-side tests.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Development of a point-of-care test and rapid bed-side tests.
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING;Development of a point-of-care test and rapid bed-side tests.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Development of a point-of-care test and rapid bed-side tests.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Development of a point-of-care test and rapid bed-side tests.
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor;Development of a point-of-care test and rapid bed-side tests.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Development of a point-of-care test and rapid bed-side tests.
Point‐of‐care lung ultrasound in patients with COVID‐19 – a narrative review;Development of a point-of-care test and rapid bed-side tests.
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis;Development of a point-of-care test and rapid bed-side tests.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Development of a point-of-care test and rapid bed-side tests.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR;Development of a point-of-care test and rapid bed-side tests.
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department;Development of a point-of-care test and rapid bed-side tests.
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge;Development of a point-of-care test and rapid bed-side tests.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Development of a point-of-care test and rapid bed-side tests.
Coronavirus disease 2019, whart we know : Review;Development of a point-of-care test and rapid bed-side tests.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Development of a point-of-care test and rapid bed-side tests.
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing medrxiv;Development of a point-of-care test and rapid bed-side tests.
Molecular immune pathogenesis and diagnosis of COVID-19;Development of a point-of-care test and rapid bed-side tests.
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection medrxiv;Development of a point-of-care test and rapid bed-side tests.
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area;Development of a point-of-care test and rapid bed-side tests.
Recent advances and perspectives of nucleic acid detection for coronavirus;Development of a point-of-care test and rapid bed-side tests.
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv;Development of a point-of-care test and rapid bed-side tests.
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis;Development of a point-of-care test and rapid bed-side tests.
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Euro Surveill;Development of a point-of-care test and rapid bed-side tests.
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?;Development of a point-of-care test and rapid bed-side tests.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Development of a point-of-care test and rapid bed-side tests.
SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.;Development of a point-of-care test and rapid bed-side tests.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Development of a point-of-care test and rapid bed-side tests.
Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO;Development of a point-of-care test and rapid bed-side tests.
Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification;Development of a point-of-care test and rapid bed-side tests.
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19);Development of a point-of-care test and rapid bed-side tests.
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Development of a point-of-care test and rapid bed-side tests.
2020 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Development of a point-of-care test and rapid bed-side tests.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Development of a point-of-care test and rapid bed-side tests.
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan medrxiv;Development of a point-of-care test and rapid bed-side tests.
Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology;Development of a point-of-care test and rapid bed-side tests.
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia;Development of a point-of-care test and rapid bed-side tests.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR;Development of a point-of-care test and rapid bed-side tests.
Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity;Development of a point-of-care test and rapid bed-side tests.
Rapid Isothermal Amplification and portable detection system for SARS-COV2;Development of a point-of-care test and rapid bed-side tests.
Rapid and accurate detection of three genes in SARS-CoV-2 using RT-LAMP method;Development of a point-of-care test and rapid bed-side tests.
Development of a rapid test kit for SARS-CoV-2: an example of product design (review) , Loop-mediated Isothermal Amplification (LAMP) of Gene Sequences and Simple Visual Detection of Products (1);Development of a point-of-care test and rapid bed-side tests.
Antibody responses to SARS-CoV-2 in patients with COVID-19;Development of a point-of-care test and rapid bed-side tests.
Evaluation of nine commercial SARS-CoV-2 immunoassays;Diagnosing SARS-COV-2 with antibodies.
Diagnosing COVID-19: The Disease and Tools for Detection;Diagnosing SARS-COV-2 with antibodies.
Pixelated colorimetric nucleic acid assay;Diagnosing SARS-COV-2 with antibodies.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with antibodies.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Diagnosing SARS-COV-2 with antibodies.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Diagnosing SARS-COV-2 with antibodies.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Diagnosing SARS-COV-2 with antibodies.
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis;Diagnosing SARS-COV-2 with antibodies.
Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection medrxiv;Diagnosing SARS-COV-2 with antibodies.
Molecular immune pathogenesis and diagnosis of COVID-19;Diagnosing SARS-COV-2 with antibodies.
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing medrxiv;Diagnosing SARS-COV-2 with antibodies.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with antibodies.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Diagnosing SARS-COV-2 with antibodies.
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department;Diagnosing SARS-COV-2 with antibodies.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Diagnosing SARS-COV-2 with antibodies.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Diagnosing SARS-COV-2 with antibodies.
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING;Diagnosing SARS-COV-2 with antibodies.
The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays;Diagnosing SARS-COV-2 with antibodies.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with antibodies.
Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnosing COVID-19: The Disease and Tools for Detection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Sensitive one-step isothermal detection of pathogen-derived RNAs medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design biorxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Pixelated colorimetric nucleic acid assay;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2 biorxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Development and Evaluation of A CRISPR-based Diagnostic 2 For 2019-novel Coronavirus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Recent advances in the detection of respiratory virus infection in humans Journal of Medical Virology;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
A  Single and Two-Stage, Closed-Tube, Molecular Test for the 2019  Novel Coronavirus (COVID-19)at Home, Clinic, and Points of Entry;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China Journal of Microbiology, Immunology and Infection;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19);Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid colorimetric detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform: iLACO;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020 Euro Surveill;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP medrxiv;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Recent advances and perspectives of nucleic acid detection for coronavirus;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Molecular immune pathogenesis and diagnosis of COVID-19;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Coronavirus disease 2019, whart we know : Review;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.;Diagnosing SARS-COV-2 with Nucleic-acid based tech.
Optimal policies for control of the novel coronavirus (COVID-19);Effectiveness of a multifactorial strategy to prevent secondary transmission.
A model for COVID-19 with isolation, quarantine and testing as control measures;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling and forecasting of the COVID-19 pandemic in India;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Now casting and Forecasting of COVID-19 outbreak in the National Capital Region of Delhi;Effectiveness of a multifactorial strategy to prevent secondary transmission.
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling serological testing to inform relaxation of social distancing for COVID-19 control;Effectiveness of a multifactorial strategy to prevent secondary transmission.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of Social Distancing Measures on COVID-19 Healthcare Demand in Central Texas;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Social interventions can lower COVID-19 deaths in middle-income countries;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Data Driven Modeling of Projected Mitigation and Suppressing Strategy Interventions for SARS-COV 2 in Ghana;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Estimating cost-benefit of quarantine length for COVID-19 mitigation;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Evidence Based Management Guideline for the COVID-19 Pandemic - Review article;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Sustainable social distancing through facemask use and testing during the Covid-19 pandemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
New measures for COVID-19 response: a lesson from the Wenzhou experience;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of a multifactorial strategy to prevent secondary transmission.
General Model for COVID-19 Spreading with Consideration of Intercity Migration, Insufficient Testing and Active Intervention: Application to Study of Pandemic Progression in Japan and USA;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study The Lancet Public Health;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A COVID-19 Epidemiological Model for Community and Policy Maker Use;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Impact of self-imposed prevention measures and short-term government intervention on mitigating and delaying a COVID-19 epidemic;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the epidemic dynamics and control of COVID-19 outbreak in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province;Effectiveness of a multifactorial strategy to prevent secondary transmission.
The impact of social distancing and epicenter lockdown on the COVID-19 epidemic in mainland China: A data-driven SEIQR model study;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
A simple model to assess Wuhan lock-down effect and region efforts during COVID-19 epidemic in China Mainland;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model medrxiv;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Spatially Explicit Modeling of 2019-nCoV Epidemic Trend based on Mobile Phone Data in Mainland China;Effectiveness of a multifactorial strategy to prevent secondary transmission.
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Using epidemic simulators for monitoring an ongoing epidemic;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Contact tracing strategies for COVID-19 containment with attenuated physical distancing;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Now casting and Forecasting of COVID-19 outbreak in the National Capital Region of Delhi;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A stochastic epidemic model of COVID-19 disease;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Impact of virus testing on COVID-19 case fatality rate: estimate using a fixed-effects model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Institutional, not home-based, isolation could contain the COVID-19 outbreak;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management medrxiv;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effectiveness of isolation, testing, contact tracing and physical distancing on reducing transmission of SARS-CoV-2 in different settings;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A simulation of a COVID-19 epidemic based on a deterministic SEIR model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
How Reliable are Test Numbers for Revealing the COVID-19 Ground Truth and Applying Interventions?;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Data Driven Modeling of Projected Mitigation and Suppressing Strategy Interventions for SARS-COV 2 in Ghana;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Analysis of the COVID-19 epidemic in french overseas department Mayotte based on a modified deterministic and stochastic SEIR model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the transmission of new coronavirus in Sao Paulo State, Brazil -- Assessing epidemiological impacts of isolating young and elder persons;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Household Secondary Attack Rate of COVID-19 and Associated Determinants;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A hybrid multi-scale model of COVID-19 transmission dynamics to assess the potential of non-pharmaceutical interventions;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The effect of non-pharmaceutical interventions on COVID-19 cases, deaths and demand for hospital services in the UK: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The Effectiveness of Targeted Quarantine for Minimising Impact of COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Different scenarios in the Dynamics of SARS-Cov-2 Infection: an adapted ODE model;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
COVID-19 infection and recovery in various countries: Modeling the dynamics and evaluating the non-pharmaceutical mitigation scenarios;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A single holiday was the turning point of the COVID-19 policy of Israel;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Symptom-Based Isolation Policies: Evidence from a Mathematical Model of Outbreaks of Influenze and COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Scientific and ethical basis for social-distancing interventions against COVID-19;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis medrxiv;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Short-term predictions and prevention strategies for COVID-2019: A model based study;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Calibrated Intervention and Containment of the COVID-19 Pandemic;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the epidemic dynamics and control of COVID-19 outbreak in China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
A Time Delay Dynamical Model for Outbreak of 2019-nCoV and the Parameter Identification;Effectiveness of case isolation_isolation of exposed individuals to prevent secondary transmission.
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability;Effectiveness of community contact reduction.
A model for COVID-19 with isolation, quarantine and testing as control measures;Effectiveness of community contact reduction.
Social Distancing is Effective at Mitigating COVID-19 Transmission in the United States;Effectiveness of community contact reduction.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of community contact reduction.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of community contact reduction.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of community contact reduction.
A stochastic epidemic model of COVID-19 disease;Effectiveness of community contact reduction.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of community contact reduction.
Investigating duration and intensity of Covid-19 social-distancing strategies;Effectiveness of community contact reduction.
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies;Effectiveness of community contact reduction.
Modelling the potential impact of social distancing on the COVID-19 epidemic in South Africa;Effectiveness of community contact reduction.
Mathematical modeling of COVID-19 containment strategies with considerations for limited medical resources;Effectiveness of community contact reduction.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of community contact reduction.
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus;Effectiveness of community contact reduction.
The December 2019 New Corona Virus (SARS-CoV-2) Outbreak: A Behavioral Infectious Disease Policy Model;Effectiveness of community contact reduction.
Optimal Control applied to a SEIR model of 2019-nCoV with social distancing;Effectiveness of community contact reduction.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of community contact reduction.
Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness;Effectiveness of community contact reduction.
Flattening the curve before it flattens us: hospital critical care capacity limits and mortality from novel coronavirus (SARS-CoV2) cases in US counties;Effectiveness of community contact reduction.
COVID-19 infection and recovery in various countries: Modeling the dynamics and evaluating the non-pharmaceutical mitigation scenarios;Effectiveness of community contact reduction.
The SARS-CoV-2 epidemic outbreak: a review of plausible scenarios of containment and mitigation for Mexico;Effectiveness of community contact reduction.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China;Effectiveness of community contact reduction.
Effectiveness and cost-effectiveness of public health measures to control COVID-19: a modelling study;Effectiveness of community contact reduction.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of community contact reduction.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan, China through status dynamic modeling;Effectiveness of community contact reduction.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of community contact reduction.
Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess;Effectiveness of community contact reduction.
Modeling and forecasting of the COVID-19 pandemic in India;Effectiveness of inter_inner travel restriction.
COVID-19 pandemic control: balancing detection policy and lockdown intervention under ICU sustainability;Effectiveness of inter_inner travel restriction.
Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China;Effectiveness of inter_inner travel restriction.
A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control;Effectiveness of inter_inner travel restriction.
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States;Effectiveness of inter_inner travel restriction.
Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study;Effectiveness of inter_inner travel restriction.
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study;Effectiveness of inter_inner travel restriction.
Detection and isolation of asymptomatic individuals can make the difference in COVID-19 epidemic management;Effectiveness of inter_inner travel restriction.
COVID-19 pandemic scenario in India compared to China and rest of the world: a data driven and model analysis medrxiv;Effectiveness of inter_inner travel restriction.
Lockdown, one, two, none, or smart. Modeling containing covid-19 infection. A conceptual model;Effectiveness of inter_inner travel restriction.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of inter_inner travel restriction.
The effect of inter-city travel restrictions on geographical spread of COVID-19: Evidence from Wuhan, China;Effectiveness of inter_inner travel restriction.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of inter_inner travel restriction.
Derivation of the effective reproduction number R for COVID-19 in relation to mobility restrictions and confinement;Effectiveness of inter_inner travel restriction.
Assessment of 21 Days Lockdown Effect in Some States and Overall India: A Predictive Mathematical Study on COVID-19 Outbreak;Effectiveness of inter_inner travel restriction.
Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US;Effectiveness of inter_inner travel restriction.
Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China;Effectiveness of inter_inner travel restriction.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan, China through status dynamic modeling;Effectiveness of inter_inner travel restriction.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Effectiveness of inter_inner travel restriction.
Lessons learnt from 288 COVID-19 international cases: importations over time, effect of interventions, underdetection of imported cases;Effectiveness of inter_inner travel restriction.
Estimation of the epidemic properties of the 2019 novel coronavirus: A mathematical modeling study;Effectiveness of inter_inner travel restriction.
Estimating the Efficacy of Traffic Blockage and Quarantine for the Epidemic Caused by 2019-nCoV (COVID-19);Effectiveness of inter_inner travel restriction.
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19);Effectiveness of inter_inner travel restriction.
The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated;Effectiveness of inter_inner travel restriction.
Effectiveness of Surgical and Cotton Masks in Blocking SARSCoV-2: A Controlled Comparison in 4 Patients;Effectiveness of personal protective equipment (PPE).
Respiratory virus shedding in exhaled breath and efficacy of face masks;Effectiveness of personal protective equipment (PPE).
Can physical interventions help reduce the spread of respiratory viruses?;Effectiveness of personal protective equipment (PPE).
Association between 2019-nCoV transmission and N95 respirator use;Effectiveness of personal protective equipment (PPE).
COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope;Effectiveness of school distancing.
Modeling the COVID-19 epidemic in Okinawa;Effectiveness of school distancing.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis medrxiv;Effectiveness of school distancing.
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19;Effectiveness of school distancing.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of school distancing.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of school distancing.
Modelling transmission and control of the COVID-19 pandemic in Australia;Effectiveness of school distancing.
Can the COVID-19 epidemic be controlled on the basis of daily test reports?;Effectiveness of school distancing.
Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis;Effectiveness of workplace distancing to prevent secondary transmission.
Estimating cost-benefit of quarantine length for COVID-19 mitigation;Effectiveness of workplace distancing to prevent secondary transmission.
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Lancet Infectious Diseases;Effectiveness of workplace distancing to prevent secondary transmission.
The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis;Effectiveness of workplace distancing to prevent secondary transmission.
SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19;Effectiveness of workplace distancing to prevent secondary transmission.
Spatially Explicit Modeling of 2019-nCoV Epidemic Trend based on Mobile Phone Data in Mainland China;Effectiveness of workplace distancing to prevent secondary transmission.
Assessment of COVID-19 Knowledge Among University Students: Implications for Future Risk Communication Strategies;Efforts to develop qualitative assessment frameworks.
Knowledge, Perceptions and Preventive Practices Towards COVID-19 Early in the Outbreak Among Jimma University Medical Center Visitors, Southwest Ethiopia;Efforts to develop qualitative assessment frameworks.
Public Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Study in Malaysia;Efforts to develop qualitative assessment frameworks.
Analysis of Public Perception of the Israeli Government's Early Emergency Instructions Regarding COVID-19: Online Survey Study;Efforts to develop qualitative assessment frameworks.
Knowledge and Behaviors Toward COVID-19 Among US Residents During the Early Days of the Pandemic: Cross-Sectional Online Questionnaire;Efforts to develop qualitative assessment frameworks.
No Place Like Home: A Cross-National Assessment of the Efficacy of Social Distancing During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
The urgent need for integrated science to fight COVID-19 pandemic and beyond;Efforts to develop qualitative assessment frameworks.
Implications of the Lack of a Unified Research Project Framework: An Investigation Into the Registration of Clinical Trials of COVID-19;Efforts to develop qualitative assessment frameworks.
Dynamic Interventions to Control COVID-19 Pandemic: A Multivariate Prediction Modelling Study Comparing 16 Worldwide Countries;Efforts to develop qualitative assessment frameworks.
Mobile Health Clinic Model in the COVID-19 Pandemic: Lessons Learned and Opportunities for Policy Changes and Innovation;Efforts to develop qualitative assessment frameworks.
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps and Opportunities;Efforts to develop qualitative assessment frameworks.
Modeling COVID-19 Latent Prevalence to Assess a Public Health Intervention at a State and Regional Scale;Efforts to develop qualitative assessment frameworks.
Predictions of Covid-19 Related Unemployment On Suicide and Excess Mortality in the United States;Efforts to develop qualitative assessment frameworks.
Digital Health and the COVID-19 Epidemic: An Assessment Framework for Apps From an Epidemiological and Legal Perspective;Efforts to develop qualitative assessment frameworks.
What Is Inconvenient for You Is Life-saving for Me': How Health Inequities Are Playing Out During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
Royal Flying Doctor Service COVID-19 Activity and Surge Modelling in Australia;Efforts to develop qualitative assessment frameworks.
Forecasting COVID-19-Associated Hospitalizations Under Different Levels of Social Distancing in Lombardy and Emilia-Romagna, Northern Italy: Results From an Extended SEIR Compartmental Model;Efforts to develop qualitative assessment frameworks.
[Quarantine Alone or in Combination With Other Public Health Measures to Control COVID-19: A Rapid Review (Review)];Efforts to develop qualitative assessment frameworks.
Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level;Efforts to develop qualitative assessment frameworks.
A Simple Remote Nutritional Screening Tool and Practical Guidance for Nutritional Care in Primary Practice During the COVID-19 Pandemic;Efforts to develop qualitative assessment frameworks.
Social Media as a Recruitment Platform for a Nationwide Online Survey of COVID-19 Knowledge, Beliefs, and Practices in the United States: Methodology and Feasibility Analysis;Efforts to develop qualitative assessment frameworks.
The Predictive Capacity of Air Travel Patterns During the Global Spread of the COVID-19 Pandemic: Risk, Uncertainty and Randomness;Efforts to develop qualitative assessment frameworks.
Assessing the Effects of Metropolitan-Wide Quarantine on the Spread of COVID-19 in Public Space and Households;Efforts to develop qualitative assessment frameworks.
Predictors of adherence to public health instructions during the COVID-19 pandemic;Efforts to develop qualitative assessment frameworks.
Coping with diabetes during the COVID – 19 lockdown in India: Results of an online pilot survey;Efforts to develop qualitative assessment frameworks.
Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: what are the mental health risks?;Efforts to develop qualitative assessment frameworks.
Data Mining and Content Analysis of the Chinese Social Media Platform Weibo During the Early COVID-19 Outbreak: Retrospective Observational Infoveillance Study;Efforts to develop qualitative assessment frameworks.
Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis;Efforts to develop qualitative assessment frameworks.
Modeling the COVID-19 outbreaks and the effectiveness of the containment measures adopted across countries;Efforts to develop qualitative assessment frameworks.
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study;Efforts to develop qualitative assessment frameworks.
Perceptions of the Adult US Population Regarding the Novel Coronavirus Outbreak;Efforts to develop qualitative assessment frameworks.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Efforts to develop qualitative assessment frameworks.
Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic;Efforts to develop qualitative assessment frameworks.
Data-Driven Study of the COVID-19 Pandemic via Age-Structured Modelling and Prediction of the Health System Failure in Brazil amid Diverse Intervention Strategies;Efforts to develop qualitative assessment frameworks.
Coronavirus Disease 2019 (COVID-19) and Mental Health for Children and Adolescents;Efforts to develop qualitative assessment frameworks.
KCDC Risk Assessments on the Initial Phase of the COVID-19 Outbreak in Korea;Efforts to develop qualitative assessment frameworks.
Data for Understanding the Risk Perception of COVID-19 From Vietnamese Sample;Efforts to develop qualitative assessment frameworks.
The missing pieces in the jigsaw and need for cohesive research amidst COVID 19 global response;Efforts to develop qualitative assessment frameworks.
Increased Detection coupled with Social Distancing and Health Capacity Planning Reduce the Burden of COVID-19 Cases and Fatalities: A Proof of Concept Study using a Stochastic Computational Simulation Model;Efforts to develop qualitative assessment frameworks.
Political Beliefs affect Compliance with COVID-19 Social Distancing Orders;Efforts to develop qualitative assessment frameworks.
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review.;Efforts to develop qualitative assessment frameworks.
Travel health risk perceptions of Chinese international students in Australia – Implications for COVID-19;Efforts to develop qualitative assessment frameworks.
School Opening Delay Effect on Transmission Dynamics of Coronavirus Disease 2019 in Korea: Based on Mathematical Modeling and Simulation Study.;Efforts to develop qualitative assessment frameworks.
Considering inequalities in the school closure response to COVID-19.;Efforts to develop qualitative assessment frameworks.
Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19;Efforts to develop qualitative assessment frameworks.
"COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception";Efforts to develop qualitative assessment frameworks.
Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19;Efforts to develop qualitative assessment frameworks.
Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020;Efforts to develop qualitative assessment frameworks.
Measuring Two Distinct Psychological Threats of COVID-19 and their Unique Impacts on Well-being and Adherence to Public Health Behaviors;Efforts to develop qualitative assessment frameworks.
COVID-19 pandemic and addiction: Current problems and future concerns;Efforts to develop qualitative assessment frameworks.
Data and Statistics on Children's Mental Health;Efforts to develop qualitative assessment frameworks.
Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries;Efforts to develop qualitative assessment frameworks.
COVID-19 Modelling: the Effects of Social Distancing;Efforts to develop qualitative assessment frameworks.
Age-structured impact of social distancing on the COVID-19 epidemic in India;Efforts to develop qualitative assessment frameworks.
Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management;Efforts to develop qualitative assessment frameworks.
Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people;Efforts to develop qualitative assessment frameworks.
Scientific and ethical basis for social-distancing interventions against COVID-19;Efforts to develop qualitative assessment frameworks.
Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19);Efforts to develop qualitative assessment frameworks.
Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries;Efforts to develop qualitative assessment frameworks.
Impact of city and residential unit lockdowns on prevention and control of COVID-19;Efforts to develop qualitative assessment frameworks.
Knowledge, Attitudes, and Practices Towards COVID-19 Among Chinese Residents During the Rapid Rise Period of the COVID-19 Outbreak: A Quick Online Cross-Sectional Survey;Efforts to develop qualitative assessment frameworks.
The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19;Efforts to develop qualitative assessment frameworks.
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China;Efforts to develop qualitative assessment frameworks.
How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know;Efforts to develop qualitative assessment frameworks.
Research Frontiers of Health Emergency and Disaster Risk Management: What Do We Know So Far?;Efforts to develop qualitative assessment frameworks.
How will country-based mitigation measures influence the course of the COVID-19 epidemic?;Efforts to develop qualitative assessment frameworks.
Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are Under Quarantine;Efforts to develop qualitative assessment frameworks.
Psychological interventions for people affected by the COVID-19 epidemic;Efforts to develop qualitative assessment frameworks.
Susceptibility of tree shrew to SARS-CoV-2 infection;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Is COVID-19 the first pandemic that evolves into a panzootic?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
A rapid review of evidence of infection of pets and livestock with human-associated coronavirus diseases, SARS, MERS, and COVID-19, and evidence of the fomite potential of pets and livestock;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Serological survey of SARS‐CoV‐2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
An Overview of SARS‐CoV‐2 and Animal Infection;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
COVID-19 and pets: When pandemic meets panic;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Can companion animals become infected with Covid-19?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-3;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-4;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-5;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-6;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-7;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Coronavirus Disease 2019 (COVID-19) Outbreak: Could Pigs Be Vectors for Human Infections?;Evidence that domesticated_farm animals can be infected and maintain transmissibility of the disease.
Clinical Laboratory Parameters Associated with Severe or Critical Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-analysis;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Case fatality rate in COVID-19: a systematic review and meta-analysis;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Current Trends in Diagnostics of Viral Infections of Unknown Etiology Viruses;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;How can we measure changes in COVID-19_s behavior in a human host as the virus evolves over time_.
Containing the Spread of Coronavirus Disease 2019 (COVID-19): Meteorological Factors and Control Strategies;How does temperature and humidity affect the transmission of 2019-nCoV_.
COVID-19: Effects of weather conditions on the propagation of respiratory droplets;How does temperature and humidity affect the transmission of 2019-nCoV_.
The Modest Impact of Weather and Air Pollution on COVID-19 Transmission;How does temperature and humidity affect the transmission of 2019-nCoV_.
Higher Temperature, Pressure, and Ultraviolet Are Associated with Less COVID-19 Prevalence: Meta-Regression of Japanese Prefectural Data;How does temperature and humidity affect the transmission of 2019-nCoV_.
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2;How does temperature and humidity affect the transmission of 2019-nCoV_.
The effect of ambient temperature on worldwide COVID-19 cases and deaths - an epidemiological study;How does temperature and humidity affect the transmission of 2019-nCoV_.
Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature and relative humidity are not major contributing factor on the occurrence 2 of COVID-19 pandemic: An observational study in 57 countries (2020-05-08);How does temperature and humidity affect the transmission of 2019-nCoV_.
Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-;How does temperature and humidity affect the transmission of 2019-nCoV_.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effect of Temperature on the Transmission of COVID-19: A Machine Learning Case Study in Spain;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil;How does temperature and humidity affect the transmission of 2019-nCoV_.
The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature and humidity on the spread of COVID-19: A systematic review;How does temperature and humidity affect the transmission of 2019-nCoV_.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;How does temperature and humidity affect the transmission of 2019-nCoV_.
Evidence that higher temperatures are associated with lower incidence of COVID-19 in pandemic state, cumulative cases reported up to March 27, 2020;How does temperature and humidity affect the transmission of 2019-nCoV_.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;How does temperature and humidity affect the transmission of 2019-nCoV_.
Meteorological factors correlate with transmission of 2019-nCoV: Proof of incidence of novel coronavirus pneumonia in Hubei Province, China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temperature, humidity, and wind speed are associated with lower Covid-19 incidence;How does temperature and humidity affect the transmission of 2019-nCoV_.
No Evidence for Temperature-Dependence of the COVID-19 Epidemic;How does temperature and humidity affect the transmission of 2019-nCoV_.
COVID-19 transmission in Mainland China is associated with temperature and humidity: a time-series analysis;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature on COVID-19 transmission;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;How does temperature and humidity affect the transmission of 2019-nCoV_.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Association between ambient temperature and COVID-19 infection in 122 cities from China;How does temperature and humidity affect the transmission of 2019-nCoV_.
Roles of meteorological conditions in COVID-19 transmission on a worldwide scale;How does temperature and humidity affect the transmission of 2019-nCoV_.
Effects of temperature variation and humidity on the mortality of COVID-19 in Wuhan;How does temperature and humidity affect the transmission of 2019-nCoV_.
High Temperature and High Humidity Reduce the Transmission of COVID-19;How does temperature and humidity affect the transmission of 2019-nCoV_.
Role of temperature and humidity in the modulation of the doubling time of COVID-19 cases;How does temperature and humidity affect the transmission of 2019-nCoV_.
Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic period;How does temperature and humidity affect the transmission of 2019-nCoV_.
Potential Factors Influencing Repeated SARS Outbreaks in China.;How does temperature and humidity affect the transmission of 2019-nCoV_.
"The Effects of ""Fangcang Huoshenshan and Leishenshan"" Makeshift Hospitals and Temperature on the Mortality of COVID-19";How does temperature and humidity affect the transmission of 2019-nCoV_.
Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV);How does temperature and humidity affect the transmission of 2019-nCoV_.
Analysis of meteorological conditions and prediction of epidemic trend of 2019-nCoV infection in 2020;How does temperature and humidity affect the transmission of 2019-nCoV_.
The role of absolute humidity on transmission rates of the COVID-19 outbreak;How does temperature and humidity affect the transmission of 2019-nCoV_.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical and virological data of the first cases of COVID-19 in Europe;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
A Well Infant With Coronavirus Disease 2019 With High Viral Load;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Understanding COVID-19: what does viral RNA load really mean?;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Temporal dynamics in viral shedding and transmissibility of COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Duration of viral detection in throat and rectum of a patient with COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Virological assessment of hospitalized cases of coronavirus disease 2019;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients;How does viral load relate to disease presentations and likelihood of a positive diagnostic test_.
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents;How long can other HCoV strains remain viable on common surfaces_.
Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials.;How long can other HCoV strains remain viable on common surfaces_.
Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections;How long can other HCoV strains remain viable on common surfaces_.
Stability and inactivation of SARS coronavirus;How long can other HCoV strains remain viable on common surfaces_.
Significantly longer Covid-19 incubation times for the elderly, from a case study of 136 patients throughout China;Incubation period across different age groups.
The clinical and immunological features of pediatric COVID-19 patients in China;Incubation period across different age groups.
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study;Incubation period across different age groups.
Children are unlikely to have been the primary source of household SARS-CoV-2 infections;Incubation period across different age groups.
Viral Kinetics and Antibody responses in Patients with COVID-19;Incubation period across different age groups.
Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)?;Incubation period across different age groups.
Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series;Incubation period across different age groups.
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Incubation period across different age groups.
Estimate the incubation period of coronavirus 2019 (COVID-19);Incubation period across different age groups.
Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China;Length of viral shedding after illness onset.
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.;Length of viral shedding after illness onset.
Prolonged SARS‐CoV‐2 RNA shedding: Not a rare phenomenon;Length of viral shedding after illness onset.
Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration;Length of viral shedding after illness onset.
Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study;Length of viral shedding after illness onset.
Risk Factors for Viral RNA Shedding in COVID-19 Patients;Length of viral shedding after illness onset.
Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan;Length of viral shedding after illness onset.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Length of viral shedding after illness onset.
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review;Length of viral shedding after illness onset.
The duration of viral shedding of discharged patients with severe COVID-19;Length of viral shedding after illness onset.
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes;Length of viral shedding after illness onset.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study;Length of viral shedding after illness onset.
Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19);Length of viral shedding after illness onset.
Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China;Length of viral shedding after illness onset.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;Length of viral shedding after illness onset.
Viral Kinetics and Antibody Responses in Patients with COVID-19;Length of viral shedding after illness onset.
Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients;Length of viral shedding after illness onset.
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples;Length of viral shedding after illness onset.
Patients with respiratory symptoms are at greater risk of COVID-19 transmission;Length of viral shedding after illness onset.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Length of viral shedding after illness onset.
COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province China;Length of viral shedding after illness onset.
COVID-19 outbreak at a large homeless shelter in Boston: Implications for universal testing;Management of patients who are underhoused or otherwise lower social economic status.
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science;Management of patients who are underhoused or otherwise lower social economic status.
U.S. county-level characteristics to inform equitable COVID-19 response;Management of patients who are underhoused or otherwise lower social economic status.
Epidemiology of COVID-19 among people experiencing homelessness: Early evidence from Boston;Management of patients who are underhoused or otherwise lower social economic status.
The Challenge of Preventing COVID-19 Spread in Correctional Facilities;Management of patients who are underhoused or otherwise lower social economic status.
Mitigating and learning from the impact of COVID-19 infection on addictive disorders;Management of patients who are underhoused or otherwise lower social economic status.
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness;Management of patients who are underhoused or otherwise lower social economic status.
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons;Management of patients who are underhoused or otherwise lower social economic status.
Fighting covid-19 outbreaks in prisons;Management of patients who are underhoused or otherwise lower social economic status.
Addressing the Threat of COVID-19-Related Housing Instability and Displacement in Delaware;Management of patients who are underhoused or otherwise lower social economic status.
"Estimated Emergency and Observational/ Quarantine Capacity Need for the US Homeless Population Related to COVID-19 Exposure by County; Projected Hospitalizations, Intensive Care Units and Mortality";Management of patients who are underhoused or otherwise lower social economic status.
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically;Management of patients who are underhoused or otherwise lower social economic status.
Efforts escalate to protect homeless people from COVID-19 in UK;Management of patients who are underhoused or otherwise lower social economic status.
Covid-19: control measures must be equitable and inclusive;Management of patients who are underhoused or otherwise lower social economic status.
Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid’s Response to COVID-19;Management of patients who are underhoused or otherwise lower social economic status.
Prisons and custodial settings are part of a comprehensive response to COVID-19;Management of patients who are underhoused or otherwise lower social economic status.
The Coronavirus Could Hit People Experiencing Homelessness Hard;Management of patients who are underhoused or otherwise lower social economic status.
COVID-19: a potential public health problem for homeless populations;Management of patients who are underhoused or otherwise lower social economic status.
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gender-Based Disparities in COVID-19 Patient Outcomes: A Propensity-matched Analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID19 Infection;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gastrointestinal symptoms as Covid-19 onset in hospitalized Italian patients;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Cardiac and arrhythmic complications in patients with COVID-19.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Features of COVID-19-Related Liver Damage;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19);Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Predicting COVID-19 malignant progression with AI techniques;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
COVID-19 Myocarditis and Severity Factors： An Adult Cohort Study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19);Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: A cross-sectional study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Acute Myocardial Injury of Patients with Coronavirus Disease 2019;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Manifestations of COVID-19 including but not limited to possible cardiomyopathy and cardiac arrest.
Flattening the Curve by Getting Ahead of It: How the VA Healthcare System Is Leveraging Telehealth to Provide Continued Access to Care for Rural Veterans.;Measures to reach marginalized and disadvantaged populations.
Compounding Health Risks and Increased Vulnerability to SARS-CoV-2 for Racial and Ethnic Minorities and Low Socioeconomic Status Individuals in the United States;Measures to reach marginalized and disadvantaged populations.
Mental Health Services in Lombardy during COVID-19 outbreak.;Measures to reach marginalized and disadvantaged populations.
Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery.;Measures to reach marginalized and disadvantaged populations.
Telemedicine in the Time of Coronavirus;Measures to reach marginalized and disadvantaged populations.
Feeding Low-Income Children during the Covid-19 Pandemic;Measures to reach marginalized and disadvantaged populations.
Use of a Real-Time Locating System for Contact Tracing of Health Care Workers During the COVID-19 Pandemic at an Infectious Disease Center in Singapore: Validation Study;Methods to control the spread in communities.
Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate;Methods to control the spread in communities.
Early Transmission Dynamics of COVID-19 in a Southern Hemisphere Setting: Lima-Peru: February 29th-March 30th, 2020;Methods to control the spread in communities.
Coping With Diabetes During the COVID - 19 Lockdown in India: Results of an Online Pilot Survey;Methods to control the spread in communities.
To Mask or Not to Mask Children to Overcome COVID-19;Methods to control the spread in communities.
Criminal Justice-Involved Women Navigate COVID-19: Notes From the Field.;Methods to control the spread in communities.
COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020.;Methods to control the spread in communities.
Quantifying the Impact of Physical Distance Measures on the Transmission of COVID-19 in the UK;Methods to control the spread in communities.
Modeling Behavioral Change and COVID-19 Containment in Mexico: A Trade-Off Between Lockdown and Compliance;Methods to control the spread in communities.
Mathematical Assessment of the Impact of Non-Pharmaceutical Interventions on Curtailing the 2019 Novel Coronavirus;Methods to control the spread in communities.
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak;Methods to control the spread in communities.
Disability, Urban Health Equity, and the Coronavirus Pandemic: Promoting Cities for All.;Methods to control the spread in communities.
The Role of Community-Wide Wearing of Face Mask for Control of Coronavirus Disease 2019 (COVID-19) Epidemic Due to SARS-CoV-2;Methods to control the spread in communities.
Inter Nation Social Lockdown Versus Medical Care Against COVID-19, a Mild Environmental Insight With Special Reference to India;Methods to control the spread in communities.
To Mask or Not to Mask: Modeling the Potential for Face Mask Use by the General Public to Curtail the COVID-19 Pandemic;Methods to control the spread in communities.
Preparedness, prevention and control of coronavirus disease (COVID-19) for refugees and migrants in non-camp settings;Methods to control the spread in communities.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Methods to control the spread in communities.
COVID-19 Preparedness in Michigan Nursing Homes.;Methods to control the spread in communities.
Special Article: Risk Communication During COVID-19;Methods to control the spread in communities.
Public perceptions and experiences of social distancing and social isolation during the COVID-19 pandemic: A UK-based focus group study;Methods to control the spread in communities.
Self-reported compliance and attitudes about social distancing during the COVID-19 outbreak;Methods to control the spread in communities.
Self-Isolation Compliance in the COVID-19 Era Influenced by Compensation: Findings From a Recent Survey In Israel;Methods to control the spread in communities.
Quarantine Alone or in Combination With Other Public Health Measures to Control COVID-19: A Rapid Review;Methods to control the spread in communities.
Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review;Methods to control the spread in communities.
Political Beliefs affect Compliance with COVID-19 Social Distancing Orders;Methods to control the spread in communities.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Methods to control the spread in communities.
Functional Fear Predicts PublicHelath Compliance in the COVID-19 Pandemic;Methods to control the spread in communities.
The effectiveness of moral messages on public health behavioral intentions during the COVID-19 pandemic;Methods to control the spread in communities.
Age-structured impact of social distancing on the COVID-19 epidemic in India;Methods to control the spread in communities.
Community pharmacists and communication in the time of COVID-19: Applying the health belief model;Methods to control the spread in communities.
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study;Methods to control the spread in communities.
Getting your workplace ready for COVID-19;Methods to control the spread in communities.
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts;Methods to control the spread in communities.
Emojis in public health and how they might be used for hand hygiene and infection prevention and control;Methods to control the spread in communities.
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo;Methods to understand and regulate the spread in communities.
Quantifying human mobility behavior changes in response to non-pharmaceutical interventions during the COVID-19 outbreak in the United States.;Methods to understand and regulate the spread in communities.
A reality check on the use of face masks during the COVID-19 outbreak in Hong Kong;Methods to understand and regulate the spread in communities.
Non-compliance with COVID-19-related public health measures among young adults: Insights from a longitudinal cohort study;Methods to understand and regulate the spread in communities.
Mapping the intercounty transmission risk of COVID-19 in New York State;Methods to understand and regulate the spread in communities.
Modelling the role of media induced fear conditioning in mitigating post-lockdown COVID-19 pandemic: perspectives on India;Methods to understand and regulate the spread in communities.
Agent-Level Pandemic Simulation (ALPS) for Analyzing Effects of Lockdown Measures;Methods to understand and regulate the spread in communities.
What are the Underlying Transmission Patterns of COVID-19 Outbreak? - An Age-specific Social Contact Characterization;Methods to understand and regulate the spread in communities.
Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.;Methods to understand and regulate the spread in communities.
Voluntary and Mandatory Social Distancing: Evidence on COVID-19 Exposure Rates from Chinese Provinces and Selected Countries;Methods to understand and regulate the spread in communities.
Association of County-Level Socioeconomic and Political Characteristics with Engagement in Social Distancing for COVID-19;Methods to understand and regulate the spread in communities.
Adoption of Personal Protective Measures by Ordinary Citizens during the COVID-19 Outbreak in Japan;Methods to understand and regulate the spread in communities.
Little Risk of the COVID-19 Resurgence on Students in China (outside Hubei) Caused by School Reopening;Methods to understand and regulate the spread in communities.
Exponential Phase of COVID19 Expansion is not Driven by Climate at Global Scale;Methods to understand and regulate the spread in communities.
Impact of School Closures for COVID-19 on the US Health-Care Workforce and Net Mortality: a Modelling Study.;Methods to understand and regulate the spread in communities.
Eliminating COVID-19: A Community-based Analysis;Methods to understand and regulate the spread in communities.
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.;Methods to understand and regulate the spread in communities.
Compliance with COVID-19 Social-Distancing Measures in Italy: The Role of Expectations and Duration;Methods to understand and regulate the spread in communities.
Assessment of COVID-19 Knowledge Among University Students: Implications for Future Risk Communication Strategies;Modes of communicating with target high-risk populations.
Knowledge, Perceptions and Preventive Practices Towards COVID-19 Early in the Outbreak Among Jimma University Medical Center Visitors, Southwest Ethiopia;Modes of communicating with target high-risk populations.
Public Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Study in Malaysia;Modes of communicating with target high-risk populations.
The Value of Remote Monitoring for the COVID-19 Pandemic;Modes of communicating with target high-risk populations.
Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.;Modes of communicating with target high-risk populations.
Going viral: how to boost the spread of coronavirus science on social media;Modes of communicating with target high-risk populations.
Access to Telemedicine-Are We Doing All That We Can during the COVID-19 Pandemic?;Modes of communicating with target high-risk populations.
Creation of Educational Videos for Patients Undergoing Nonelective Surgery: Tools for the COVID-19 Era.;Modes of communicating with target high-risk populations.
Bereavement support on the frontline of COVID-19: Recommendations for hospital clinicians.;Modes of communicating with target high-risk populations.
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic.;Modes of communicating with target high-risk populations.
Healthy communication in the promotion of healthy aging during COVID-19 pandemic;Modes of communicating with target high-risk populations.
Interdisciplinary Perspectives on Health Literacy Research Around the World: More Important Than Ever in a Time of COVID-19.;Modes of communicating with target high-risk populations.
Humanism in the Age of COVID-19: Renewing Focus on Communication and Compassion;Modes of communicating with target high-risk populations.
Information Overload: A Method to Share Updates among Frontline Staff during the COVID-19 Pandemic;Modes of communicating with target high-risk populations.
Secure Communication Conduits During COVID19 Lockdown;Modes of communicating with target high-risk populations.
Preparedness, prevention and control of coronavirus disease (COVID-19) for refugees and migrants in non-camp settings;Modes of communicating with target high-risk populations.
More effective strategies are required to strengthen public awareness of COVID-19: Evidence from Google Trends.;Modes of communicating with target high-risk populations.
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.;Modes of communicating with target high-risk populations.
A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study;Modes of communicating with target high-risk populations.
Use of Handheld Transceiver for Hospital Healthcare Workers-Caregiver Communication During the Coronavirus disease 2019 (COVID-19) Outbreak in Pediatric Emergency Department;Modes of communicating with target high-risk populations.
The effective use of telemedicine to save lives and maintain structure in a healthcare system: Current response to COVID-19;Modes of communicating with target high-risk populations.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures;Modes of communicating with target high-risk populations.
Communication Skills in the Age of COVID-19;Modes of communicating with target high-risk populations.
"COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception";Modes of communicating with target high-risk populations.
Applying Palliative Care Principles to Communicate with Children about COVID-19;Modes of communicating with target high-risk populations.
Protecting the psychological health of children through effective communication about COVID-19;Modes of communicating with target high-risk populations.
COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes;Modes of communicating with target high-risk populations.
Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19);Modes of communicating with target high-risk populations.
Bearing the brunt of covid-19: older people in low and middle income countries;Modes of communicating with target high-risk populations.
WeChat, a Chinese social media, may early detect the SARS-CoV-2 outbreak in 2019;Modes of communicating with target high-risk populations.
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know;Modes of communicating with target high-risk populations.
Communication, transparency key as Canada faces new coronavirus threat;Modes of communicating with target high-risk populations.
Communication, collaboration and cooperation can stop the 2019 coronavirus;Modes of communicating with target high-risk populations.
Isothermal evaporation rate of deposited liquid aerosols and the SARS-CoV-2 coronavirus survival;Persistence of virus on surfaces of different materials.
Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1;Persistence of virus on surfaces of different materials.
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China;Proportion of all positive COVID19 patients who were asymptomatic.
Management of mild COVID-19: Policy implications of initial experience in India;Proportion of all positive COVID19 patients who were asymptomatic.
The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis;Proportion of all positive COVID19 patients who were asymptomatic.
What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate, serial interval, and asymptomatic infection;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington;Proportion of all positive COVID19 patients who were asymptomatic.
The first 100 days of SARS-CoV-2 control in Vietnam;Proportion of all positive COVID19 patients who were asymptomatic.
CT imaging features of 34 patients infected with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Identifying baseline clinical features of people with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis;Proportion of all positive COVID19 patients who were asymptomatic.
A systematic review of asymptomatic infections with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Study on Transmission Dynamic of 15 Clusters of Coronavirus Disease 2019 Cases in Ningbo;Proportion of all positive COVID19 patients who were asymptomatic.
Screening of SARS-CoV-2 among homeless people, asylum seekers and other people living in precarious conditions in Marseille, France, March April 2020.;Proportion of all positive COVID19 patients who were asymptomatic.
Viral dynamics in asymptomatic patients with COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Contagiousness and Secondary Attack Rate of 2019 Novel Coronavirus Based on Cluster Epidemics of COVID-19 in Guangzhou;Proportion of all positive COVID19 patients who were asymptomatic.
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China;Proportion of all positive COVID19 patients who were asymptomatic.
High proportion of asymptomatic and presymptomatic COVID-19 infections in travelers and returning residents to Brunei;Proportion of all positive COVID19 patients who were asymptomatic.
Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological and clinical features of asymptomatic patients with SARS‐CoV‐2 infection;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;Proportion of all positive COVID19 patients who were asymptomatic.
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility;Proportion of all positive COVID19 patients who were asymptomatic.
Early epidemiological and clinical manifestations of COVID-19 in Ja;Proportion of all positive COVID19 patients who were asymptomatic.
Cluster of COVID-19 in northern France: A retrospective closed cohort study;Proportion of all positive COVID19 patients who were asymptomatic.
Suppression of COVID-19 outbreak in the municipality of Vo, Italy;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical characteristics of 3,062 COVID‐19 patients: a meta‐analysis;Proportion of all positive COVID19 patients who were asymptomatic.
COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19;Proportion of all positive COVID19 patients who were asymptomatic.
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital;Proportion of all positive COVID19 patients who were asymptomatic.
A considerable proportion of individuals with asymptomatic SARS-CoV-2 infection in Tibetan population;Proportion of all positive COVID19 patients who were asymptomatic.
Modes of contact and risk of transmission in COVID-19 among close contacts;Proportion of all positive COVID19 patients who were asymptomatic.
Clinical characteristics and reasons of different duration from onset to release from quarantine for patients with COVID-19 Outside Hubei province, China;Proportion of all positive COVID19 patients who were asymptomatic.
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China;Proportion of all positive COVID19 patients who were asymptomatic.
High transmissibility of COVID-19 near symptom onset;Proportion of all positive COVID19 patients who were asymptomatic.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Proportion of all positive COVID19 patients who were asymptomatic.
Chest CT Findings in Cases from the Cruise Ship “Diamond Princess” with Coronavirus Disease 2019 (COVID-19);Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Proportion of all positive COVID19 patients who were asymptomatic.
Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Proportion of all positive COVID19 patients who were asymptomatic.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China;Proportion of all positive COVID19 patients who were asymptomatic.
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020;Proportion of all positive COVID19 patients who were asymptomatic.
Characteristics of COVID-19 infection in Beijing;Proportion of all positive COVID19 patients who were asymptomatic.
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea;Proportion of all positive COVID19 patients who were asymptomatic.
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19);Proportion of all positive COVID19 patients who were asymptomatic.
Clinical and Transmission Dynamics Characteristics of 406 Children with Coronavirus Disease 2019 in China: A Review;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical features of pediatric patients with coronavirus disease (COVID-19);Proportion of pediatric COVID19 patients who were asymptomatic.
A follow-up study of children infected with SARS-CoV-2 from Western China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis;Proportion of pediatric COVID19 patients who were asymptomatic.
Epidemiological and Clinical Characteristics of Children with Coronavirus Disease 2019;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study;Proportion of pediatric COVID19 patients who were asymptomatic.
High incidence of asymptomatic SARS-CoV-2 infection, Chongqing, China;Proportion of pediatric COVID19 patients who were asymptomatic.
SARS-CoV-2 Infection in Children;Proportion of pediatric COVID19 patients who were asymptomatic.
Epidemiology of COVID-19 Among Children in China;Proportion of pediatric COVID19 patients who were asymptomatic.
The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan, China;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children;Proportion of pediatric COVID19 patients who were asymptomatic.
A retrospective study of the clinical characteristics of COVID-19 infection in 26 children;Proportion of pediatric COVID19 patients who were asymptomatic.
Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China;Proportion of pediatric COVID19 patients who were asymptomatic.
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data;Proportion of pediatric COVID19 patients who were asymptomatic.
Containing the Spread of Coronavirus Disease 2019 (COVID-19): Meteorological Factors and Control Strategies;Seasonality of transmission.
COVID-19: Effects of weather conditions on the propagation of respiratory droplets;Seasonality of transmission.
The Modest Impact of Weather and Air Pollution on COVID-19 Transmission;Seasonality of transmission.
Higher Temperature, Pressure, and Ultraviolet Are Associated with Less COVID-19 Prevalence: Meta-Regression of Japanese Prefectural Data;Seasonality of transmission.
The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2;Seasonality of transmission.
Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study;Seasonality of transmission.
The effect of ambient temperature on worldwide COVID-19 cases and deaths - an epidemiological study;Seasonality of transmission.
Statistical analysis of the impact of environmental temperature on the exponential growth rate of cases infected by COVID-;Seasonality of transmission.
Temperature and relative humidity are not major contributing factor on the occurrence 2 of COVID-19 pandemic: An observational study in 57 countries (2020-05-08);Seasonality of transmission.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;Seasonality of transmission.
Effect of Temperature on the Transmission of COVID-19: A Machine Learning Case Study in Spain;Seasonality of transmission.
Warmer weather and global trends in the coronavirus COVID-19;Seasonality of transmission.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;Seasonality of transmission.
Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries;Seasonality of transmission.
Temperature significantly changes COVID-19 transmission in (sub)tropical cities of Brazil;Seasonality of transmission.
Trends of SARS-Cov-2 infection in 67 countries: Role of climate zone, temperature, humidity and curve behavior of cumulative frequency on duplication time;Seasonality of transmission.
Climatic factors influence COVID-19 outbreak as revealed by worldwide mortality;Seasonality of transmission.
Seasonality and uncertainty in COVID-19 growth rates;Seasonality of transmission.
The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change;Seasonality of transmission.
Meteorological factors and domestic new cases of coronavirus disease (COVID-19) in nine Asian cities: A time-series analysis;Seasonality of transmission.
Effects of temperature and humidity on the spread of COVID-19: A systematic review;Seasonality of transmission.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;Seasonality of transmission.
Evidence that higher temperatures are associated with lower incidence of COVID-19 in pandemic state, cumulative cases reported up to March 27, 2020;Seasonality of transmission.
Climatic influences on the worldwide spread of SARS-CoV-2;Seasonality of transmission.
Susceptible supply limits the role of climate in the COVID-19 pandemic;Seasonality of transmission.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;Seasonality of transmission.
Meteorological factors correlate with transmission of 2019-nCoV: Proof of incidence of novel coronavirus pneumonia in Hubei Province, China;Seasonality of transmission.
Eco-epidemiological assessment of the COVID-19 epidemic in China, January-February 2020;Seasonality of transmission.
Temperature, humidity, and wind speed are associated with lower Covid-19 incidence;Seasonality of transmission.
No Evidence for Temperature-Dependence of the COVID-19 Epidemic;Seasonality of transmission.
Climate effect on COVID-19 spread rate: an online surveillance tool;Seasonality of transmission.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;Seasonality of transmission.
Temperature dependence of COVID-19 transmission;Seasonality of transmission.
COVID-19 transmission in Mainland China is associated with temperature and humidity: a time-series analysis;Seasonality of transmission.
Effects of temperature on COVID-19 transmission;Seasonality of transmission.
Climate affects global patterns of COVID-19 early outbreak dynamics;Seasonality of transmission.
Modeling the Corona Virus Outbreak in IRAN;Seasonality of transmission.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;Seasonality of transmission.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;Seasonality of transmission.
Social distancing strategies for curbing the COVID-19 epidemic;Seasonality of transmission.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;Seasonality of transmission.
The first 100 days of SARS-CoV-2 control in Vietnam;Serial Interval (time between symptom onset in infector-infectee pair).
A rapid review of available evidence on the serial interval and generation time of COVID-19;Serial Interval (time between symptom onset in infector-infectee pair).
Clinical onset serial interval and diagnostic serial interval of SARS-CoV-2/COVID-19 in South Korea;Serial Interval (time between symptom onset in infector-infectee pair).
Estimation of the time-varying reproduction number of COVID-19 outbreakin China;Serial Interval (time between symptom onset in infector-infectee pair).
The epidemiologic parameters for COVID-19: A Systematic Review and Meta-Analysis;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;Serial Interval (time between symptom onset in infector-infectee pair).
COVID-19 serial interval estimates based on confirmed cases in public reports from 86 Chinese cities;Serial Interval (time between symptom onset in infector-infectee pair).
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study;Serial Interval (time between symptom onset in infector-infectee pair).
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China;Serial Interval (time between symptom onset in infector-infectee pair).
Analysis on epidemiological characteristics of new-type coronavirus pneumonia family aggregation epidemic in Zhejiang Province;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults;Serial Interval (time between symptom onset in infector-infectee pair).
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;Serial Interval (time between symptom onset in infector-infectee pair).
Close contacts and household transmission of SARS-CoV-2 in China: a content analysis based on local Heath Commissions' public disclosures.;Serial Interval (time between symptom onset in infector-infectee pair).
Transmission interval estimates suggest pre-symptomatic spread of COVID-19;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiologic Characteristics of COVID-19 in Guizhou, China;Serial Interval (time between symptom onset in infector-infectee pair).
Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts;Serial Interval (time between symptom onset in infector-infectee pair).
The serial interval of COVID-19 from publicly reported confirmed cases;Serial Interval (time between symptom onset in infector-infectee pair).
Serial interval of novel coronavirus (2019-nCoV) infections;Serial Interval (time between symptom onset in infector-infectee pair).
Estimation of the Time-Varying Reproduction Number of COVID-19 Outbreak in China;Serial Interval (time between symptom onset in infector-infectee pair).
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters;Studies to monitor potential adaptations.
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology;Studies to monitor potential adaptations.
Coronavirus Infection and PARP Expression Dysregulate the NAD Metabolome: A Potentially Actionable Component of Innate Immunity;Studies to monitor potential adaptations.
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series;Studies to monitor potential adaptations.
Potential Factors for Prediction of Disease Severity of COVID-19 Patients;Studies to monitor potential adaptations.
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2;Studies to monitor potential adaptations.
The potential role of IL-6 in monitoring severe case of coronavirus disease 2019;Studies to monitor potential adaptations.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;Studies to monitor potential adaptations.
Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions;Studies to monitor potential adaptations.
Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China;Studies to monitor potential adaptations.
Current Trends in Diagnostics of Viral Infections of Unknown Etiology Viruses;Studies to monitor potential adaptations.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;Studies to monitor potential adaptations.
The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against COVID-19 biorxiv;Studies to monitor potential adaptations.
2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus;Studies to monitor potential adaptations.
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency;Susceptibility to environmental cleaning agents.
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient (Journal of the American Medical Association);Susceptibility to environmental cleaning agents.
Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols (bioRxiv);Susceptibility to environmental cleaning agents.
Coronavirus disease 2019 (covid-19): a guide for UK GPs (BMJ (British Medical Journal));Susceptibility to environmental cleaning agents.
Water, sanitation, hygiene and waste management for the COVID-19 virus (WHO);Susceptibility to environmental cleaning agents.
The outbreak of COVID-19 An overview (Journal of the Chinese Medical Association);Susceptibility to environmental cleaning agents.
Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of COVID-19 in Non-Healthcare Premises;Susceptibility to environmental cleaning agents.
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Application An expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians;What are recommendations for combating_overcoming resource failures_.
Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-10 Outbreak in Daegu, Korea;What are recommendations for combating_overcoming resource failures_.
N95 Mask Decontamination using Standard Hospital Sterilization Technologies;What are recommendations for combating_overcoming resource failures_.
Can N95 respirators be reused after disinfection? And for how many times?;What are recommendations for combating_overcoming resource failures_.
Where to buy face masks? Survey of applications using Taiwan's open data in the time of COVID-19;What are recommendations for combating_overcoming resource failures_.
Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.;What are recommendations for combating_overcoming resource failures_.
When Resources Are Scarce - Feasibility of Emergency Ventilation of Two Patients With One Ventilator;What are recommendations for combating_overcoming resource failures_.
FFP-2 respirator masks in times of crisis;What are recommendations for combating_overcoming resource failures_.
Modifying reusable elastomeric respirators to utilise breathing system filters with 3D printed adapters, a safe alternative to N95 during COVID-19;What are recommendations for combating_overcoming resource failures_.
Separate Fever Clinics Prevent the Spread of COVID-19 and Offload Emergency Resources: Analysis from a large tertiary hospital in China;What are recommendations for combating_overcoming resource failures_.
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the Covid-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
The Importance of Minimum Dosage Necessary for UVC Decontamination of N95 Respirators during the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States;What are recommendations for combating_overcoming resource failures_.
Concise Communication: COVID-19 and the N95 Respirator Shortage: Closing the Gap;What are recommendations for combating_overcoming resource failures_.
Hospital Emergency Management Plan During the COVID‐19 Epidemic;What are recommendations for combating_overcoming resource failures_.
Use of a Single Ventilator to Support Multiple Patients: Modeling Tidal Volume Response to Heterogeneous Lung Mechanics;What are recommendations for combating_overcoming resource failures_.
Alternative Qualitative  Fit Testing Method for N95 Equivalent Respirators in the Setting of Resource Scarcity at the George Washington University;What are recommendations for combating_overcoming resource failures_.
Management of Ovarian cancer during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Nonmedical Masks in Public for Respiratory Pandemics: Droplet Retention by Two-Layer Textile Barrier Fully Protects Germ-free Mice from Bacteria in Droplets;What are recommendations for combating_overcoming resource failures_.
Coping with COID-19: ventilator splitting with differential driving pressures using standard hospital equipment;What are recommendations for combating_overcoming resource failures_.
Possible consequences of a shortage of hydroxychloroquine for Lupus patients amid the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
A Simulated Single Ventilator / Dual Patient Ventilation Strategy for Acute Respiratory Distress Syndrome During the COVID-19 Pandemic;What are recommendations for combating_overcoming resource failures_.
Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.;What are recommendations for combating_overcoming resource failures_.
Calculated decisions: COVID-19 calculators during extreme resource-limited situations.;What are recommendations for combating_overcoming resource failures_.
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multi level risks;What are recommendations for combating_overcoming resource failures_.
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations;What are recommendations for combating_overcoming resource failures_.
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process;What are recommendations for combating_overcoming resource failures_.
Opinion to address a potential personal protective equipment shortage in the global community during the COVID-19 outbreak;What are recommendations for combating_overcoming resource failures_.
Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy;What are recommendations for combating_overcoming resource failures_.
Echo in Pandemic: Front Line Perspective, Expanding Role of Ultrasound and Ethics of Resource Allocation;What are recommendations for combating_overcoming resource failures_.
Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures;What are recommendations for combating_overcoming resource failures_.
Medication Shortages During the COVID-19 Crisis: What We Must Do;What are recommendations for combating_overcoming resource failures_.
Rural Healthcare Center Preparation and Readiness Response to Threat of COVID-19;What are recommendations for combating_overcoming resource failures_.
Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review;What are recommendations for combating_overcoming resource failures_.
Care of Patients with Liver disease during the COVID-19 pandemic: EASL-ESCMID position paper;What are recommendations for combating_overcoming resource failures_.
Fangcang shelter hospitals: a novel concept for responding to public health emergencies;What are recommendations for combating_overcoming resource failures_.
Emerging infectious diseases and outbreaks: implications for women’s reproductive health and rights in resource-poor settings;What are recommendations for combating_overcoming resource failures_.
Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic;What are recommendations for combating_overcoming resource failures_.
Demand for hospitalization services for COVID-19 patients in Brazil;What are recommendations for combating_overcoming resource failures_.
The Essential Role of Patient Blood Management in a Pandemic: A Call for Action;What are recommendations for combating_overcoming resource failures_.
Creating a Palliative Care Inpatient Response Plan for COVID19- The UW Medicine Experience;What are recommendations for combating_overcoming resource failures_.
Caring for children and adolescents with eating disorders in the current COVID-19 Pandemic: A Singapore perspective;What are recommendations for combating_overcoming resource failures_.
Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.;What are recommendations for combating_overcoming resource failures_.
Individualized System for Augmenting Ventilator Efficacy (iSAVE): A Rapidly deployable system to expand ventilator capacity;What are recommendations for combating_overcoming resource failures_.
Response and Operating Room Preparation for the COVID-19 Outbreak: A Perspective From the National Heart Centre in Singapore;What are recommendations for combating_overcoming resource failures_.
What Should Palliative Care’s Response Be to the COVID-19 Pandemic?;What are recommendations for combating_overcoming resource failures_.
Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse;What are recommendations for combating_overcoming resource failures_.
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment from a Comprehensive Cancer Center in the United States;What are recommendations for combating_overcoming resource failures_.
Challenges for NHS hospitals during covid-19 epidemic;What are recommendations for combating_overcoming resource failures_.
Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19);What are recommendations for combating_overcoming resource failures_.
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China;What are recommendations for combating_overcoming resource failures_.
The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform;What are recommendations for combating_overcoming resource failures_.
Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta‐analysis;What are recommendations for combating_overcoming resource failures_.
Adoption of COVID-19 triage strategies for low-income settings;What are recommendations for combating_overcoming resource failures_.
The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities;What are recommendations for combating_overcoming resource failures_.
Duty to Plan: Health Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2;What are recommendations for combating_overcoming resource failures_.
Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19);What are recommendations for combating_overcoming resource failures_.
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China;What are recommendations for combating_overcoming resource failures_.
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation;What are recommendations for combating_overcoming resource failures_.
Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China;What are recommendations for combating_overcoming resource failures_.
Infection Prevention and Control Compliance in Tanzanian Outpatient Facilities: A Cross-Sectional Study With Implications for the Control of COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Absence of Nosocomial Transmission of Coronavirus Disease 2019 (COVID-19) Due to SARS-CoV-2 in the Pre-Pandemic Phase in Hong Kong;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Safe and Effective Management of Tracheostomy in COVID-19 Patients;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Personal Protective Equipment for Preventing Highly Infectious Diseases Due to Exposure to Contaminated Body Fluids in Healthcare Staff;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Precautions and Recommendations for Orthodontic Settings During the COVID-19 Outbreak: A Review;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Elective Tracheostomy During Mechanical Ventilation in Patients Affected by COVID-19: Preliminary Case Series From Lombardy, Italy;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Cancer Treatment During the Coronavirus Disease 2019 Pandemic: Do Not Postpone, Do It!;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Quantifying the Improvement in Confirmation Efficiency of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During the Early Phase of the Outbreak in Hong Kong in 2020;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: the experience of a tertiary hospital in Singapore.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Repurposing and reshaping of hospitals during the COVID-19 outbreak in South Korea.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19, superinfections and antimicrobial development: What can we expect?;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Environmental Contamination of SARS-CoV-2 in Healthcare Premises.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Rapid Implementation of an Adult COVID-19 Unit in a Children's Hospital.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Limiting the Risks for Eye Care Professionals.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2);What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The prevention and management of the coronavirus disease 2019 (COVID-19) outbreak in radiology departments in epidemic areas.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Can N95 respirators be reused after disinfection? And for how many times?;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Nosocomial infections in psychiatric hospitals during the new coronavirus pneumonia (NCP) outbreak.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
How to avoid nosocomial spread during Tracheostomy for Covid-19 patients.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
How to transform a general hospital into an “infectious disease hospital” during the epidemic of COVID-19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Nosocomial infection among patients with coronavirus disease-2019: a retrospective data analysis of 918 cases from a single center in Wuhan city, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Assessment of preparedness against emerging infectious disease among private hospitals in a district of South India;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Application of refined management in prevention and control of the coronavirus disease 2019 epidemic in non-isolated areas of a general hospital;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Guidelines for dental care provision during the COVID-19 pandemic;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A model to forecast regional demand for COVID-19 related hospital beds;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Separate Fever Clinics Prevent the Spread of COVID-19 and Offload Emergency Resources: Analysis from a large tertiary hospital in China;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Fangcang shelter hospitals: a novel concept for responding to public health emergencies;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Practitioners specialized in oral health and coronavirus disease 2019: Professional guidelines from the French society of stomatology, maxillofacial surgery and oral surgery, to form a common front against the infectious risk.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Radiotherapy Workflow and Protection Procedures During the Coronavirus Disease 2019 (COVID-19) Outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Maximizing the Calm before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19);What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
RESOURCES FOR SMOKE & GAS EVACUATION DURING OPEN, LAPAROSCOPIC, AND ENDOSCOPIC PROCEDURES;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Screening and managing of suspected or confirmed novel coronavirus (COVID-19) patients: experiences from a tertiary hospital outside Hubei province;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Forecasting short term hospital needs in France;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19 outbreak: less stethoscope, more ultrasound;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
The prevention of nosocomial SARS-CoV2 transmission in endoscopy: a systematic review of recommendations within gastroenterology to identify best practice.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A high efficient hospital emergency responsive mode is the key of successful treatment of 100 COVID-19 patients in Zhuhai;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
COVID-19: Recommendations for Management of Elective Surgical Procedures;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Guidance for health system contingency planning during widespread transmission of SARS-CoV-2 with high impact on healthcare services;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Hospital biopreparedness in the Looming Presence of SARS‐CoV‐2/COVID‐19;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Practical experiences and suggestions for the ‘eagle-eyed observer’: a novel promising role for controlling nosocomial infection in the COVID-19 outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical Data on Hospital Environmental Hygiene Monitoring and Medical Staff Protection during the Coronavirus Disease 2019 Outbreak;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Healthcare Facilities: Preparing for Community Transmission / Interim Guidance for Healthcare Facilities: Preparing for Community Transmission of COVID-19 in the United States;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Staff safety during emergency airway management for COVID-19 in Hong Kong;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Reply to “Coronavirus 2019-nCoV: A brief perspective from the front line”: Nosocomial SARS-CoV-2 infection among nurses in Wuhan from a single center;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Protecting health-care workers from subclinical coronavirus infection;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.;What are ways to create hospital infrastructure to prevent nosocomial outbreaks_.
A Statistical Model for Quantifying the Needed Duration of Social Distancing for the COVID-19 Pandemic;What do models for transmission predict_.
Uncertainty Quantification in Epidemiological Models for COVID-19 Pandemic;What do models for transmission predict_.
Predictions for Europe for the Covid-19 pandemic from a SIR model;What do models for transmission predict_.
A pandemic at the Tunisian scale. Mathematical modelling of reported and unreported COVID-19 infected cases;What do models for transmission predict_.
Transmission in Latent Period Causes A Large Number of Infected People in the United States;What do models for transmission predict_.
COVID-19 puzzle in China: a serendipitous interplay between transmissibility and social distancing measures;What do models for transmission predict_.
Tracking R of COVID-19: A New Real-Time Estimation Using the Kalman Filter;What do models for transmission predict_.
COVID-19 and Tuberculosis: A mathematical model based forecasting in Delhi, India;What do models for transmission predict_.
Predictions of COVID-19 dynamics in the UK: short-term forecasting and analysis of potential exit strategies;What do models for transmission predict_.
Development of New Hybrid Model of Discrete Wavelet Decomposition and Autoregressive Integrated Moving Average (ARIMA) Models in Application to One Month Forecast the Casualties Cases of COVID-19;What do models for transmission predict_.
Inferring change points in the COVID-19 spreading reveals the effectiveness of interventions;What do models for transmission predict_.
Real-time time-series modelling for prediction of COVID-19 spread and intervention assessment;What do models for transmission predict_.
COVID-19 in Iran: A Deeper Look Into The Future;What do models for transmission predict_.
Estimating the impact of mobility patterns on COVID-19 infection rates in 11 European countries;What do models for transmission predict_.
Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis;What do models for transmission predict_.
The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States;What do models for transmission predict_.
COVID-19 Asymptomatic Infection Estimation;What do models for transmission predict_.
The Effect of Population Size for Pathogen Transmission on Prediction of COVID-19 Pandemic Spread;What do models for transmission predict_.
Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19;What do models for transmission predict_.
A Bayesian analysis of the total number of cases of the COVID 19 when only a few data is available. A case study in the state of Goias, Brazil;What do models for transmission predict_.
Modeling the COVID-19 epidemic in Okinawa;What do models for transmission predict_.
Sequential data assimilation of the stochastic SEIR epidemic model for regional COVID-19 dynamics;What do models for transmission predict_.
Epidemic Landscape and Forecasting of SARS-CoV-2 in India;What do models for transmission predict_.
A Bayesian Logistic Growth Model for the Spread of COVID-19 in New York;What do models for transmission predict_.
COVID-19 in India: Predictions, Reproduction Number and Public Health Preparedness;What do models for transmission predict_.
Long-term predictions for COVID-19 pandemic dynamics in Ukraine, Austria and Italy;What do models for transmission predict_.
Outbreak dynamics of COVID-19 in China and the United States;What do models for transmission predict_.
Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom;What do models for transmission predict_.
COVID-19 UK Lockdown Forecasts and R0;What do models for transmission predict_.
Monitoring Italian COVID-19 spread by an adaptive SEIRD model;What do models for transmission predict_.
Parametric analysis of early data on COVID-19 expansion in selected European countries;What do models for transmission predict_.
Forecasting COVID 19 growth in India using Susceptible-Infected-Recovered (S.I.R) model;What do models for transmission predict_.
Early behavior of Madrid Covid-19 disease outbreak: A mathematical model;What do models for transmission predict_.
Transmission Dynamics and Control Methodology of COVID-19: a Modeling Study;What do models for transmission predict_.
Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission;What do models for transmission predict_.
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing;What do models for transmission predict_.
COVID-19 outbreak in Algeria: A mathematical Model to predict cumulative cases;What do models for transmission predict_.
Estimating unobserved SARS-CoV-2 infections in the United States;What do models for transmission predict_.
Estimation of Basic Reproduction Number of the COVID-19 Epidemic in Denmark using a Two-Step Model;What do models for transmission predict_.
Strongly heterogeneous transmission of COVID-19 in mainland China: local and regional variation.;What do models for transmission predict_.
Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative;What do models for transmission predict_.
Inferring the number of COVID-19 cases from recently reported deaths;What do models for transmission predict_.
Revealing the influence of national public health policies for the outbreak of the SARS-CoV-2 epidemic in Wuhan China through status dynamic modeling;What do models for transmission predict_.
Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province;What do models for transmission predict_.
Relations of parameters for describing the epidemic of COVID―19 by the Kermack―McKendrick model;What do models for transmission predict_.
Estimating the basic reproduction number of COVID-19 in Wuhan China;What do models for transmission predict_.
Infection Dynamics of Coronavirus Disease 2019 (Covid-19) Modeled with the Integration of the Eyring Rate Process Theory and Free Volume Concept;What do models for transmission predict_.
A mathematical model for simulating the phase-based transmissibility of a novel coronavirus;What do models for transmission predict_.
The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system;What do models for transmission predict_.
Estimation of the epidemic properties of the 2019 novel coronavirus: A mathematical modeling study;What do models for transmission predict_.
Early dynamics of transmission and control of COVID-19: a mathematical modelling study;What do models for transmission predict_.
Assessing the Tendency of 2019-nCoV (COVID-19) Outbreak in China;What do models for transmission predict_.
Reporting Epidemic Growth and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic;What do models for transmission predict_.
Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions;What do models for transmission predict_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in blood_.
Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients;What do we know about viral shedding in blood_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in blood_.
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity;What do we know about viral shedding in blood_.
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes;What do we know about viral shedding in blood_.
The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients;What do we know about viral shedding in stool_.
Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.;What do we know about viral shedding in stool_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in stool_.
Prolonged Viral Shedding in Feces of Pediatric Patients with Coronavirus Disease 2019;What do we know about viral shedding in stool_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in stool_.
Do children need a longer time to shed SARS-CoV-2 in stool than adults?;What do we know about viral shedding in stool_.
Prolonged Presence of SARS-CoV-2 Viral RNA in faecal samples;What do we know about viral shedding in stool_.
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau;What do we know about viral shedding in stool_.
Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster;What do we know about viral shedding in stool_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in stool_.
Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia;What do we know about viral shedding in stool_.
Evidence for gastrointestinal infection of SARS-CoV-2;What do we know about viral shedding in stool_.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;What do we know about viral shedding in the nasopharynx_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in the nasopharynx_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in the nasopharynx_.
Viral dynamics in mild and severe cases of COVID-19;What do we know about viral shedding in the nasopharynx_.
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau;What do we know about viral shedding in the nasopharynx_.
Patients with respiratory symptoms are at greater risk of COVID-19 transmission;What do we know about viral shedding in the nasopharynx_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in the nasopharynx_.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients;What do we know about viral shedding in urine_.
Viral Kinetics and Antibody Responses in Patients with COVID-19;What do we know about viral shedding in urine_.
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore;What do we know about viral shedding in urine_.
COVID-19-associated nephritis: early warning for disease severity and complications?;What do we know about viral shedding in urine_.
Detection of SARS-CoV-2 in Different Types of Clinical Specimens;What do we know about viral shedding in urine_.
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology;What is known about adaptations (mutations) of the virus_.
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites;What is known about adaptations (mutations) of the virus_.
Translational adaptation of human viruses to the tissues they infect;What is known about adaptations (mutations) of the virus_.
Re-insights into origin and adaptation of SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
A Genomic Survey of SARS-CoV-2 Reveals Multiple Introductions into Northern California without a Predominant Lineage;What is known about adaptations (mutations) of the virus_.
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del) Clinical Microbiology and Infection;What is known about adaptations (mutations) of the virus_.
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies;What is known about adaptations (mutations) of the virus_.
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site;What is known about adaptations (mutations) of the virus_.
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability;What is known about adaptations (mutations) of the virus_.
Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis;What is known about adaptations (mutations) of the virus_.
Zoonotic origins of human coronaviruses;What is known about adaptations (mutations) of the virus_.
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV;What is known about adaptations (mutations) of the virus_.
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species;What is known about adaptations (mutations) of the virus_.
Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients;What is known about adaptations (mutations) of the virus_.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;What is known about adaptations (mutations) of the virus_.
Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions Healthcare;What is known about adaptations (mutations) of the virus_.
Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China;What is known about adaptations (mutations) of the virus_.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;What is known about adaptations (mutations) of the virus_.
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Acute limb ischemia in patients with COVID-19 pneumonia;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
COVID-19 Coagulopathy in Caucasian patients;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Heparin therapy improving hypoxia in COVID-19 patients - a case series;What is the best method to combat the hypercoagulable state seen in COVID-19_.
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Hospital-based use of thromboprophylaxis in patients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-1;What is the best method to combat the hypercoagulable state seen in COVID-19_.
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Incidence of thrombotic complications in critically ill ICU patients with COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series;What is the best method to combat the hypercoagulable state seen in COVID-19_.
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction;What is the best method to combat the hypercoagulable state seen in COVID-19_.
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study;What is the efficacy of novel therapeutics being tested currently_.
Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome;What is the efficacy of novel therapeutics being tested currently_.
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study.;What is the efficacy of novel therapeutics being tested currently_.
An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI);What is the efficacy of novel therapeutics being tested currently_.
Why Tocilizumab could be an effective treatment for severe COVID-19;What is the efficacy of novel therapeutics being tested currently_.
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial;What is the efficacy of novel therapeutics being tested currently_.
Compassionate Use of Remdesivir for Patients with Severe Covid-19;What is the efficacy of novel therapeutics being tested currently_.
A Review of SARS-CoV-2 and the Ongoing Clinical Trials. [Review];What is the efficacy of novel therapeutics being tested currently_.
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.;What is the efficacy of novel therapeutics being tested currently_.
Current Drugs with Potential for Treatment of COVID-19: A Literature Review.;What is the efficacy of novel therapeutics being tested currently_.
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection;What is the efficacy of novel therapeutics being tested currently_.
Treatment of 5 critically ill patients with COVID-19 with Convalescent Plasma;What is the efficacy of novel therapeutics being tested currently_.
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants;What is the efficacy of novel therapeutics being tested currently_.
The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study;What is the efficacy of novel therapeutics being tested currently_.
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019;What is the efficacy of novel therapeutics being tested currently_.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;What is the efficacy of novel therapeutics being tested currently_.
Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19;What is the efficacy of novel therapeutics being tested currently_.
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study;What is the efficacy of novel therapeutics being tested currently_.
Medication Patterns and Disease Progression Among 165 Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective, Observational Study;What is the efficacy of novel therapeutics being tested currently_.
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies;What is the efficacy of novel therapeutics being tested currently_.
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China;What is the efficacy of novel therapeutics being tested currently_.
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study;What is the efficacy of novel therapeutics being tested currently_.
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19;What is the efficacy of novel therapeutics being tested currently_.
A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Traditional Chinese medicine for COVID-19 treatment;What is the efficacy of novel therapeutics being tested currently_.
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report.;What is the efficacy of novel therapeutics being tested currently_.
Therapeutic options for the 2019 novel coronavirus (2019-nCoV);What is the efficacy of novel therapeutics being tested currently_.
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.;What is the efficacy of novel therapeutics being tested currently_.
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines;What is the efficacy of novel therapeutics being tested currently_.
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease;What is the efficacy of novel therapeutics being tested currently_.
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;What is the efficacy of novel therapeutics being tested currently_.
Discovering drugs to treat coronavirus disease 2019 (COVID-19);What is the efficacy of novel therapeutics being tested currently_.
Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China;What is the incubation period of the virus_.
Estimation of the incubation period of SARS-CoV-2 in Vietnam;What is the incubation period of the virus_.
The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research;What is the incubation period of the virus_.
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study;What is the incubation period of the virus_.
Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China;What is the incubation period of the virus_.
Statistical and network analysis of 1212 COVID-19 patients in Henan, China;What is the incubation period of the virus_.
The clinical and immunological features of pediatric COVID-19 patients in China;What is the incubation period of the virus_.
Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories;What is the incubation period of the virus_.
Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19;What is the incubation period of the virus_.
Epidemiological Characteristics of COVID-19: A Systemic Review and Meta-Analysis;What is the incubation period of the virus_.
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study;What is the incubation period of the virus_.
Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis;What is the incubation period of the virus_.
Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study;What is the incubation period of the virus_.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia;What is the incubation period of the virus_.
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study;What is the incubation period of the virus_.
Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries;What is the incubation period of the virus_.
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms;What is the incubation period of the virus_.
A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet;What is the incubation period of the virus_.
The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: The need of a longer quarantine period;What is the incubation period of the virus_.
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures;What is the incubation period of the virus_.
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study;What is the incubation period of the virus_.
Epidemiologic Characteristics of COVID-19 in Guizhou, China;What is the incubation period of the virus_.
Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population;What is the incubation period of the virus_.
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application;What is the incubation period of the virus_.
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole;What is the incubation period of the virus_.
The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease;What is the incubation period of the virus_.
Transmission interval estimates suggest pre-symptomatic spread of COVID-19;What is the incubation period of the virus_.
Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China;What is the incubation period of the virus_.
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing China;What is the incubation period of the virus_.
Transmission characteristics of the COVID-19 outbreak in China: a study driven by data;What is the incubation period of the virus_.
Estimate the incubation period of coronavirus 2019 (COVID-19);What is the incubation period of the virus_.
Clinical Characteristics of Coronavirus Disease 2019 in China;What is the incubation period of the virus_.
Characteristics of COVID-19 infection;What is the incubation period of the virus_.
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series;What is the incubation period of the virus_.
The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province;What is the incubation period of the virus_.
A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention;What is the incubation period of the virus_.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;What is the incubation period of the virus_.
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data;What is the incubation period of the virus_.
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea;What is the incubation period of the virus_.
The incubation period of 2019-nCoV infections among travellers from Wuhan, China;What is the incubation period of the virus_.
The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application;What is the incubation period of the virus_.
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics;What is the likelihood of significant changes in transmissibility in changing seasons_.
Association between climate variables and global transmission oF SARS-CoV-2;What is the likelihood of significant changes in transmissibility in changing seasons_.
The correlation between the spread of COVID-19 infections and weather variables in 30 Chinese provinces and the impact of Chinese government mitigation plans;What is the likelihood of significant changes in transmissibility in changing seasons_.
Seasonality and uncertainty in COVID-19 growth rates;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020;What is the likelihood of significant changes in transmissibility in changing seasons_.
Investigation of effective climatology parameters on COVID-19 outbreak in Iran;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climate variability and seasonal weather related to COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Global COVID-19 transmission rate is influenced by precipitation seasonality and the speed of climate temperature warming;What is the likelihood of significant changes in transmissibility in changing seasons_.
Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climatic influences on the worldwide spread of SARS-CoV-2;What is the likelihood of significant changes in transmissibility in changing seasons_.
No Association of COVID-19 transmission with temperature or UV radiation in Chinese cities;What is the likelihood of significant changes in transmissibility in changing seasons_.
Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia;What is the likelihood of significant changes in transmissibility in changing seasons_.
The Effect of Temperature Upon Transmission of COVID-19: Australia And Egypt Case Study.;What is the likelihood of significant changes in transmissibility in changing seasons_.
Eco-epidemiological assessment of the COVID-19 epidemic in China, January-February 2020;What is the likelihood of significant changes in transmissibility in changing seasons_.
Association between ambient temperature and COVID-19 infection in 122 cities from China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature dependence of COVID-19 transmission;What is the likelihood of significant changes in transmissibility in changing seasons_.
Climate affects global patterns of COVID-19 early outbreak dynamics;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal;What is the likelihood of significant changes in transmissibility in changing seasons_.
Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China;What is the likelihood of significant changes in transmissibility in changing seasons_.
The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China;What is the likelihood of significant changes in transmissibility in changing seasons_.
Transmissibility of COVID-19 and its association with temperature and humidity;What is the likelihood of significant changes in transmissibility in changing seasons_.
The Role of Environmental Factors on Transmission Rates of the COVID-19 Outbreak: An Initial Assessment in Two Spatial Scales.;What is the likelihood of significant changes in transmissibility in changing seasons_.
High Temperature and High Humidity Reduce the Transmission of COVID-19;What is the likelihood of significant changes in transmissibility in changing seasons_.
"The Effects of ""Fangcang, Huoshenshan, and Leishenshan"" Makeshift Hospitals and Temperature on the Mortality of COVID-19";What is the likelihood of significant changes in transmissibility in changing seasons_.
Temperature significant change COVID-19 Transmission in 429 cities;What is the likelihood of significant changes in transmissibility in changing seasons_.
The role of absolute humidity on transmission rates of the COVID-19 outbreak;What is the likelihood of significant changes in transmissibility in changing seasons_.
A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy;What regional genetic variations (mutations) exist.
Genomic characterization of a novel SARS-CoV-2;What regional genetic variations (mutations) exist.
A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses;What regional genetic variations (mutations) exist.
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2;What regional genetic variations (mutations) exist.
Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2);What regional genetic variations (mutations) exist.
Potential T-cell and B-cell Epitopes of 2019-nCoV;What regional genetic variations (mutations) exist.
The establishment of reference sequence for SARS‐CoV‐2 and variation analysis;What regional genetic variations (mutations) exist.
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2;What regional genetic variations (mutations) exist.
Mutations, Recombination and Insertion in the Evolution of 2019-nCoV;What regional genetic variations (mutations) exist.
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13;What regional genetic variations (mutations) exist.
Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2;What regional genetic variations (mutations) exist.
Genetic diversity and evolution of SARS-CoV-2;What regional genetic variations (mutations) exist.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Age.
Obesity and COVID-19: an Italian snapshot;Age.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Age.
Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history;Age.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Age.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication;Age.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Age.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Age.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Age.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Age.
Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China;Age.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Age.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Age.
Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool;Age.
High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation;Age.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Age.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;Age.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up;Age.
A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China;Age.
Radiographic Findings and other Predictors in Adults with Covid-19;Age.
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China;Age.
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study;Age.
Prognostic value of C-reactive protein in patients with COVID-19;Age.
Clinical progression of patients with COVID-19 in Shanghai, China;Age.
Epidemiological characteristics of confirmed COVID-19 cases in Tianjin;Age.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Age.
Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19;Age.
Case fatality risk of novel coronavirus diseases 2019 in China;Age.
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China;Age.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Age.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Age.
Clinical Presentation of COVID19 in Dementia Patients;Age.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Asthma.
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.;Asthma.
Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience;Asthma.
Asthma prolongs intubation in COVID-19;Asthma.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Asthma.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Asthma.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Asthma.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Asthma.
Clinical Characteristics of Covid-19 in New York City;Asthma.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Autoimmune disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Autoimmune disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Autoimmune disorders.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Cancer.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Cancer.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Cancer.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Cancer.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Cancer.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Cancer.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Cancer.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Cancer.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Cancer.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Cancer.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Cancer.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Cancer.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Cancer.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Cancer.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Cancer.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Cancer.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Cancer.
Cancer is associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis;Cancer.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Cancer.
Systematic investigations of COVID-19 in 283 cancer patients;Cancer.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Cancer.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Cancer.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Cancer.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Cancer.
Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City. Title: Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York;Cancer.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Cancer.
Outcomes of the 2019 Novel Coronavirus in patients with or without a history of cancer - a multi-centre North London experience;Cancer.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Cancer.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Cancer.
Factors associated with hospitalization and critical illness among 4,103 patients with;Cancer.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Cancer.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Cancer.
Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings;Cancer.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Cancer.
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis;Cancer.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Cancer.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Cardio- and cerebrovascular disease.
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors;Cardio- and cerebrovascular disease.
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study;Cardio- and cerebrovascular disease.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Cardio- and cerebrovascular disease.
Predicting COVID-19 malignant progression with AI techniques;Cardio- and cerebrovascular disease.
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China;Cardio- and cerebrovascular disease.
Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study;Cardio- and cerebrovascular disease.
Caution on Kidney Dysfunctions of COVID-19 Patients;Cardio- and cerebrovascular disease.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Cerebrovascular disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Cerebrovascular disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Cerebrovascular disease.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Cerebrovascular disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Cerebrovascular disease.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Cerebrovascular disease.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Cerebrovascular disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Cerebrovascular disease.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Cerebrovascular disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Cerebrovascular disease.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Cerebrovascular disease.
Systematic investigations of COVID-19 in 283 cancer patients;Cerebrovascular disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Cerebrovascular disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Cerebrovascular disease.
Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature;Cerebrovascular disease.
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28;Cerebrovascular disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Cerebrovascular disease.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Cerebrovascular disease.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up;Cerebrovascular disease.
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study;Cerebrovascular disease.
Prognostic value of C-reactive protein in patients with COVID-19;Cerebrovascular disease.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Cerebrovascular disease.
Epidemiological characteristics of confirmed COVID-19 cases in Tianjin;Cerebrovascular disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Cerebrovascular disease.
Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression;Cerebrovascular disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Cerebrovascular disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Cerebrovascular disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic digestive disorders.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic digestive disorders.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Chronic digestive disorders.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic digestive disorders.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Chronic digestive disorders.
Predicting COVID-19 malignant progression with AI techniques;Chronic digestive disorders.
Caution on Kidney Dysfunctions of COVID-19 Patients;Chronic digestive disorders.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Chronic kidney disease.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Chronic kidney disease.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Chronic kidney disease.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Chronic kidney disease.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Chronic kidney disease.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Chronic kidney disease.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19;Chronic kidney disease.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Chronic kidney disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic kidney disease.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Chronic kidney disease.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Chronic kidney disease.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Chronic kidney disease.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Chronic kidney disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic kidney disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Chronic kidney disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic kidney disease.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Chronic kidney disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic kidney disease.
When a nephrology ward becomes a COVID-19 ward: the Cremona experience;Chronic kidney disease.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Chronic kidney disease.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Chronic kidney disease.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Chronic kidney disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Chronic kidney disease.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Chronic kidney disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Chronic kidney disease.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Chronic kidney disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Chronic kidney disease.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Chronic kidney disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Chronic kidney disease.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Chronic kidney disease.
Systematic investigations of COVID-19 in 283 cancer patients;Chronic kidney disease.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Chronic kidney disease.
The Chronic Kidney Disease and Acute Kidney Injury Involvement in COVID-19 Pandemic: A Systematic Review and Meta-analysis;Chronic kidney disease.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Chronic kidney disease.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Chronic kidney disease.
ICU and ventilator mortality among critically ill adults with COVID-19;Chronic kidney disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Chronic kidney disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Chronic kidney disease.
Characterization and Clinical Course of 1000 Patients with COVID-19 in New York: retrospective case series;Chronic kidney disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic kidney disease.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Chronic kidney disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Chronic kidney disease.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;Chronic kidney disease.
Factors associated with hospitalization and critical illness among 4,103 patients with;Chronic kidney disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Chronic kidney disease.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic kidney disease.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Chronic kidney disease.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Chronic kidney disease.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Chronic kidney disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Chronic liver disease.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Chronic liver disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Chronic liver disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic liver disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic liver disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic liver disease.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Chronic liver disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Chronic liver disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic liver disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Chronic liver disease.
Systematic investigations of COVID-19 in 283 cancer patients;Chronic liver disease.
Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China;Chronic liver disease.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Chronic liver disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Chronic liver disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Chronic liver disease.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic liver disease.
Prognostic value of C-reactive protein in patients with COVID-19;Chronic liver disease.
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan China;Chronic liver disease.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Chronic respiratory diseases.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Chronic respiratory diseases.
Obesity and COVID-19: an Italian snapshot;Chronic respiratory diseases.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Chronic respiratory diseases.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-21;Chronic respiratory diseases.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Chronic respiratory diseases.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Chronic respiratory diseases.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Chronic respiratory diseases.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Chronic respiratory diseases.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Chronic respiratory diseases.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Chronic respiratory diseases.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic respiratory diseases.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Chronic respiratory diseases.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Chronic respiratory diseases.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Chronic respiratory diseases.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Chronic respiratory diseases.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Chronic respiratory diseases.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Chronic respiratory diseases.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Chronic respiratory diseases.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Chronic respiratory diseases.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Chronic respiratory diseases.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Chronic respiratory diseases.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Chronic respiratory diseases.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Chronic respiratory diseases.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Chronic respiratory diseases.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Chronic respiratory diseases.
Early prediction of mortality risk among severe COVID-19 patients using machine learning;Chronic respiratory diseases.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia;Chronic respiratory diseases.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Chronic respiratory diseases.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Chronic respiratory diseases.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Chronic respiratory diseases.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Chronic respiratory diseases.
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China;Chronic respiratory diseases.
Prognostic value of C-reactive protein in patients with COVID-19;Chronic respiratory diseases.
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study;Chronic respiratory diseases.
Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study [medrxiv];Chronic respiratory diseases.
Caution on Kidney Dysfunctions of COVID-19 Patients;Chronic respiratory diseases.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;COPD.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;COPD.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;COPD.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;COPD.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;COPD.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;COPD.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;COPD.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;COPD.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;COPD.
The impact of COPD and smoking history on the severity of COVIDâ€19: A systemic review and metaâ€analysis;COPD.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;COPD.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;COPD.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;COPD.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;COPD.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;COPD.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;COPD.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;COPD.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;COPD.
Systematic investigations of COVID-19 in 283 cancer patients;COPD.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;COPD.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;COPD.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;COPD.
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol;COPD.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;COPD.
Clinical Characteristics of Covid-19 in New York City;COPD.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;COPD.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;COPD.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;COPD.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;COPD.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;COPD.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;COPD.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;COPD.
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up [Journal of Infection];COPD.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;COPD.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;COPD.
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis [medrxiv];COPD.
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19);COPD.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;COPD.
Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection;COPD.
Prognostic value of NT-proBNP in patients with severe COVID-19;COPD.
Clinical Characteristics of Coronavirus Disease 2019 in China;COPD.
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis [medrxiv];COPD.
Clinical characteristics of 2019 novel coronavirus infection in China;COPD.
Obesity and COVID-19: an Italian snapshot;Dementia.
Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study;Dementia.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Dementia.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Dementia.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Dementia.
Clinical Presentation of COVID19 in Dementia Patients;Dementia.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Dementia.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Dementia.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Dementia.
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Diabetes.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Diabetes.
Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.;Diabetes.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Diabetes.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Diabetes.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Diabetes.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Diabetes.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Diabetes.
Obesity and COVID-19: an Italian snapshot;Diabetes.
Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients;Diabetes.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Diabetes.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Diabetes.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-23;Diabetes.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Diabetes.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Diabetes.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Diabetes.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Diabetes.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Diabetes.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Diabetes.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Diabetes.
Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study;Diabetes.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Diabetes.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Diabetes.
COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter;Diabetes.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Diabetes.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Diabetes.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Diabetes.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Diabetes.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Diabetes.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Diabetes.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Diabetes.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;Diabetes.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study;Diabetes.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Diabetes.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Diabetes.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Diabetes.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Diabetes.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Diabetes.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Diabetes.
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis Q1 patients with SARS-CoV-2 infection;Diabetes.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Diabetes.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Diabetes.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Diabetes.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Diabetes.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Diabetes.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Diabetes.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Diabetes.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Diabetes.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Diabetes.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Diabetes.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2024;Diabetes.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Diabetes.
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis;Diabetes.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Diabetes.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Diabetes.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Diabetes.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Diabetes.
Systematic investigations of COVID-19 in 283 cancer patients;Diabetes.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Diabetes.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Diabetes.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Diabetes.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Diabetes.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Diabetes.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Diabetes.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Diabetes.
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection;Diabetes.
Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China;Diabetes.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Diabetes.
Clinical determinants for fatality of 44,672 patients with COVID-19;Diabetes.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Diabetes.
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes;Diabetes.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Diabetes.
ICU and ventilator mortality among critically ill adults with COVID-19;Diabetes.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Diabetes.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Diabetes.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Diabetes.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Diabetes.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Diabetes.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Diabetes.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Diabetes.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Diabetes.
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis;Diabetes.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Drinking.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Drinking.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Drinking.
Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage;Drinking.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Endocrine diseases.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Endocrine diseases.
The clinical course and its correlated immune status in COVID-19 pneumonia;Endocrine diseases.
Caution on Kidney Dysfunctions of COVID-19 Patients;Endocrine diseases.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Ethnicity_ Hispanic vs. non-Hispanic.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Ethnicity_ Hispanic vs. non-Hispanic.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Ethnicity_ Hispanic vs. non-Hispanic.
Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history;Ethnicity_ Hispanic vs. non-Hispanic.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Ethnicity_ Hispanic vs. non-Hispanic.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Ethnicity_ Hispanic vs. non-Hispanic.
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans;Ethnicity_ Hispanic vs. non-Hispanic.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Ethnicity_ Hispanic vs. non-Hispanic.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Ethnicity_ Hispanic vs. non-Hispanic.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Ethnicity_ Hispanic vs. non-Hispanic.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Ethnicity_ Hispanic vs. non-Hispanic.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Ethnicity_ Hispanic vs. non-Hispanic.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Ethnicity_ Hispanic vs. non-Hispanic.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Ethnicity_ Hispanic vs. non-Hispanic.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Ethnicity_ Hispanic vs. non-Hispanic.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Ethnicity_ Hispanic vs. non-Hispanic.
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years;Ethnicity_ Hispanic vs. non-Hispanic.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Heart Disease.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Heart Disease.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Heart Disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Heart Disease.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Heart Disease.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Heart Disease.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Heart Disease.
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.;Heart Disease.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Heart Disease.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Heart Disease.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Heart Disease.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-20;Heart Disease.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Heart Disease.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Heart Disease.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Heart Disease.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Heart Disease.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Heart Disease.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Heart Disease.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Heart Disease.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Heart Disease.
COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter;Heart Disease.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Heart Disease.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Heart Disease.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Heart Disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Heart Disease.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Heart Disease.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Heart Disease.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Heart Disease.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Heart Disease.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Heart Disease.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Heart Disease.
Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 â€“ Systematic Review, Meta-analysis, and Meta-regression;Heart Disease.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Heart Disease.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Heart Disease.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Heart Disease.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Heart Disease.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Heart Disease.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Heart Disease.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Heart Disease.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Heart Disease.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Heart Disease.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Heart Disease.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Heart Disease.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Heart Disease.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Heart Disease.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Heart Disease.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Heart Disease.
Systematic investigations of COVID-19 in 283 cancer patients;Heart Disease.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Heart Disease.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2019;Heart Disease.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Heart Disease.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Heart Disease.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Heart Disease.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Heart Disease.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Heart Disease.
Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis;Heart Disease.
Clinical determinants for fatality of 44,672 patients with COVID-19;Heart Disease.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Heart Disease.
ICU and ventilator mortality among critically ill adults with COVID-19;Heart Disease.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Heart Disease.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Heart Disease.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Heart Disease.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Heart Disease.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Heart Disease.
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis;Heart Disease.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Heart Disease.
Clinical Characteristics of Covid-19 in New York City;Heart Disease.
Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts;Heart Disease.
Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui;Heart Disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Disease.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv];Heart Disease.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Disease.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis;Heart Disease.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Heart Disease.
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28;Heart Disease.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Heart Disease.
Factors associated with hospitalization and critical illness among 4,103 patients with;Heart Disease.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Heart Disease.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Heart Disease.
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis;Heart Disease.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Heart Disease.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Heart Failure.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Heart Failure.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Heart Failure.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Heart Failure.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Heart Failure.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Heart Failure.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Heart Failure.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Heart Failure.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Heart Failure.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Heart Failure.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Heart Failure.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Heart Failure.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Heart Failure.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Heart Failure.
ICU and ventilator mortality among critically ill adults with COVID-19;Heart Failure.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Heart Failure.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Heart Failure.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis;Heart Failure.
Factors associated with hospitalization and critical illness among 4,103 patients with;Heart Failure.
History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study;Heart Failure.
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort;Heart Failure.
Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV;Heart Failure.
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis;Hypertension.
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China;Hypertension.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Hypertension.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Hypertension.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Hypertension.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Hypertension.
Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19;Hypertension.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Hypertension.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Hypertension.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study;Hypertension.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Hypertension.
Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis;Hypertension.
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.;Hypertension.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Hypertension.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Hypertension.
Psychiatric Predictors of COVID-19 Outcomes in a Skilled Nursing Facility Cohort;Hypertension.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Hypertension.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-22;Hypertension.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Hypertension.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Hypertension.
Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences;Hypertension.
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis;Hypertension.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Hypertension.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Hypertension.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Hypertension.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Hypertension.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Hypertension.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Hypertension.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Hypertension.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19;Hypertension.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Hypertension.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.;Hypertension.
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.;Hypertension.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Hypertension.
The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis;Hypertension.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Hypertension.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.;Hypertension.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Hypertension.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Hypertension.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Hypertension.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Hypertension.
Clinical characteristics of patients diagnosed with COVID-19 in Beijing;Hypertension.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Hypertension.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Hypertension.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Hypertension.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Hypertension.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Hypertension.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Hypertension.
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence;Hypertension.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Hypertension.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Hypertension.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2022;Hypertension.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Hypertension.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Hypertension.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Hypertension.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Hypertension.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Hypertension.
Systematic investigations of COVID-19 in 283 cancer patients;Hypertension.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Hypertension.
Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea;Hypertension.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Hypertension.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China;Hypertension.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Hypertension.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Hypertension.
Hypertension and Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19;Hypertension.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Hypertension.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Hypertension.
Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection;Hypertension.
Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China;Hypertension.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Hypertension.
Clinical determinants for fatality of 44,672 patients with COVID-19;Hypertension.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Hypertension.
Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission;Hypertension.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Hypertension.
Characterization of clinical progression of COVID-19 patients in Shenzhen, China;Hypertension.
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes;Hypertension.
ICU and ventilator mortality among critically ill adults with COVID-19;Hypertension.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Hypertension.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Hypertension.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Hypertension.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Hypertension.
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients;Hypertension.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Hypertension.
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy;Hypertension.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Immune system disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Immune system disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Immune system disorders.
The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails;Immune system disorders.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Immune system disorders.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Immune system disorders.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Male gender.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Male gender.
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study;Male gender.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.;Male gender.
The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort;Male gender.
Anakinra for severe forms of COVID-19: a cohort study;Male gender.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Male gender.
Obesity and COVID-19: an Italian snapshot;Male gender.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Male gender.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Male gender.
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19;Male gender.
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-24;Male gender.
Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases;Male gender.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Male gender.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Male gender.
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study;Male gender.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Male gender.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Male gender.
Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study;Male gender.
Clinical characteristics of patients diagnosed with COVID-19 in Beijing;Male gender.
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China;Male gender.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea;Male gender.
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City;Male gender.
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19;Male gender.
Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored;Male gender.
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019;Male gender.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Male gender.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Male gender.
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.;Male gender.
Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center Report;Male gender.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Male gender.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2021;Male gender.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Male gender.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Male gender.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Male gender.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Male gender.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Male gender.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Male gender.
Longitudinal association between markers of liver injury and mortality in COVIDâ€19 in China;Male gender.
Incidence of venous thromboembolism in hospitalized patients with COVID-20;Male gender.
Cohort profile: Preliminary experience of 500 COVID-19 postive cases at a South West London District General Hospital.;Male gender.
Characteristics of COVID-19 infection in Beijing;Male gender.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Male gender.
Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China;Male gender.
Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals;Male gender.
Gender-Based Disparities in COVID-19: Clinical Characteristics and Propensity-matched Analysis of Outcomes;Male gender.
Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection;Male gender.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Male gender.
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China;Male gender.
Clinical determinants for fatality of 44,672 patients with COVID-19;Male gender.
Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients;Male gender.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Male gender.
Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China;Male gender.
"Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up";Male gender.
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes;Male gender.
No Clear Benefit to the Use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study;Male gender.
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes.;Male gender.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Male gender.
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients;Male gender.
Impact of blood analysis and immune function on the prognosis of patients with COVID-19;Male gender.
Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology];Male gender.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Male gender.
Early prediction of mortality risk among severe COVID-19 patients using machine learning;Male gender.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Male gender.
Clinical Characteristics of Covid-19 in New York City;Male gender.
Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts;Male gender.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Male gender.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Male gender.
Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis [medrxiv];Male gender.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Male gender.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Male gender.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv];Male gender.
Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study;Male gender.
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China First Authors;Male gender.
The clinical course and its correlated immune status in COVID-19 pneumonia;Male gender.
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severity and mortality in adult COVID-19 1 inpatients in Wuhan;Male gender.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Male gender.
Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China;Male gender.
Factors associated with hospitalization and critical illness among 4,103 patients with;Male gender.
Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool;Male gender.
Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression;Male gender.
Blood glucose is a representative of the clustered indicators of multi-organ injury for predicting mortality of COVID-19 in Wuhan China;Male gender.
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis;Male gender.
Compassionate Use of Remdesivir for Patients with Severe Covid-19;Male gender.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Neurological disorders.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Neurological disorders.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Neurological disorders.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Neurological disorders.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Neurological disorders.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Neurological disorders.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Overweight or obese.
Obesity and COVID-19: an Italian snapshot;Overweight or obese.
Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort;Overweight or obese.
COVID-19: Impact of Obesity and Diabetes in Disease Severity;Overweight or obese.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Overweight or obese.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Overweight or obese.
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.;Overweight or obese.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Overweight or obese.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Overweight or obese.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Overweight or obese.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Overweight or obese.
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France;Overweight or obese.
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Overweight or obese.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Overweight or obese.
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy;Overweight or obese.
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China;Overweight or obese.
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.;Overweight or obese.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Overweight or obese.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2026;Overweight or obese.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Overweight or obese.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Overweight or obese.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Overweight or obese.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Overweight or obese.
Key predictors of attending hospital with COVID19: An association study from the COVID Symptom Tracker App in 2,618,948 individuals;Overweight or obese.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Overweight or obese.
Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease;Overweight or obese.
Clinical Characteristics of Covid-19 in New York City;Overweight or obese.
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS;Overweight or obese.
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio;Overweight or obese.
Factors associated with hospitalization and critical illness among 4,103 patients with;Overweight or obese.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Overweight or obese.
Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission;Overweight or obese.
High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation;Overweight or obese.
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China;Overweight or obese.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Overweight or obese.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Overweight or obese.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Race_ Asian vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Asian vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Asian vs. White.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Race_ Asian vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Asian vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Asian vs. White.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Race_ Asian vs. White.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Race_ Asian vs. White.
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System;Race_ Black vs. White.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019;Race_ Black vs. White.
Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people;Race_ Black vs. White.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Race_ Black vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Black vs. White.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Race_ Black vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Black vs. White.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Race_ Black vs. White.
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Race_ Black vs. White.
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans;Race_ Black vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Black vs. White.
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter;Race_ Black vs. White.
Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area;Race_ Black vs. White.
Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study;Race_ Black vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Black vs. White.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Race_ Black vs. White.
Pre-Existing Characteristics Associated with Covid-19 Illness Severity;Race_ Black vs. White.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Race_ Black vs. White.
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System Short COVID-19 Infection in Heart Failure Corresponding Author;Race_ Black vs. White.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Race_ Black vs. White.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Race_ Black vs. White.
Estimating Survival of Hospitalized COVID-19 Patients from Admission Information;Race_ Black vs. White.
ICU and ventilator mortality among critically ill adults with COVID-19;Race_ Black vs. White.
Clinical Characteristics of Hospitalized Covid-19 Patients in New York City;Race_ Black vs. White.
The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities;Race_ Black vs. White.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Race_ Other vs. White.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Race_ Other vs. White.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Race_ Other vs. White.
Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study;Race_ Other vs. White.
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom;Race_ Other vs. White.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Race_ Other vs. White.
Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort;Race_ Other vs. White.
ICU and ventilator mortality among critically ill adults with COVID-19;Race_ Other vs. White.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Respiratory system diseases.
Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis;Respiratory system diseases.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Respiratory system diseases.
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection];Respiratory system diseases.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Respiratory system diseases.
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis;Respiratory system diseases.
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis;Respiratory system diseases.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Respiratory system diseases.
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19;Smoking Status.
COVID-19 with Different Severities: A Multicenter Study of Clinical Features;Smoking Status.
Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.;Smoking Status.
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Smoking Status.
Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET);Smoking Status.
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.;Smoking Status.
Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19;Smoking Status.
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis;Smoking Status.
Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York;Smoking Status.
Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience;Smoking Status.
Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico;Smoking Status.
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.;Smoking Status.
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.;Smoking Status.
Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.;Smoking Status.
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis;Smoking Status.
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.;Smoking Status.
Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis;Smoking Status.
Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2025;Smoking Status.
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study;Smoking Status.
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study;Smoking Status.
Risk Factors of the Severity of COVID-19: A Meta-Analysis;Smoking Status.
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes;Smoking Status.
Systematic investigations of COVID-19 in 283 cancer patients;Smoking Status.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19;Smoking Status.
Association of Obesity with Disease Severity among Patients with COVIDâ€19;Smoking Status.
Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.;Smoking Status.
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis;Smoking Status.
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.;Smoking Status.
Smoking is Associated with COVID-19 Progression: A Meta-Analysis;Smoking Status.
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study [medrxiv];Smoking Status.
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Smoking Status.
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score;Smoking Status.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Smoking Status.
The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis;Smoking Status.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep];Smoking Status.
Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis;Smoking Status.
Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19;Smoking Status.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China;Smoking Status.
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis;Smoking Status.
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China;Smoking Status.
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China;Smoking Status.
Prognostic value of C-reactive protein in patients with COVID-19;Smoking Status.
Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence;Smoking Status.
Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship Â“Diamond PrincessÂ” in Japan;Smoking Status.
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan;Smoking Status.
Tobacco Induced Diseases COVID-19 and smoking: A systematic review of the evidence;Smoking Status.
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan;Smoking Status.
Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis;Smoking Status.
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19);Smoking Status.
Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study;Smoking Status.
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Smoking Status.
Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study;Smoking Status.
Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China;Smoking Status.
Clinical Characteristics of Coronavirus Disease 2019 in China;Smoking Status.
Clinical characteristics of 2019 novel coronavirus infection in China;Smoking Status.
